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ABSTRACT 
The term “click chemistry” was first coined by Sharpless and co-workers in 2001 
1
 and encompasses a range of high yielding organic coupling reactions which are 
rapid, highly selective and proceed with good functional group tolerance. 
Furthermore the reaction conditions are mild and require minimal workup and 
product purification. The most prominent example of these reactions is the copper 
catalysed alkyne/azide cycloaddition (CuAAC) for the formation of 1,4-
disubstituted-1,2,3-triazoles. 2, 3 CuACC has been utilised in a variety of chemical 
disciplines including organic synthesis, the modification of biological 
macromolecules 4 and in polymer and materials chemistry. 5-7 More recently this 
reaction has shown a growing interest from the inorganic community for the 
design of new ligands for transition metal complexes 8-10 and their supramolecular 
assemblies.11-13 
In this thesis, I present my results on the use of the 'click' chemistry in 
coordination and supramolecular chemical applications.  
Described in chapter 3 is the synthesis of 1,4-disubstituted-1,2,3-triazole ligands 
which can act as either axial monodentate ligands, through the N3 atom of the 
triazole ring, or as bidentate N^N donor ligands if a pyridyl substituent is 
incorporated into a chelate ligand framework. The photophysical effects of these 
ligands were investigated on rhenium tricarbonyl complexes. It was found that 
replacing the Cl- ligand by the triazole stabilises the energy of the HOMO with 
respect to the LUMO and results in a blue shift of the emission maximum whilst 
changing the bidentate ligand by replacing the bipyridyl ligand by pyridine-
triazole ligand elevates the LUMO with respect to the HOMO again resulting in a 
blue shift in luminescence.  
Described in chater 4 is the synthesis of 4-azido-2,2’-bipyridyl and 4,4’-diazido-
2,2’-bipyridyl ligands and the CuAAC modification thereof. 4-azido-2,2’-
bipyridyl was incorporated in to [Ru(p-cymene)( 4-azido-2,2’-bipyridyl)Cl]+ type 
complexes. The CuAAC reaction was utilised to chemi
 iii 
of a metal complex when an azido substituted ligand is allowed to react with a 
range of alkynes. Through this approach a second metal binding domain can 
easily be introduced upon reaction with 2-pyridyl acetylene. [Ru(p-cymene)( 4-
azido-2,2’-bipyridyl)Cl]+ and “click” chemistry can be used as a potential tool in 
building metallo-supramolecular species. We have therefore made some of the 
first steps towards the goal of the development of a general “click” chemistry-
based methodology for the construction of functional supramolecular architectures 
via azide-functionalised transition metal complexes.  
Desciribed in chapter 5 is the preperation of 1,2,3-triazole bridged luminescent 
redox switches. Ruthenium, iridium and rhenium complexes incorporating 
ferrocenyl-bipyridyl ligand in which the ferrocene unit is tethered to the bipyridyl 
through a 1,2,3-triazole linkage were prepared. We have developed two potential 
luminescent switches with ferrocene tagged bipyridyl ligands containing a 
CuAAC derived triazole linker. The ferrocene moiety quenches the Ru/Ir based 
luminescent emission, presumably by electron transfer across the triazole bridge. 
We have demonstrated that the luminescent emission can be switched on by 
oxidation of the Fc moiety to Fc+.  
Described in chapter 6 is the synthesis and characterisation of a range of ligands, 
incorporating the 1,2,3-triazole moiety, which have designed to act as bridging 
ligands for the construction of supramolecular assemblies. We have subsequently 
prepared two dinuclear ruthenium and iridium complexes of the 4-pyridyl-1-(2,2’-
bipyrid-4-yl)-1,2,3-triazole bridging ligand, and carried photophysical studies. We 
have shown that the dinuclear species exhibit greater luminescent intensities than 
mono-nuclear model complexes because the metal centre coordinated to the 
pyridine-triazole domain acts as a sensitizer for the metal centre coordinated to the 
bipyridyl domain through a photoinduced energy transfer mechanism. This shows 
that there is efficient transfer across the bridging ligand. 
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1 INTRODUCTION 
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1.1 Introduction 
The synthesis and preparation of photo- and redox-active transition metal 
complexes and their supramolecular architectures has become an area of intense 
interest. The strong interest in this area stems from the potential application of 
these materials for the modelling of energy transfer processes in biological 
photosynthesis, the development of new light harvesting photocatalysts and novel 
materials for solar energy conversion. Therefore reactions that enable the facile 
routes to modular construction of new ligands and these architectures are 
particularly useful in the development of such materials.   
A series of such candidate coupling reactions exist and fall under the umbrella 
term of ‘click’ chemistry. 1, 3 The predominant reaction within this category is the 
copper catalysed azide-alkyne cycloaddition (CuAAC) reaction to form 1,2,3-
triazoles. 
Here, the general principles of ‘click’ chemistry are introduced with a focus on 
CuAAC and its applications in transition metal coordination chemistry. 
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1.2 Click Chemistry 
The term “click chemistry” was first coined by Professor K. Barry Sharpless and 
co-workers in 2001 1 who defined a set of stringent criteria which must be adhered 
to for a reaction to be considered a “click” reaction.  The reaction must be 
efficient and high yielding, modular and wide in scope, generate few or no side 
products and where the derived product can easily be isolated, ideally without the 
use of chromatographic techniques. 
Furthermore Sharpless et al. also discussed the criteria with regards to reaction 
conditions for an ideal “click” reaction; the reaction must be simple and 
insensitive to both oxygen and water, the starting materials must be readily 
available or accessible and the reaction should be carried out with no solvent or a 
solvent that is benign or easily removed. The product should also be stable under 
physiological conditions (as much of the early work focused on potential for 
biologically active molecules).  
Therefore it can be said that the term “click” chemistry can be used to define any 
chemical process that is simple and efficient. Furthermore we can say that the idea 
of “click” chemistry is not a new type of chemistry, but it is a concept, which 
groups a variety of reactions which can create a wide range of complex molecules 
in a very efficient manner.  
Although the criteria for “click” reactions are quite specific, there are a number of 
reactions which have been identified as good “click” reactions. These include 
nucleophilic substitution reactions, particularly ring opening reactions of strained 
 4 
heterocyclic electrophiles such as epoxides, aziridines, aziridinium ions etc., 
carbonyl chemistry of the “non-aldol” type such as formation of ureas, aromatic 
heterocycles, oxime ethers etc., additions to carbon-carbon multiple bonds, such 
as epoxidation, dihydroxylation etc., Michael additions of Nu-H reactants and 
finally cycloaddition reactions such as 1,3-dipolar cycloaddition reactions and 
Diels-Alder transformations (Figure 1.1). 
 
[O]
[O]
Cu(I)
CatalystDiels-AlderCycloaddition
C=C Additions
Nucleophilic
Ring Opening
Non-Aldol
Carbonyl Chemistry
Cu(I) Catalysed 1,3-dipolar
Cycloaddition
Natural Sources
 
Figure 1.1 A selection of reactions which match the “click chemistry” 
criteria.   
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1.2.1 Copper catalysed azide-alkyne cycloaddition (CuAAC) 
The most widely known and utilised ‘click’ reaction is the copper catalysed azide-
alkyne cycloaddition (CuAAC) for the synthesis of 1,2,3-triazoles which occurs 
by the 1,3-dipolar cycloaddition of organic azides to terminal alkynes. The 
thermally induced [3+2] cycloaddition between alkynes and organic azides was 
discovered in 1893 14 and the reaction was studied extensively  in the 1960’s 15, 16 
by Huisgen and co-workers. This 1,2,3-triazole formation was traditionally an 
uncatalysed reaction which results in the formation of the two regioisomeric, 1,4- 
and 1,5-disubstituted-1,2,3-triazole products (Figure 1.2). The 1,4- and the 1,5-
disubstituted isomers are formed in approximately a 1:1 molar ratio and 
furthermore when it was originally reported the experimental conditions  did not 
satisfy the criteria of a click reaction as it required long reaction times and 
elevated temperatures. 
 

 
Figure 1.2 Uncatalysed 1,3-dipolar cycloaddition of organic azides to alkynes 
to yield 1,4- and 1,5-substituted-1,2,3-triazoles. 
  
 6 
In 2002 the groups of Sharpless2 and Meldal17 independently reported a modified 
version of this reaction, in which they used a copper(I) catalyst, with a resultant 
increase in the rate of the reaction by approximately 107 fold and allowed the 
reaction to be carried out at room temperature. 18, 19 The introduction of a copper 
catalyst also resulted in the formation of exclusively the 1,4-disubstituted-1,2,3-
triazole regioisomer in very high yields with few or no side products (Figure 1.3). 
Furthermore, steric or electronic factors do not have a significant effect on the 
reaction which is also tolerant of a wide range of functional groups. Alkyne and 
azide functionality can easily be incorporated into a wide range of compounds, 
and the use of protecting groups is not required. The reaction also proceeds 
efficiently in water as well as organic solvents, with almost complete conversion 
and selectivity for the 1,2,3-triazole product which is often easily isolable by 
simple filtration. The resultant 1,2,3 triazole is also a very stable moiety and is 
unaffected by oxidation, reduction and hydrolysis. The reaction has been utilised 
in many different areas of chemistry 3 and is fast becoming the synthetic method 
of choice in materials synthesis, 20-24 polymer synthesis, 25-28 interlocked 
architectures, 29-32 bioconjugation 6, 21, 33-37 and drug discovery 6, 37 
Cu(I)
 
Figure 1.3 The copper catalysed azide-alkyne cycloaddition (CuAAC) 
resulting in the formation of exclusively the 1,4-disubstituted-1,2,3-triazole 
regioisomer.  
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1.2.1.1 General CuAAC reaction conditions 
The CuAAC reaction is an extremely robust and versatile reaction therefore a vast 
number of successful experimental variations have been developed and a wide 
range of copper sources have been exploited. Sharpless and co-workers carried 
out their original work using CuSO4 or Cu(OAc)2 as the source of copper. These 
copper compounds were used in conjunction with sodium ascorbate as a reducing 
agent to generate Cu(I) in situ in an aqueous environment. 2 Since this original 
publication, alternative sources of copper have been utilised due to the specific 
reaction conditions, for example CuI has been shown to be a more desirable 
source of copper when the CuAAC reaction is carried out in organic solvents (e.g. 
CH3CN, DMF, DMSO, THF). Yoo et al. 38 have shown that a catalytic quantity of 
CuI results in formation of the desired 1,4-disubstitued-1,2,3-triazole in non-
aqueous conditions, however, use of a base is required (typically an N-donor base 
such as 2,6-lutidine) in order to promote the generation of an intermediate copper 
acetylide. 39  Alternative sources of copper which have been utilised in the 
CuAAC reaction include; metallic copper Cu(0), 40, 41 copper nano particles, 42 
and copper catalysts immobilised on solid supports43.  
To date, most CuAAC syntheses are carried out at room temperature, however, 
when the temperature of the reaction is increased using a microwave reactor, the 
time required for the reaction can be drastically decreased with no detrimental 
effect to the desired products.18, 44  Substrate concentrations seem not to be 
important on the outcome of the CuAAC reaction3 as there have been reports 
using both very dilute concentrations up to neat concentrations. 
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CuAAC reactions to prepare triazoles with the potential for metal chelation, can 
result in problems with regards to isolation of the pure product due to copper 
coordination. For compounds which are soluble in organic solvents the most 
effective method of purification is liquid-liquid extraction. Washing with aqueous 
ammonia solution or ethylenediaminetetraacetic acid (EDTA) solution is the most 
commonly used method for the extraction of copper from the reaction media, in 
both liquid and solid phases. 12, 17, 45 Removing the copper from the reaction media 
has also been undertaken with the use of commercially available metal scavenger 
resins. 46 However, to date there have been numerous publications which have 
employed the CuAAC reaction to prepare multidentate products which have been 
isolated and in good yields. 46, 47   
The introduction of coligands in order to accelerate CuAAC reactions has also 
been widely studied. Although metal stabilizing ligands are not essential for the 
catalytic activity of Cu(I) in the CuAAC reaction, they have often been employed 
to enhance the rate of the reaction and to protect the Cu(I) from oxidation to 
Cu(II) and/or disproportionation to Cu(0) and Cu(II). 48, 49 Protecting the catalyst 
from oxidation is beneficial, to ensure that there is a sufficient concentration of 
the catalyst throughout the time scale of the reaction. Whilst carrying out early 
mechanistic studies Fokin et al. discovered that the rates of reaction for the 
formation of certain polyvalent products were unusually high and that these 
reactions seemed to be autocatalytic. They hypothesized based on their results that 
the resulting polytriazole products, were acting as rate-accelerating ligands for the 
Cu(I) catalyst. 47 On  testing a range of metal stabilising ligands for a model 
reaction between phenyl acetylene and benzyl azide, ligands that were found to be 
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the best performing ligands shared a similar oligotriazole structural motif based 
on cycloaddition to a propargylamine core (Figure 1.4). Tris-
(benzyltriazolymethyl)amine (TBTA) was identified as being most efficient 
ligand in this family for accelerating the rate of CuAAC reactions. After further 
comparing the rate-accelerating ability of TBTA to other polydentate ligands, 
Finn et al. concluded that tris-(2-benzimidazolylmethyl)amines are also promising 
rate accelerating ligands as they gave considerable improvements in both rate and 
yield. 50, 51  
TBTA
 
Figure 1.4 A selection of metal stabilising ligands which have been used to 
enhance the rate of reaction for the CuAAC reaction. 
Well defined Cu(I) complexes with N-heterocyclic carbene (NHC) ligands have 
successfully been used as catalysts for CuAAC reactions. Díez-González et al. 
have shown that using NHC copper(I) complexes yields 1,4-disubstituted products 
in excellent yields52, 53 (Figure 1.5). 
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Figure 1.5 A selection of N-heterocyclic carbene complexes which have been 
used as catalysts for CuAAC reactions. 
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1.2.1.2 One-Pot CuAAC reactions 
In the previously discussed methodologies pre-prepared azides and alkynes were 
synthesised and isolated prior to their use in CuAAC reactions. However low 
molecular weight azides are often thermally and shock sensitive and may 
detonate. In an effort to improve the efficiency, scope and safety of the CuAAC 
reactions a number of groups have developed one-pot CuAAC methodologies in 
which either the alkyne or azide reactants are generated in situ and reacted 
immediately without isolation or purification. 
Crowley 11, 12 and Schubert 10, 54 have shown that organic azides can be generated 
in situ from their corresponding halides or boronic acids, and then further reacted 
with terminal alkynes in a one pot CuAAC reaction. Crowley and co-workers 
utilised the one-pot CuAAC methodology for the safe generation of benzyl-, 
alkyl- and aryl-substituted 2-(1H-1,2,3-triazol-4-yl)pyridine and 2,6-bis(1H-1,2,3-
triazol-4-yl)pyridine ligands. Exploiting the conditions that were developed by 
Folkin, 55 the benzyl- and alkyl-substituted ligands were synthesised using, 
sodium azide and the appropriate alkyl halide.  
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Fletcher et al. have shown that trimethylsilyl (TMS) -protected alkynes can be 
deprotected in situ and then “clicked” to preformed organic azides to form bi-, tri- 
and quadridentate pyridyltriazole ligands in excellent yields. They have also 
shown that commercially available 1,4-bis(trimethylsilyl)butadiyne can be 
deprotected in situ for the convenient synthesis of 4,4’-bis-1,2,3-triazolyl ligands, 
without the need for preparation of unstable gaseous butadiyne (Figure 1.6). 56 
2.0 R-N3
2.0 K2CO3
0.4 CuSO4
0.8 Na Ascorbate
t-BuOH/H2O
10 pyridine
24 hours
 
Figure 1.6 Tandem in situ deprotection of bis(trimethylsilyl)butadiyne and 
“click” reaction to synthesise 4,4’-bis-1,2,3-triazolyl ligands. 
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1.2.1.3 Mechanism for CuAAC reaction 
The significant rate enhancement observed under Cu(I) catalysis with respect to 
the uncatalysed reaction is best explained by a stepwise cycloaddition mechanism, 
catalysed by a Cu(I) species which lowers the activation barrier relative to the 
uncatalysed reaction by as much as 11 kcal mol-1. 39, 40 Mononuclear and dinuclear 
mechanisms have been proposed (Figure 1.7) which are first order and second 
order with respect to copper respectively. In both mechanisms the first step 
involves the formation of a copper acetylide intermediate. In the first order 
mechanism the acetylide formed is thought to be capable of immediately forming 
an acetylide-azide complex, while in the second order mechanism a second copper 
centre is required to activate the azide. The copper acetylide-azide complexes then 
undergo cyclisation and formation of a metallocycle through nucleophilic attack 
on the acetylide by the azide group. Finally, ring contraction occurs to yield a 
copper triazolide intermediate which eliminates the product triazole upon 
protonation (Figure 1.7).  
  
 14 
A)
 
B)
2
2
 
Figure 1.7 Proposed catalytic cycles for the stepwise CuAAC reaction A) First 
order with respect to copper; and B) second order with respect to copper. 
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1.2.2 Ruthenium catalysed azide-alkyne cycloaddition (RuAAC) 
Fokin et al. 57 have shown that ruthenium pentamethylcyclopentadienyl 
complexes can be used as efficient catalysts for the regioselective formation of the 
alternative 1,5-disubstituted-1,2,3-triazole (Figure 1.6). For example 
[Cp*RuCl(PPh3)2], [Cp*RuCl2]2 and [Cp*RuCl(COD)]. Whist the scope and 
functional group tolerance of RuAAC reaction are excellent, the reaction is more 
sensitive to the choice of solvent and the steric demands of the azide reactant than 
in CuAAC reactions. As such, it has not yet been applied as widely. 58-60  
 
Figure 1.8 The ruthenium catalysed azide-alkyne cycloaddition (RuAAC) 
resulting in the formation of exclusively the 1,5-disubstituted-1,2,3-triazole 
regioisomer 
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1.3 Coordination chemistry of CuAAC derived ligands 
Whilst the coordination chemistry of 1,2,4-triazoles 61-67 and the unsubstituted 1H-
1,2,3-triazole 61, 67 have been extensively explored, metal complexes of 1,2,3-
triazoles remained relatively unexplored until recently. The majority of reported 
applications of the CuAAC reaction had utilised the 1,2,3-triazole moiety as a 
stable linker unit for two chemical or biochemical components, with little 
attention being paid to the heterocycle itself. This is despite the fact that the 1,4-
disubstituted-1,2,3-triazole is similar in terms of molecular dimension and 
planarity to amide bonds, and is expected to have similar coordination properties 
to substituted imidazole 37, 46, 68 for example. The 1,4-disubstitued-1,2,3-triazole 
moiety has enormous potential for metal coordination. 69 The triazole can act as a 
N-donor ligand through the more basic N3 position but coordination could also 
occur through the N2 atom (Figure 1.9). In addition coordination can also occur 
through the C5 position in anionic triazolides or mesoionic triazolylidene NHCs. 
 Since 2007 there has been a rapid increase in the use of 1,4-disubstitued-1,2,3-
triazole as ligands derived through CuAAC reactions.   



	
	
 
Figure 1.9 The potential metal coordination sites of 1,4-disubstitued-1,2,3-
triazole ligands   
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The remainder of this section forms a systematic review of the use of triazole-
based “click” chemistry in coordination chemistry.  
1.3.1 1,4-Disubstituted-1,2,3-Triazoles as Monodentate N-Donor Ligands  
Van Köten and co-workers have used the CuAAC reaction to prepare 1,4-
disubstituted-1,2,3-triazoles as tuneable monodentate ligands for aryl diamine 
cyclometalated pincer complexes of Pd and Pt (Figure 1.10). 70 An X-ray crystal 
structure of a Pd complex showed that coordination to the metal occurs through 
the N3 atom of the triazole ring. The coordination behaviour of the triazole in the 
complex was studied by variable temperature 1H NMR spectroscopy. These 
experimental observations indicate that at room temperature intermolecular 
triazole ligand exchange at Pd is fast on the NMR timescale while exchange for 
the corresponding Pt complexes is much slower throughout the temperature scale 
studied. In order to assess the relative coordination strength of the triazole ligand, 
competitive ligand exchange experiments were carried out with more common 
Lewis bases such as H2O, triphenylphosphine, 1-methylimidazole, diethylsulfide, 
dimethylsulfoxide, aniline, acetonitrile and pyridine. The data show that the 
triazole ligand is a better ligand than H2O, dimethylsulfoxide and acetonitrile, 
comparable in strength to aniline and a slightly weaker donor than pyridine. It was 
found that by varying the substituents of the triazole the relative binding strength 
of these ligands could be tuned. 
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Figure 1.10 Structure of monodentate 1,4-disubstituted-1,2,3-triazoles N^C^C 
pincer complexes. 
Following on from this work Astruc et al. 71 prepared three novel ligands 
containing either one, two or three ferrocenyl triazole moieties, starting from the 
corresponding azidomethylbenzene and ethynylferrocene.71 The 
mono(ferrocenyltriazole) ligand was reacted with [PdCl2(C6H5CN)2] to yield a 
trans bis triazole complex in which the triazole ligands are again coordinated to 
the metal through the N3 of the triazole position. The X-ray crystal structure is 
shown in Figure 1.11.  
 
Figure 1.11 Molecular structure of trans-[PdCl2L2] (L= 1-({4-
methoxylphenyl}methyl-4-ferrocenyl-1,2,3-triazole))71 
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When 1H NMR spectra were recorded in d6-dimethylsulfoxide solutions the 
complexes were found to exist in equilibrium with free ligand and a monotriazole 
solvento complex.  
Crowley and co-workers have reported that di-1,4-substituted-1,2,3-triazole 
ligands can be used as pyridine surrogates to self-assemble coordinatively 
saturated, quadruply stranded helicate cages with Pd(II) ions. 13 The species are 
stable in both solution and solid-state as they have been fully characterised by 
NMR, HRMS and X-ray crystallography. X-ray crystallography again shows 
coordination to the metal through the more basic N3 atom of the triazole ring. 
In one final example Osuka, Shinokubo and co-workers have synthesised 1,4-
disubstituted-1,2,3-triazole appended Zn(II)-porphyrin complexes. NMR studies 
show that the complexes dimerise in solution and X-ray crystallography shows 
that dimerisation is driven by bridging coordination of the pendant 1,4-
disubstituted-1,2,3-triazole to Zn of a second porphyrin complex. As with the 
other complexes of a similar type the triazole is coordinated to the metal through 
the N3 of the triazole. 72  
There are a number of other reported 1,4-disubstituted-1,2,3-triazole metal 
complexes in which monodentate coordination is assumed, however none of these 
compounds have been structurally characterised, and therefore it is not known 
whether coordination to the 1,4-disubstituted-1,2,3-triazole is through the N2 or 
the N3 of the 1,2,3-triazole. 72-78  
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1.3.2 1,4-Disubstituted-1,2,3-Triazoles as Bridging N-Donor Ligands 
Related ligands to 1,4-disubstituted-1,2,3-triazoles with neighbouring nitrogen 
donor atoms, such as pyrazolates and 1,2,4-triazole have been widely used as 
bridging ligands. Therefore it is surprising that only one report of 
crystallographically characterised complexes containing bridging-1,2,3-triazole 
ligands has appeared. Crowley and co-workers have prepared two silver 
complexes, which display the same dinuclear core in which the two silver ions are 
bridged by two 1,4-disubstituted-1,2,3-triazole units 79 (Figure 1.12). 
 
Figure 1.12 1,2,3-triazole bridged silver complex 
Steel et al. 80 have prepared a series of ruthenium complexes in which they 
utilised an anionic 1,2,3-triazolate based ligand to bridge two metal centres. The 
new ligand was prepared by the reaction of di(pyrid-2-yl)acetylene and 
azidotrimethylsilane. This is not strictly “click” chemistry however it is copper 
catalysed. The new ligand was analysed by X-ray crystallography and it was 
found that in the solid state the ligand exists in a zwitterionic form. When the 
ligand was reacted with excess [Ru(bpy)2Cl2] a dinuclear complex was formed 
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and found to exist in an approximate 1:1 ratio as two diastereoisomers (meso and 
rac) isomers could easily be separated using column chromatography. Reaction of 
the ligand with one equivalent of [Ru(bpy)2Cl2] led to the mononuclear complex 
leaving one of pyridyl-triazole domains vacant. The X-ray crystal structure 
(Figure 1.13) of the dinuclear complex was obtained and it was noted that the 
plane of the dipyridyltriazolate ligand is somewhat distorted with deviation from 
coplainarity of the pyridyl and triazolate rings. The electronic absorption spectra 
and redox potentials of the complex were also measured and the mononuclear 
complex was more readily oxidised than [Ru(bpy)3]2+ and was significantly harder 
to reduce. The difference in the first oxidation potential and the red-shifted 
absorption indicates a smaller HOMO-LUMO gap than that of [Ru(bpy)3]2+. The 
two stereoisomers of the dinuclear complex both show well separated oxidation 
potentials indicating a strong metal-metal interaction. 
 
 
Figure 1.13 Molecular structure of [{Ru(bpy)2}2L]n+ (L= 4,5-di(pyrid-2-yl)-
1,2,3-triazolate) 80 
 22 
1.3.3 1,4-Disubstiuted-1,2,3-Triazoles as Monodentate C-Donor Ligands  
The most favoured metal coordination sites of the 1,4-disubstitued-1,2,3-traizole 
is the N2 and N3 of the triazole ring however as discussed previously there is the  
potential for functionalisation at the C5 position. Due to the relatively acidic 
nature of the hydrogen atom at C5 it can be relatively easily be deprotonated and 
yield anionic 1,4-disubstituted-1,2,3-triazolide ligands. Straub and co-workers 
successfully isolated a copper 1,4-disubstituted-1,2,3-triazolide complex. The 
complex was prepared by reacting a bulky copper acetylide with azidodi-4-
tolylmethane and the molecular structure of the complex was confirmed through 
X-ray crystallography. In this work they state that this copper complex is an 
isolated intermediate in the catalytic cycle of the CuAAC. 81 Furthermore they 
demonstrated that this copper complex showed catalytic activity for the CuAAC 
reaction, providing strong evidence for the role of the 1,2,3-triazolide intermediate 
in the catalytic mechanism. Another example of this C5 coordination of the 
triazole ring was demonstrated by Gray and co-workers, 82 who prepared a family 
of luminescent gold 1,2,3-triazolide complexes. (Figure 1.14) Excitation at 312 
nm leads to dual emission, a shorter-wavelength emission peak near 383 nm and a 
longer-wavelength, O2-quenchable emission near 475 nm. Time-resolved 
measurements at 77 K find that the emissions near 475 nm last from hundreds of 
microseconds to tens of milliseconds. 
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Figure 1.14 Molecular structure of luminescent gold-1,2,3-triazolide 
complexes82 
Gandelman et al. also investigated the uses of the 1,2,3-triazole as a potential 
pincer ligand. 83 Here, they synthesised a range of 1,4-disubstituted-1,2,3-triazoles 
with donor substituents using the copper catalysed reaction, and utilised the 
relatively acidic C-H of the triazole for insertion by the metal in analogous 
fashion to more established 1,3-disubstituted phenyl based systems. 
Representative example ligand precurseors that were prepared by this approach 
included PCP-, PCN- and PCS-. The new pincer ligands demonstrate typical 
tridentate coordination upon reaction with late-transition metals. The molecular 
structure of one of the Pd complexes was determined by X-ray crystallography 
and it was confirmed that coordination to the metal occurs through the C5 atom of 
the triazole ring and through the donor groups attached at the N1 and C4 positions 
(Figure 1.15). The influence of these pincer ligands on catalytic activity was 
investigated, and the results showed that the PCP and PCN based systems are 
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extremely efficient catalysts for the Heck reaction, where as the PCS system has 
substantially lower activity. 
 
Figure 1.15 Molecular structure of palladium-1,2,3-triazolide pincer ligand 
complex 83 
Gandelman et al. 84 have used the 1,2,3-triazole to prepared a range of cationic N-
donor N-heterocyclic nitrenium ions that are isoelectronic and isostructural to 
NHCs, and studied their ligand properties.  Experimental and computational 
studies of the electronic properties of this novel type of ligand suggest that they 
are poor -donors and good -acceptors. 
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Figure 1.16 Nitrenium ions as ligands for transition metal complexes. 84 
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As well as allowing access to 1,4-disubstituted-1,2,3-triazolide ligands 1,2,3-
triazoles can also be easily alkylated at the N3 position to give 1,3,4-trisubstitued-
1,2,3-triazolium salts. N-heterocyclic carbenes have become very popular ligands 
in late transition metal chemistry predominantly due to their good catalytic 
activity. 85 Recent reports have shown the use of 1,2,3-triazolium salts for the 
generation of ‘abnormal’ mesoionic N-heterocyclic “click” carbenes. 86 
Deprotonation of the 1,3,4-trisubstitued-1,2,3-triazolium salts with Ag2O 
generates the moderately stable silver 1,3,4-trisubstitued-1,2,3-triazol-5-ylidene 
which can then be used to synthesise a wide range (including complexes of Pd(II), 
86-88
 Ru(II), 89 Rh(I), 86, 87 Ir(I), 86 Cu(I) 90, 91 and Au(I) 92) of stable metal 1,3,4-
trisubstitued-1,2,3-triazolidene complexes by transmetallation. 91 93 Infra-red 
stretching frequencies for iridium dicarbonyl chloride complexes show that these 
“click” carbenes are better donors than conventional carbenes but not as good as 
imidazole-5-ylidene ligands. Copper complexes of these ligands have also been 
utilised as catalysts for CuAAC reactions. 90, 91 X-ray crystal structures of two 
complexes are shown in Figure 1.17. 
 
Figure 1.17 Molecular structure of 1,3,4-trisubstitued-1,2,3-triazol-5-ylidene 
N-heterocyclic carbenes complexes 86 
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1.3.4 Bidentate N^N donor Ligands  
Bidentate ligands containing 1,4-disubstituted-1,2,3-triazole ligands are by far the 
most widely studied CuAAC derived ligand systems. Common ligands include 
pyridyl-1,2,3-triazole, 2-(1-R-1H-1,2,3-triazol-4-yl)pyridine and [2-(4-R-1H-
1,2,3-triazol-1-yl)methyl]pyridine frameworks (Figure 1.18). 
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Figure 1.18 Bidentate ligands containing 1,4-disubstituted-1,2,3-triazoles       
2-(1-R-1H-1,2,3-triazol-4-yl)pyridine and [2-(4-R-1H-1,2,3-triazol-1-
yl)methyl]pyridine. 
The 2-(1,2,3-triazol-4-yl)pyridine (pytz) type ligands have been studied as readily 
tuneable bpy analogues. Monofunctionalised triazole compounds incorporating 
pyridine can easily be synthesised by a simple CuAAC reaction of 2-ethynyl 
pyridine with an organic azide. Complexes of a number of metals have now been 
reported and include octahedral complexes of Re(I), 94-96 Tc(I), 94 Ru(II), 10, 56, 80, 
97-99
 Ir(III), 98, 100-102 tetrahedral complexes of Ag(I) and Cu(I) 12, 103 and some 
square planar complexes of Pd(II) and Pt(II). 104-108   
Over the past few decades there has been interest in complexes of bpy ligands 
such as [Ru(bpy)3]2+ and [Re(bpy)(CO)3Cl], stemming mainly from their 
interesting electrochemical and photophysical luminescent properties. This has 
therefore encouraged a number of groups to examine the optoelectronic properties 
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of complexes of pytz type ligands that are analogues to bpy. Obata and Yano 96 
and Benoist 94, 95 have prepared several rhenium complexes using this ligand 
framework by refluxing a stoichiometric quantity of the corresponding ligand with 
[Re(CO)5Cl] in an alcoholic solvent to yield the complexes of the type 
[Re(pytz)(CO)3Cl] (Figure 1.19). Characterisation data indicates that exclusively 
the fac isomers of the complexes were prepared as observed for the bpy 
analogues. These complexes exhibit UV-visible absorption spectra with blue-
shifted bands compared to those of [Re(bpy)(CO)3Cl]. Absorptions were assigned 
as the mixed metal-to-ligand-to-ligand charge transfer (MLLCT) in nature from 
time-dependent density functional theory (DFT) calculations and are blue shifted 
due to higher energy LUMO of the pytz ligand. Similarly, a blue-shifted 
maximum was observed in luminescence spectra when compared to that of the 
complex [Re(bpy)(CO)3Cl]. Luminescent lifetime measurements were also carried 
out on the complexes and an almost three fold increase in lifetime for the pytz 
complexes was observed over the bpy analogue. Benoist, Machura and co-
workers have also prepared radiolabeled technetium-99 complexes of this ligand 
framework as potential imaging probes for nervous system receptors. 94 
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Figure 1.19 X-ray structure of [Re(pytz)(CO)3Cl].96 
Fletcher 56 and Schubert 10 have independently prepared pytz analogues of 
[Ru(bpy)3]2+ by reacting RuCl3.H2O with three equivalents of the pytz ligand. Due 
to the asymmetry of the pytz ligands preparation of these homoleptic complexes 
results in a mixture of the mer and fac isomers which prove difficult to separate 
unless a bulky substituent is present at the N1 position of the triazole heterocycle. 
In contrast to their bpy analogues it was found that the homoleptic complexes are 
only modestly coloured and are not emissive. 10, 56 Schubert et al. also investigated 
mixed bpy/pytz heteroleptic complexes. 10, 80, 99 The photophysical and 
electrochemical properties of the series of complexes [Ru(bpy)3-n(pytz)n]2+ (Figure 
1.20) were studied  and it was found as the number of pytz ligands increases in the 
complex a blue shift in both the MLCT band in the UV-visible absorption spectra 
and in the photoluminescence emission spectra are observed and also leads to 
quenching of emission intensity. Consistent with this, the increase in the number 
of pytz ligands leads to an increase in the energy of the LUMO as observed by 
cyclic voltammetry.  
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Figure 1.20 Structure of [Ru(bpy)2(pytz)]2+, [Ru(bpy)(pytz)2]2+ and 
[Ru(pytz)3]2+ 
Baurele, Gratzel, Zakeeruddin and co-workers have utilised the pytz ligand to 
prepare the heteroleptic Ru(II) complex [Ru(L)(dcbpy)(NCS)2] (L = 2-(1-(4-
hexylphenyl)-1,2,3-triazol-4-yl)pyridine) and have demonstrated its use as a 
sensitizer in dye-sensitized solar cells (DSSC) (Figure 1.21). 109 DSSC devices, 
with an acetonitrile-based I3-/I- electrolyte showed a respectable power conversion 
efficiency of 7.8%, which is quite high taking into account the diminished light 
absorption properties of the complex when compared to [Ru(dcbpy)2(NCS)2] (~10 
% efficiency dcbpy is 4,4’-dicarboxylic-2,2’-bipyridyl). 
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Figure 1.21 An example of 2-(1-R-1,2,3-triazol-4-yl)pyridine ligands used as 
sensitizers for a DSSC. 
Cyclometallated Ir(III) complexes with pytz ancillary ligands have also been 
prepared. DeCola et al. have prepared complexes of the type [Ir(ppy)2(pytz)]+ and 
[Ir(F2ppy)2(pytz)]+ (where ppy = 2-phenylpyridine and F2ppy = 2-(2,4-
difluorophenyl)pyridine) and examined their photophysical and electrochemical 
properties. 98, 100-102 These complexes displayed excellent emission quantum 
yields, (0.16-0.32 in degassed dichloromethane), long luminescent lifetimes, 
(0.53-1.3 µs) and show reversible oxidation behaviour. The authors have also 
shown that these complexes show electrochemiluminescence where the emission 
colour can be modulated from green to blue by modification of the cyclometalated 
ligands. 102 The same series of complexes have been used to develop light-
emitting electrochemical cells (LEEC), which can be used as an alternative to the 
more studied prevalent organic light emitting diode (OLED) devices. The LEECs 
generated using the F2ppy Ir(III) complexes display very blue emission and have 
drastically reduced response time, which in the past have been problematic with 
LEEC technology, therefore bringing practical LEECs a step closer. 101     
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Another group of bidentate “click” ligands are the 4,4’-bi-1,2,3-triazolyl ligands 
(btz). A number of groups including our own have attempted to exploit the use of 
these symmetrical ligands as readily prepared bpy analogues.56, 110, 111  
 
Figure 1.22 Structure of bidentate 4,4’-bis-1,2,3-triazolyl ligands. 
Fletcher et al. 56 and Monkowius and co-workers 111 independently reported 
ruthenium complexes of the type [Ru(btz)3]2+. The optoelectronic properties of 
these complexes were studied and it was found that the MLCT absorption bands 
appear at significantly higher energy in comparison to that of [Ru(bpy)3]2+such 
that [Ru(btz)3]2+ is not at all strongly coloured. These homoleptic btz complexes 
do not display any measurable luminescent emission at room temperature. 56 
Monkowius and co-workers 111 also prepared copper and rhenium complexes of 
the form [Cu(btz)L]+ (L= bis[2-(diphenylphosphanyl)phenyl] ether) and 
[Re(btz)(CO)3Cl]. The UV-visible spectra of the btz complexes again revealed 
absorption bands which were significantly higher in energy than the analogous 
bpy complexes. Again, unlike their bpy analogues neither of these btz complexes 
are emissive in either the solid state or in solution. 
The group of Elliott have prepared and characterised a family of complexes 
[Ru(bpy)3−n(btz)n][PF6]2 (n = 1 to 3) and investigated the resultant photophysical 
effects of the btz ligand across the series. 112 The experimental data reveal a blue-
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shifting in the absorption bands consistent with the destabilization of the LUMO 
relative to the HOMO, with a very large blue-shift being observed on replacement 
of the final bpy ligand by btz. The data indicates that the LUMO in all the bpy-
containing complexes is bpy-centred, whereas that for [Ru(btz)3]2+ is btz-centred. 
The inclusion of btz also results in blue-shifted luminescent emission for 
[Ru(bpy)2(btz)]2+, which is highly quenched compared to that of [Ru(bpy)3]2+. 
Luminescent emission for [Ru(bpy)(btz)2]2+ can only be observed on cooling to 77 
K. These data are consistent with quenching through thermal population of 3MC 
states from elevated 3MLCT states. Theoretical studies showed that the 
replacement of bpy ligands by btz ligands infact leads to a fundamental change in 
the ordering of excited states such that the nature of the lowest energy excited 
state changes from MLCT in nature to MC for [Ru(btz)3]2+. 112 
2PF62PF62PF6
 
Figure 1.23 Structures of the complexes [Ru(bpy)2(btz)](PF6)2, [Ru(bpy)(btz)2] 
(PF6)2 and [Ru(btz)3] (PF6)2. 
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The more flexible ligand [2-(1,2,3-triazol-1-yl)methyl]pyridine has also been 
studied. Like 2-(1,2,3-triazol-4-yl)pyridine it also behaves as an N-N bidentate 
ligand, chelating through the pyridyl and the triazole rings forming a six-
membered chelate ring. Chelation through the coordination of the pyridyl donor 
forces coordination via N2 rather than the more basic N3 position. A range of 
complexes have been prepared and characterised using this ligand scaffold, 
including octahedral complexes of Cu(II), 12, 113-116 Co(II), 116 Ni(II), Ru(II), 115, 117 
tetrahedral complexes of Ag(I) 12, 115 and Zn(II) and square planar complexes of 
Ag(I), Pd(II) and Pt(II). 104, 105, 115, 118-120 Whilst the majority of work with this 
ligand framework has focused on the synthetic and structural chemistry of the 
ligand, applications of the resulting complexes are beginning to emerge. Scrivanti 
et al. have prepared a cationic palladium allyl complex with this type of ligand 
(Figure 1.24) and have shown that it exhibits good activity in the Suzuki-Miyaura 
couplings of aryl bromides with phenyl boronic acid. 121 Brastos, Turel and co-
workers have synthesised a small family of ruthenium p-cymene complexes and 
tested them for in vitro activity against two human cancer cell lines (Figure 1.24). 
117
  
 
Figure 1.24 Examples of [2-(4-R-1H-1,2,3-triazol-1-yl)methyl]pyridine ligands 
coordination 
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1.3.5 Bidentate C^N donor Ligands  
A number of groups have explored the use of 4-phenyl-1,2,3-triazoles 9, 100, 122, 123 
as precursors for cyclometallating ligands. Schubert9 showed that refluxing 4-
phenyl-1,2,3-triazole with IrCl3.3H2O in ethoxyethanol resulted in the formation 
of a biscyclometalated chloride-bridged dimer. The dimers where treated with a 
range of different neutral and anion bidentate ancillary ligands (e.g. bpy, 
acetylacetonate (acac) and picolinate (pic)) resulting in monomeric complexes 
(Figure 1.25) in excellent yields. 9, 100 The optical-electronic properties for the 
complexes were studied and it was shown that emission colour-tuning could be 
easily achieved through changing the ancillary ligand. Using similar conditions 
DeCola and co-workers have prepared and characterised iridium dimers bearing 
4-(2,4-difluorophenyl)-1,2,3-triazolyl)pyridine (dfptz),100, 124 however 
crystallographic analysis showed that this is not a dichloro-bridged dimer but a 
dimer in which one of the 1,2,3-triazole units acts as a bridging moiety. The 
authors were able to successfully cleave the dimer and access the monomeric 
complexes e.g. [Ir(dfptz)2(bpy)]+. The complexes reported showed absorption 
features similar to those previously reported for other Ir(ppy)2 type complexes, 
with strong -* transitions in the near UV region localised on the dfptz ligand 
(~260 nm) and on the triazole (~300 nm) and weaker MLCT bands at lower 
energies between 350-450nm. The complexes with the fluorinated phenyl ring 
exhibit more intense absorption bands and display intense unstructured emission 
bands. Polymer light-emitting diode (PLEDs) devices were fabricated with these 
complexes and it was found that the electroluminescent spectra for the new 
devices were almost identical to those of the complex in isolation, with no 
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emission from the host polymer matrix. This shows that efficient energy transfer 
from the host to the guest iridium complex occurs.  Therefore, it may be possible 
to use these types of complexes as phosphorescent dopants in the fabrication of 
PLEDs.  
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Figure 1.25 Molecular structure of [Ir(dfptz)2(L)]+/0(L = bpy, acac-, pic-) 
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1.3.6 Miscellaneous Bidentate Ligands  
Amine and phosphine substituted-1,2,3-triazole ligands have also been reported. 
Bidentate amine-1,2,3-triazole ligands have been used to prepare cisplatin like 
platinum complexes for use as potential anticancer drugs. 125 Heteroleptic 
copper(I) amido-1,2,3-triazole complexes have been synthesised and used to 
develop efficient OLEDs. Ruthenium complexes of bidentate amine-1,2,3-triazole 
ligands have been used as catalysts for organic reactions. 126  
 
Figure 1.26 Structures of bidentate 4-aminomethyl-1,2,3-triazole and 4-
(diphenylphosphinomethyl)-1,2,3-triazole ligands 
Related bidentate phosphine-1,2,3-triazole ligands have also been utilised in 
catalysis. Van Maarseven et al. prepared palladium complexes of the ligand 
shown in Figure 1.26 and demonstrated that these complexes are effective 
catalysts for Suzuki coupling reactions.127 They showed that the palladium 
catalyst maybe hemilabile and exist as either the monodentate complex, where 
only the phosphine donor is coordinated to the metal or as the bidentate complex 
where coordination to the metal is through both the phosphine and the triazole N3 
position. Crystallographic analysis of the complex prepared from [Pd(allyl)Cl]2 
only showed evidence of the monodentate complexes, although the 1H and 31P 
NMR spectra suggest bidentate coordination after the complex had been treated 
with AgBF4 to abstract the chloride ligand. After mechanistic studies it was found 
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that the monoligated complex is more likely to be the catalytically active 
complex. 
1.3.7 Triazole containing Tridentate Ligands  
A range of tridentate “click” ligands have been synthesised and characterised. 
Whilst the majority of these ligands contain two or more 1,4-disubstituted-1,2,3-
triazole units, a few examples of tridentate chelators with one triazole unit have 
been reported.  
1.3.7.1 Tridentate Ligands Containing One Triazole 
Mindt and Schilibi have synthesised a family of amino acid-derived mono-1,4-
disubstitued-1,2,3-triazole containing chelators for Re(I) and 99mTc(I) as potential 
imaging agents in PET scans. 46, 128-134 Recently the authors have developed a one-
pot procedure which enable the in situ generation of both the ligand and the 
radiocomplex, further improving the synthetic efficiency. 135  
Adolfsson and co-workers have used similar ligands as chelators for rhodium and 
have shown that they are efficient in rhodium catalysed organic reactions. 136 
Chen et al. have synthesised hybrid N-heterocyclic carbene-1,2,3-triazole 
tridentate ligands and successfully characterised their Ag(I), Pd(II) and Pt(II) 
complexes. The authors showed that the palladium complex is a highly active 
catalyst for the Suzuki-Miryaura cross-coupling reactions. 137  
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1.3.7.2 Tridentate Ligands Containing Two Triazole Donors 
Another ligand which is widely used in coordination chemistry is 2,2’:6’,2”-
terpyridine (tpy). Several groups have employed the CuAAC reaction to prepare 
analogues of ligands starting from 2,6-diethynylpyridines (Figure 1.27). For the 
most part these ligands act as tpy-like tridentate ligands coordinating through the 
pyridyl and the N3 atoms of the triazole rings. Complexes of ligands of this type 
have been prepared for a wide range of metal ions including Fe(II), 138-140 Ru(II), 
140
 Cu(II), 12, 141 Zn(II), 140 Eu(III) 138, 139 and Ag(I). 12  
 
Figure 1.27 Tridentate 6-bis(1-R-1,2,3-triazol-4-yl)pyridine ligands and 
2,2’:6’,2”-terpyridine 
Flood 138 and Hecht and Limberg 139 were the first to report the synthesis of 2,6-
bis(1,2,3-triazol-4-yl)pyridine based ligands (btzpy) and reported some 
representative coordination to Fe(II) and Eu(III) (Figure 1.27). Reacting these 
ligands with Cu(II), Fe(II) and Ru(II) gave octahedral complexes which were 
characterised by X-ray crystallography. 140 The btzpy ligand was found to be less 
sterically demanding than the tpy analogues and this is demonstrated in the X-ray 
crystal structures of each of complexes. However, it was shown that there was 
greater distortion from the octahedral symmetry in the ruthenium and iron 
complexes when compared to their analogues tpy complexes. The effects of the 
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coordination on the electronic structure of the complexes was investigated using 
UV-visible absorption spectroscopy, and it was found that upon coordination the 
ligand-centered -* (LC) band was blue-shifted by ~10nm. When the ligand was 
coordinated to iron it led to a red coloured complex with an intense MLCT at 
443nm, whilst coordination to ruthenium led to an MLCT band at 393nm. These 
bands are blue shifted compared to their tpy analogues and this is attributed to the 
LUMO of the btzpy ligand being higher in energy than the tpy ligand. 
The group of Ulrich Schubert carried out a study on the series of complexes 
[Ru(tpy)2]2+, [Ru(tpy)(btzpy)]2+ and [Ru(btzpy)2]2+ (Figure 1.28).54 
Photophophysical and electrochemical properties were studied and it was found 
that the heteroleptic ruthenium complex exhibits an MLCT band at 432nm mid 
way between the two MLCT bands for the individual homoleptic btzpy and tpy 
complexes. Photoluminescence spectra were recorded at 77K and show a 
pronounced blue-shift of the emission maxima of ~20nm for the heteroleptic 
complex when compared to that of the homoleptic bis-terpyridine complex. No 
emission was detected for the homoleptic bis-btzpy complex.   
2+ 2+2+
 
Figure 1.28 Structures of [Ru(tpy)2]2+, [Ru(tpy)(btzpy)]2+ and [Ru(btzpy)2]2+ 
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Chandrasekher have prepared octahedral Fe(II) complexes with tridentate ligands 
containing a central pyridyl donor, pyrazolyl and triazolyl donors in the 2- and 6- 
position. These new ligands have been termed “super-hybrid” ligands and the iron 
complexes have shown reversible spin crossover behaviour. 142   
Cyclometallated complexes and metallostar complexes have also been synthesised 
utilising these types of ligands. Obata, Kakuchi and co-workers reacted an azido 
functionalised polystyrene polymer with 2,6-diethynylpyridine. The resulting 
ligand was reacted with Ru(II) to give a four-arm metallostar architecture. 97 
O’Reilly et al. reported a similar approach to metallostar complexes of Ru(II) and 
Eu(III).143   
Yao, Zhong and co-workers have reacted [Ru(tpy)Cl3] with the 
bis(triazolyl)benzene ligand to give an octahedral cycloruthenated complex. 144 
The same group have also utilised the CuAAC reaction to prepare bridging ligand 
precursors to construct a mixed-valance system with cyclometalated ruthenium 
complexes 145, 146 based on, 1,3,6,8-tetrakis(1-butyl-1H-1,2,3-triazol-4-yl)pyrene 
and 3,3’,5,5’-tetrakis-(1H-1,2,3-triazol-4-yl)biphenyl, the latter complex being 
shown in Figure 1.29. Electronic coupling was found to be present between 
mixed-valent redox centres of the one-electron-oxidised complexes. The one-
electron oxidation of the complex is mainly associated with the metal center 
although there is substantial participation from the anionic ligand.   
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Figure 1.29 Cyclometalated ruthenium bridged complex. 
Click-derived tridentate (C,N,C) carbene pincer ligands, derived from btzpy, have 
been utilised for the preparation of heteroleptic bis(tridentate) ruthenium 
complexes (Figure 1.30). 147, 148 The absorption profile of these complexes is 
similar to the related heteroleptic complex with the N,N,N bound ligand, however 
the absorption MLCT band of these carbene complexes is slightly blue-shifted 
with respect to that of [Ru(tpy)2](PF6)2 complex. The room-temperature emission 
of the complex revealed red emission with an unstructured emission band and 
quantum yields similar to those for [Ru(bpy)3](PF6)2. The excited-state lifetime of 
633 ns is 2500 times longer than that for [Ru(tpy)2](PF6)2 and is comparable to 
[Ru(bpy)3](PF6)2. Bis tridentate ruthenium complexes are not usually emissive due 
to low lying 3MC states arising from the coordination geometry deviating from an 
ideal octahedral geometry. The good emission properties here are due to the 
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strong -donor properties of the “click” carbene moieties that push up the energy 
of the 3MC state. 
 
Figure 1.30 Click-derived carbene pincer ligand and heteroleptic 
bis(tridentate) ruthenium complex. 148 
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The more flexible 2,6-bis(4-R-1,2,3-triazol-1-ylmethyl)pyridine ligands related to 
btzpy have also been studied (Figure 1.31). 12, 149 Crowley and co-workers 
explored the coordination of these types of ligands with Cu(II) and Ag(I). The 
silver complex was found to be polymeric in the solid state with the tetrahedral 
Ag(I) centres coordinated to the pyridyl and triazolyl nitrogens from one ligand 
along with the other two nitrogen donors from a second identical ligand resulting 
in a 4,4 net structure. 
 
Figure 1.31 Structure of 2,6-bis(4-phenyl-1,2,3-triazol-1-ylmethyl)pyridine 
ligands  
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1.4 Peripheral “click” modification of metal complexes 
As well as providing a facile route to ligand design and preparation, the CuAAC 
reaction also provides a versatile route to using the 1,2,3-triazole moiety as a 
supramolecular linking unit. 
The traditional method for the preparation of metallosupramolcular materials has 
relied on the preparation of bridging ligands with multiple coordination sites into 
which metal centres can subsequently be incorporated. This methodology suffers 
from key disadvantages with problems in controlling the selectivity of metal 
binding when, for example, heterometallic complexes are required and where the 
bridging ligand is non-symmetric. “Expanded ligand” based approaches 150 have 
also been championed in which complexes are prepared and modified at their 
periphery in order to graft onto the complex a second binding domain. 
A desirable route to such architectures would involve coupling discrete preformed 
complexes into supramolecular complexes under mild conditions, requiring as few 
steps as possible. Such an approach would require a coupling reaction that is 
highly efficient and high yielding and for which the required functional groups for 
the coupling reaction can be easily incorporated into the periphery of the metal 
complex components. With such a methodology in place and a library of suitably 
derivatised transition metal complex components available, this would allow 
facile access to supramolecular architectures with an extraordinary diversity of 
structure. The CuAAC reaction is therefore an excellent candidate for this 
purpose.  
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A few reports have appeared on the CuAAC modification of transition metal 
complexes with peripheral alkyne functionalities.  Ren first demonstrated the 
peripheral modification of an alkynyl-substituted diruthenium paddlewheel 
complex151, 152 whilst Wang et al. tethered an alkyne-substituted luminescent 
iridium complex to an azide functionalised polymer. 153 More recently, Sierra and 
co-workers reported the formation of dinuclear complexes from alkynyl 
substituted Fisher carbene complexes of pentacarbonylchromium(0) by CuAAC 
coupling with bisazide spacers including bis(azidomethyl)ferrocene.154  Similar 
results have been obtained with analogous pentacarbonyltungsten(0) complexes. 
155
  Constable et al. have demonstrated the coupling of azidosugars with alkyne-
functionalised bipyridyl ligands and the preparation of their ruthenium 
complexes.156 
The comparable use of azido-functionalised complexes is far less developed.  
Azidoferrocenes have been used for the preparation of ferrocenyl triazoles which 
have subsequently been used as monodentate ligands for example.157  Fallahpour 
has developed routes to azide derivatives of bipyridyl and terpyridyl158-160 ligands 
and demonstrated the formation of an azidoterpyridyl Fe(II) complex. Attempts to 
prepare their ruthenium complexes led to azide reduction to the amine under the 
conditions used, however.  Recently, Aukauloo and co-workers have utilized an 
azido bipyridyl ligand to prepare a chromophore tagged ligand and have shown 
efficient electron transfer through the triazole linker.161 There remains, however, 
very little in the literature regarding the CuAAC functionalisation of complexes 
with coordinated azide-substituted ligands.  Beyond ferrocene, the first example 
of CuAAC modification of an azide functionalized complex was demonstrated by 
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Constable and co-workers using bis(azidoterpyridyl)iron(II) where the ligand can 
be attached to the metal under mild conditions.162 The iron complex was prepared 
by reacting the ligand in excess with FeCl2.4H2O in EtOH at room temperature 
and was characterised by X-ray crystallography which showed that the ligand had 
been successfully coordinated to the metal with the azide remaining intact (Figure 
1.32). This complex was then reacted with phenylacteylene in the presence of 
copper(I). IR spectroscopy revealed that the azide stretch at 2110cm-1 had 
disappeared and in the 1H NMR a singlet resonance was observed at  9.35 was 
assigned to the triazole ring proton. The complex was characterised by X-ray 
crystallography which showed the successful formation of 1,2,3-triazole appended 
complex (Figure 1.32). 
 
Figure 1.32 Molecular structure of bis(azidoterpyridyl)iron(II) and bis(1-
phenyl-4-tpy-1,2,3-triazolyl)iron(II) complexes 162 
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1.5 Summary and Overlook 
The CuAAC has proven to be one of the most versatile ligation reactions 
available. The reaction is simple and robust and has led to many applications in 
many areas of chemistry and biochemistry. Despite the fact that the 1,2,3-triazoles 
formed in the reaction are capable of coordination through the N2, N3 or C5 to a 
wide range of transition metals, the potential of the CuAAC in coordination 
chemistry has only just begun to be fully exploited. The main advantage of the 
CuAAC reaction in all applications is the modular nature of the reaction and good 
functional group tolerance. These factors are particularly important when studying 
metal chelating systems, as they allow a number of potential ligands to be easily 
prepared in high yields with minimal synthetic effort. Another useful factor of the 
1,2,3-triazole moieties, with respect to metal chelating systems is that further 
functionality can easily be introduced in to the N1 and C4 positions, enabling the 
synthesis of polydentate ligand systems, where the 1,2,3-triazole is an integral part 
of the metal chelator. The modular nature of the reaction provides a 
straightforward opportunity to systematically tune the electronic properties of the 
metal centre, the steric requirements of the ligand, hydrophilicity, charge and 
other physicochemical properties of the resulting complexes. These properties are 
all crucial in the preparation of metal complexes for use in catalysis, 
environmental and pharmaceutical applications. As the examples discussed have 
highlighted, the CuAAC reaction is beginning to be utilised for the preparation of 
ligands for a wide range of metals and applications. Given the ease with which 
novel chelators can be prepared and elaborated, it is anticipated that the number 
and diversity of applications will continue to increase.  
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2 EXPERIMENTAL 
 49 
2.1 General 
Reagents and solvents were purchased from Aldrich and Acros Organics and used 
as supplied, [Re(bpy)(CO)3Cl] 163, [Re(bpy)(CO)3(Py)](PF6) 163, [Ru(bpy)2Cl2] 164 
and [Ir(ppy)2Cl]2 165 were all prepared according to literature procedures. NMR 
spectra were recorded in Bruker 500 Avance and 400 AMX spectrometers, UV-
visible absorption spectra recorded on a Varian Cary 300 spectrometer and 
luminescence spectra on a Hitachi F-4500 spectrometer (spectra were not 
corrected for detector response). Solution infrared spectra in dichloromethane 
were recorded on a Nicolet 380 FTIR spectrometer. Mass spectra were collected 
on a Bruker Micro-Q-TOF instrument. Luminescent lifetime measurements were 
carried out using an Edinburgh Instruments Mini-Tau spectrometer. 
Caution: Low molecular weight azides are often thermally and shock sensitive 
and may detonate. Therefore, low molecular weight azides should never be 
isolated and should only be generated in situ in solution and used immediatly. 
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2.1.1 Electrochemistry 
2.1.1.1 Instrumentation 
Measurements were recorded using a µ-autolab potentiometer with autolab USB 
interface The software installed was a General Purpose Electrochemical System 
(GPES) with Windows 1998. Using Ag/AgCl reference electrode. The electrode 
potential of this electrode is +0.197 V (against the standard hydrogen electrode) 
and platinum wire counter electrode. Tetrabutylammonium tetrafluoroborate was 
employed as the electrolyte. Measured potentials were referenced against Fc/Fc+ 
redox couple. 
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2.2 Ligand Synthesis 
2.2.1 Synthesis of 4-phenyl-1-methyl-1,2,3-triazole (1a) 
 
Iodomethane (3.55 mL, 11 mmol) and sodium azide (0.61 g, 9.38 mmol) were 
combined in dimethyl sulfoxide (15 mL) with one crystal of potassium iodide. 
The mixture was stirred at room temperature for two hours. The following 
reagents were then added to the reaction mixture in the following order: water (7 
mL), phenylacetylene (1.2 mL, 11 mmol), 1M sodium ascorbate solution (1.2 mL, 
1.2 mmol), copper sulfate pentahydrate (35 mg, 0.14 mmol) in water (0.3 mL), 
2,6-lutidine (1.28 mL, 11 mmol). The mixture was stirred at room temperature for 
12 hours. The reaction mixture was then diluted with water (25 mL) and the solid 
filtered and washed with water (25 mL) and dilute ammonia (25 mL). The solid 
was air dried and washed with petroleum ether (40-60 oC, 25 mL). (1.17 g, 67 %) 
1H NMR (CDCl3)  (ppm) 7.84 (d, J = 7.6 Hz, 2H, o-Ph); 7.77 (s, 1H, triazole 
CH); 7.45 (t, J = 7.5 Hz, 2H, m-Ph); 7.34 (tt, J = 7.4, 2.1 Hz, 1H, p-Ph); 4.18 (s, 
3H, Me);  13C NMR (CDCl3)  (ppm) 148.1; 130.6; 128.9; 128.2; 125.7; 120.6; 
36.8. MS (ESI) m/z 182.1 (M + Na). 
NaN3 
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2.2.2 Synthesis of 4-phenyl-1-propyl-1,2,3-triazole (1b) 
 
1-bromopropane (1 mL, 11 mmol) and sodium azide (0.61 g, 9.38 mmol) were 
combined in dimethyl sulfoxide (15 mL) with one crystal of potassium iodide. 
The mixture was stirred at room temperature for two hours. The following 
reagents were then added to the reaction mixture in the following order:  water (7 
mL), phenylacetylene (1.2 mL, 11 mmol), 1M sodium ascorbate solution (1.2 mL, 
1.2 mmol), copper sulfate pentahydrate (35 mg, 0.14 mmol) in water (0.3 mL), 
2,6-lutidine (1.28 mL, 11 mmol). The mixture was stirred at room temperature for 
12 hours. The reaction mixture was then diluted with water (25 mL) and the solid 
filtered and washed with water (25 mL) and dilute ammonia (25 mL). The solid 
was air dried and washed with petroleum ether (40-60 oC, 25 mL). (1.46 g, 71%) 
H NMR (CDCl3)  (ppm) 7.85 (d, J = 4.2 Hz, 2H, o-Ph); 7.77 (s, 1H, Tz); 7.44 (t, 
J = 7.5 Hz, 2H, m-Ph); 7.34 (t, J = 7.4 Hz, 1H, p-Ph); 4.38 (t, J = 7.2 Hz, 2H, 
CH2); 1.99 (sextet, J = 7.3 Hz, 2H, CH2); 1.00 (t, J = 7.6 Hz, 3H, Me); 13C NMR 
(CDCl3)  (ppm) 147.8; 130.8; 128.9; 128.2; 125.8; 119.6; 52.1; 23.9; 11.2 MS 
(ESI) m/z 210.1 (M + Na).  HRMS (ESI) calcd: 210.100169, found 210.100285. 
NaN3 
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2.2.3 Synthesis of 4-phenyl-1-benzyl-1,2,3-triazole. (1c) 
 
Bromomethylbenzene (0.88 mL, 11 mmol) and sodium azide (0.61 g, 9.38 mmol) 
were combined in dimethyl sulfoxide (15 mL) with one crystal of potassium 
iodide. The mixture was stirred at room temperature for two hours. The following 
reagents were then added to the reaction mixture in the following order: water (7 
mL), phenylacetylene (1.2 mL, 11 mmol), 1M sodium ascorbate solution (1.2 mL, 
1.2 mmol), copper sulfate pentahydrate (35 mg, 0.14 mmol) in water (0.3 mL), 
2,6-lutidine (1.28 mL, 11 mmol). The mixture was stirred at room temperature for 
12 hours. The reaction mixture was then diluted with water (25 mL) and the solid 
filtered and washed with water (25 mL) and dilute ammonia (25 mL). The solid 
was air dried and washed with petroleum ether (40-60 oC, 25 mL). (1.16 g, 45%) 
1H NMR (CDCl3)  (ppm) 7.82 (d, J = 7.26 Hz, 2H, o-Ph); 7.68 (s, 1H, Tz), 7.45–
7.30 (m, 8H, Ar); 5.98 (s, 2H, CH2); 13C NMR (CDCl3)  (ppm) 148.3; 134.7; 
130.6; 129.2; 128.9; 128.3; 128.1; 125.8; 119.6; 54.3.  MS (ESI) m/z 258.1 (M + 
Na) HRMS (ESI) calcd: 258.100169, found: 285.099385. 
  
NaN3 
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2.2.4 Synthesis of 4-(p-tolyl)-1-propyl-1,2,3-triazole (1d) 
 
1-bromopropane (1 mL, 11 mmol) and sodium azide (0.61 g, 9.38 mmol) were 
combined in dimethyl sulfoxide (15 mL) with one crystal of potassium iodide. 
The mixture was stirred at room temperature for two hours. The following 
reagents were then added to the reaction mixture in the following order:  water (7 
mL), p-tolylacetylene (1.39 mL, 11 mmol), 1M sodium ascorbate solution (1.2 
mL, 1.2 mmol), copper sulfate pentahydrate (35 mg, 0.14 mmol) in water (0.3 
mL), 2,6-lutidine (1.28 mL, 11 mmol). The mixture was stirred at room 
temperature for 12 hours. The reaction mixture was then diluted with water (25 
mL) and the solid filtered and washed with distilled water (25 mL) and dilute 
ammonia (25 mL). The solid was air dried and washed with petroleum ether (40-
60 oC, 25 mL). (1.41 g, 64 %) 
1H NMR (CDCl3)  (ppm): 7.75 (s, 1H, Tz); 7.73 (d, J = 7.9 Hz, 2H, Ar); 7.25 (d, 
J = 7.9 Hz, 2H, Ar); 4.38 (t, J = 7.1Hz, 2H, CH2); 2.40 (s, 3H, ArCH3); 1.99 
(sextet, J = 7.3 Hz, 2H, CH2); 1.00 (t, J = 7.5Hz, 3H, Me); 13C NMR (CDCl3)  
(ppm): 147.9; 138.0; 129.6; 128.0; 125.7; 119.2; 52.1; 23.9; 21.4; 11.2 MS (ESI) 
m/z 224.1 (M + Na). HRMS (ESI) calcd: 224.115819, found: 224.115713. 
  
NaN3 
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2.2.5 Synthesis of 2,2’-bipyridyl-N-oxide 166 
 
A solution of 2,2'-bipyridyl  (7.00 g, 44.82 mmol) in CHCl3 (25 mL), was stirred 
at 0 °C, for 35 min. A solution of m-chloroperbenzoic acid (84.5%, 9.156 g, 44.8 
mmol) in CHCl3 (87 mL), was then added dropwise over 80 min and the mixture 
allowed to stir at room temperature for 13.5 h. The solution was washed three 
times with portions of 5% aqueous Na2CO3 (500 mL), dried (MgSO4), and 
evaporated to give an oil. To remove unreacted 2,2'-bipyridyl, the residual oil was 
extracted with boiling hexane. The upper hexane layer was discarded and the 
remaining oil dried under vacuum to give the product as a hygroscopic solid. To 
improve yield, the aqueous Na2CO3 washings were extracted with CHCl3 (4 x 45 
mL). The organic layer was dried (MgSO4) and evaporated to provide more of the 
grey-brown 2,2'-bipyridyl N-oxide. (total yield 4.27 g, 55 %) 
1H NMR (CDCl3)  (ppm): 8.81 (dt, J = 8.2 & 1.0 Hz, 1H); 8.64 (ddd, J = 4.8 & 
1.0 Hz, 1H); 8.23 (dd, J = 6.5 & 1.0 Hz, 1H); 8.08 (dd, J = 8.0 & 2.1 Hz, 1H); 
7.74 (dt, J = 7.7 & 1.7 Hz, 1H); 7.31-7.24 (m, 1H); 7.19 (dt, J = 6.6 & 2.2 Hz, 
1H). 
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2.2.6 Synthesis of 4-nitro-2,2’-bipyridyl-N-oxide 166 
 
2,2’-bipyridyl-N-oxide (5.00 g, 28.7 mmol) was dissolved in concentrated sulfuric 
acid (20 mL), whilst in an ice bath. Fuming nitric acid (30 mL) in concentrated 
sulfuric acid (20mL) was added to the mixture over 20 minutes with stirring. The 
mixture was heated at 100 °C for 2 hours. The solution was poured onto ice and 
the pH was adjusted to 13 with aqueous sodium hydroxide, (25% v/v). The 
orange-brown precipitate was collected by filtration. The filtrate was dissolved in 
CHCl3 and filtered to remove any 4,4’-dinitro-2,2’-bipyridyl. The CHCl3 was then 
removed under vacuum to yield a pale yellow solid. (4.08 g, 65 %) 
1H NMR (CDCl3)  (ppm): 9.18 (d, J = 3.4 Hz, 1H); 8.90 (dt, J = 8.1 & 0.8 Hz, 
1H); 8.81 (ddd, J = 4.8 & 0.9 Hz, 1H); 8.38 (d, J = 7.3 Hz, 1H); 8.09 (dd, J = 7.3 
& 3.3 Hz, 1H); 7.90 (td, J = 7.8 & 1.7 Hz, 1H); 7.46 (ddd, J = 6.2, 4.8 & 1.22 Hz, 
1H) 
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2.2.7 Synthesis of 4-nitro-2,2’-bipyridyl 166 
 
4-nitro-2,2’-bipyridyl-N-oxide (3.00 g, 13.6 mmol) was refluxed in PCl3 (25 mL, 
290 mmol) for 21 hours. The reaction mixture was poured into 200 mL of ice 
water. This was then basified to pH 13 with concentrated NaOH and extracted 
exhaustively with CHCl3. The combined CHCl3, layers were dried (MgSO4) and 
evaporated to yield a pale yellow solid. (2.21 g, 80 %) 
1H NMR (CDCl3)  (ppm): 9.18 (d, J = 2.2 Hz, 1H); 8.97 (d, J = 5.3 Hz, 1H); 8.77 
(d, J = 4.3 Hz, 1H); 8.49 (dt, J = 8.0 & 0.9 Hz, 1H); 8.04 (dd, J = 5.4 & 2.2 Hz, 
1H); 7.90 (td, J = 7.6 & 1.8 Hz, 1H); 7.43 (ddd, J = 6.2, 4.9 & 1.2 Hz, 1H) 
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2.2.8 Synthesis of 4-azido-2,2’-bipyridyl (4a) 167 
 
A mixture of 4-nitro-2,2’-bipyridyl (0.57 g, 0.4 mmol) and NaN3 (1.50 g, 3.85 
mmol) was heated in DMF (25 mL) for 3 hours at 100 °C. The DMF was removed 
by rotary evaporation and water (40 mL) was added, the mixture was extracted 
with DCM (3 x 50 mL) and the combined organic phase was dried over MgSO4 
and the solvent was removed. 4-azido-2,2’-bipyridyl was purified by column 
chromatography (silica gel, DCM/AcOEt 1:1) to yield a yellow solid. (0.52 g, 
93.54 %) 
1H NMR (CDCl3) δ (ppm): 8.69 (ddd, J = 4.8, 1.8 & 0.9 Hz, 1H, H-6’); 8.58 (d, J 
= 5.4 Hz, 1H, H-6); 8.40 (dt, J = 7.8 & 0.9 Hz, 1H, H-4’); 8.15 (d, J = 2.3 Hz, 1H, 
H-3); 7.83 (td, J = 7.8 & 1.8, 1H, H-5’); 7.34 (ddd, J = 7.5, 4.8 & 1.2, 1H, H-3’); 
6.94 (dd, J = 5.4 & 2.3 Hz, 1H, H-5).  13C NMR (CD3Cl) δ (ppm): 160.0; 155.2; 
150.5; 149.8; 149.2; 137.1; 124.3; 121.3; 114.2; 111.2.  MS: (ESI) m/z 220 
(M+Na).  HRMS: calcd: 220.059366, found: 220.058833.  IR (ATR) 2115 cm-1. 
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2.2.9 Synthesis of 2,2’-bipyridyl-N,N’-dioxide 168 
H2O2
CH3COOH
 
A mixture of 2,2’-bipyridyl (15.7 g, 0.1 mol), hydrogen peroxide (20.4 mL, 30%) 
and glacial acetic acid (120 mL) was heated at 80 °C for 3 hours. Hydrogen 
peroxide (15 mL, 30%) was added and the heating was continued for a further 4 
hours. The pale yellow solution was allowed to cool to room temperature and 
slowly added to acetone (1500 mL). Upon cooling a white solid of 2,2’-bipyridyl-
N,N’-dioxide precipitated and was collected by filtration and air dried. (10.87 g, 
56.3 %) 
1H NMR (d6-Me2SO) δ (ppm): 8.36 (d, J = 6.4 Hz, 2H); 8.64 (dd, J = 7.8 & 1.8 
Hz, 2H); 7.52 (td, J = 7.8 & 2.0 Hz, 2H); 7.42 (t, J = 7.7 Hz, 2H) 
  
 60 
2.2.10 Synthesis of 4,4’-dinitro-2,2’-bipyridyl-N,N’-dioxide 168 
H2SO4
HNO3
 
A solution of 2,2’-bipyridyl-N,N’dioxide (5.6g, 29.8mmol) in conc. H2SO4 
(20mL) was cooled to 5°C and then fuming nitric acid (12mL) was added 
dropwise. The brown solution was heated at 120°C for 5 hours under reflux. The 
reaction mixture was allowed to cool to room temperature and then quenched by 
pouring it on to an ice-water (50% w/v) solution, which gave a pale yellow 
precipitate which was collected by filtration and washed several times with water 
and acetone, and allowed to air dry to yield a pale yellow solid as 4,4’-dinitro-
2,2’-bipyridyl-N,N’-dioxide. (2.72g, 32 %)   
1H NMR (d6-Me2SO) δ (ppm): 8.70 (d, J = 3.4 Hz, 2H); 8.60 (d, J = 7.2 Hz, 2H); 
8.37 (dd, J = 7.2 & 3.3 Hz, 2H)  
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2.2.11 Synthesis of 4,4’-dinitro-2,2’-bipyridyl 168 
PCl3
 
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4,4’-Dinitro-2,2’-bipyridyl-N,N-dioxide (3.00 g, 10.8 mmol) was refluxed in PCl3 
(25 mL, 290 mmol) for 21 hours. The reaction was thrown into 200 mL of ice 
water. This was then basified to pH 13 with concentrated NaOH and extracted 
exhaustively with CHCl3. The combined CHCl3, layers were dried (MgSO4) and 
evaporated to give a yellow solid. (2.22 g, 83 %) 
1H NMR (CDCl3) δ (ppm): 9.24 (d, J = 2.1 Hz, 2H); 9.06 (d, J = 5.3 Hz, 2H); 8.15 
(dd, J = 5.3 & 2.1 Hz, 2H).   
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2.2.12 Synthesis of 4,4’-dinitro-2,2’-bipyridyl (4b) 
NaN3
 
A mixture of 4,4’-dinitro-2,2’-bipyridyl (0.10 g, 0.4 mmol) and NaN3 (0.25 g, 
3.85 mmol) was heated in DMF (10 mL) for 3 hours at 100 °C. The DMF was 
removed by rotary evaporation and water (40 mL) was added, the mixture was 
extracted with dichloromethane (3 x 30 mL) and the combined organic phase was 
dried over MgSO4 and the solvent was removed. 4,4’-diazido-2,2’-bipyridyl was 
purified by column chromatography (silica gel, DCM/AcOEt 1:1) to yield a 
yellow solid. (0.09 g, 95.0 %) 
1H NMR (CDCl3) δ (ppm): 8.58 (d, J = 5.4 Hz, 2H, H-6); 8.14 (d, J = 2.2 Hz, 2H, 
H-3); 6.96 (dd, J = 5.4 & 2.2 Hz, 2H, H-5).  13C NMR (CDCl3) δ (ppm): 157.3; 
150.8; 150.3; 114.9; 111.8;  MS (ESI) m/z 261 (M+Na). HRMS calcd 
261.060765; found 261.060763.  IR (ATR) 2117 cm-1. 
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2.2.13 Synthesis of 4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5a) 
 
4-azido-2,2’-bipyridyl (0.5 g, 2.54 mmol) and phenylacetylene (0.39 g, 3.80 
mmol) were dissolved in THF (30 mL) and water was added (30 mL). At 20 °C 
CuSO4 (1M aqueous solution 2.54 mL) was added followed by freshly prepared 
sodium ascorbate solution (1M aqueous solution 5.08 mL) dropwise. The solution 
was allowed to stir at room temperature for 1 hour. After removing the THF under 
vacuum, dichloromethane (30 mL) and concentrated ammonia solution (15 mL) 
were added to the solution. The solution was allowed to stir for a further 30 mins. 
at room temperature to remove any remaining Cu(I). The organic phase was 
washed twice with water (30 mL) and once with brine (30 mL) and dried over 
MgSO4. The solvent was removed under vacuum and the product was 
recrystallised from dichloromethane and hexane to yield a buff coloured solid. 
(0.58g, 76.3%) 
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1H NMR (CDCl3) δ (ppm): 8.84 (d, J = 5.3 Hz, 1H, bpy H-6); 8.75 (d, J = 2.1 Hz, 
1H, bpy H-3); 8.72 (d, J = 4.5 Hz, 1H, py); 8.50 (d, J = 8.0 Hz, 1H, py); 8.48 (s, 
1H, Tz); 7.99 (dd, J = 5.3 & 2.1 Hz, 1H, py(tz)); 7.94 (d, J = 7.7 Hz, 2H, Ph); 7.87 
(td, J = 7.7 & 1.6 Hz, py); 7.48 (t, J = 7.7 Hz, 2H, Ph); 7.39 (m, 2H, Ph & py).  
13C NMR (CDCl3) δ (ppm): 158.5; 154.8; 151.1; 149.3; 149.0; 144.1; 137.1; 
129.8; 129.0; 128.8; 126.0; 124.5; 121.4; 116.9; 113.9; 110.2.  MS (ESI) m/z 322 
(M+Na).  HRMS: calcd 322.106317, found 322.106153. 
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2.2.14 Synthesis of 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5b) 
 
4-azido-2,2’-bipyridyl (0.10 g, 0.51 mmol) and ethynylferrocene (0.16 g, 0.76 
mmol) was dissolved in THF (15 mL) and water was added (15 mL). At 20 °C 
was added CuSO4 (1M aqueous solution 0.51 mL) was added followed by freshly 
prepared sodium ascorbate solution (1M aqueous solution 1.01 mL) dropwise. 
The solution was allowed to stir at room temperature for 1 hour. After removing 
the THF under vacuum, dichloromethane (30 mL) and concentrated ammonia 
solution (10 mL) were added to the solution. The solution was allowed to stir for a 
further 30 mins. at room temperature to remove any remaining Cu(I). The organic 
phase was washed twice with water (15 mL) and once with brine (15 mL) and 
dried over MgSO4. The solvent was removed under vacuum and the product was 
recrystallised from dichloromethane and hexane to yield an orange coloured solid. 
(0.087 g, 42.0 %) 
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1H NMR (CDCl3) δ (ppm): 8.83 (d, J = 5.4 Hz, 1H, py(tz)); 8.74 (ddd, J = 4.7, 1.7 
& 0.7 Hz, 1H, py); 8.69 (d, J = 2.0 Hz, 1H, py(tz)); 8.51 (d, J = 7.9 Hz, 1H, py); 
8.18 (s, 1H, Tz); 8.01 (dd, J = 5.4 & 2.1 Hz, 1H, py(tz)); 7.89 (td, J = 7.7 & 1.7 
Hz, 1H py); 7.40 (ddd, J = 7.6, 4.7 & 1.2 Hz, 1H, py); 4.82 (t, J = 1.9 Hz, 2H, 
C5H4Fe); 4.37 (t, J = 1.9 Hz, 2H, C5H4Fe); 4.12 (s, 5H, Cp).  13C NMR (CDCl3) δ 
(ppm): 158.4; 154.9; 151.1; 149.2; 148.5; 144.2; 137.2; 124.5; 121.5; 115.7; 
113.9; 110.0; 74.3; 69.7; 69.1; 66.9.  MS (ESI) m/z 430 (M+Na).  HRMS: calcd: 
430.072559, found: 430.073052. 
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2.2.15 Synthesis of 4-pyrid-2-yl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5c) 
 
4-azido-2,2’-bipyridyl (0.25 g, 1.27 mmol) and 2-ethynylpyridine (0.196 g, 1.90 
mmol) was dissolved in THF (30 mL) and water was added (30 mL). At 20 °C 
was added CuSO4 (1M aqueous solution 1.27 mL) was added followed by freshly 
prepared sodium ascorbate solution (1M aqueous solution 2.54 mL) dropwise. 
The solution was allowed to stir at room temperature for 1 hour. After removing 
the THF under vacuum, dichloromethane (30 mL) and concentrated ammonia 
solution (15 mL) were added to the solution. The solution was allowed to stir for a 
further 30 mins. at room temperature to remove any remaining Cu(I). The organic 
phase was washed twice with water (30 mL) and once with brine (30 mL) and 
dried over MgSO4. The solvent was removed under vacuum and the product was 
recrystallised from dichloromethane and hexane to yield a white coloured solid. 
(0.31 g, 81.4 %) 
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1H NMR (CDCl3) δ (ppm): 8.91 (s, 1H, Tz); 8.88 (d, J = 2.1 Hz, 1H, bpy py(tz)); 
8.85 (d, J = 5.4 Hz, 1H, bpy py(tz)); 8.72 (ddd, J = 4.8, 1.8 & 0.8 Hz, 1H, pyA); 
8.65 (ddd, J = 4.8, 1.7 & 0.8 Hz, 1H, py); 8.49 (dt,  J = 8.0 & 0.8 Hz, 1H, pyA); 
8.27 (dt, J = 8.0 & 0.9 Hz, 1H, pyB); 7.97 (dd, J = 5.4 & 2.2 Hz, 1H, bpy py(tz)); 
7.87 (td, J = 7.8 & 1.7 Hz, 1H, pyA); 7.84 (td, J = 7.8 & 1.7 Hz, 1H, pyB); 7.38 
(ddd, J = 7.5, 4.8 & 1.2 Hz, 1H, pyA); 7.30 (ddd, J = 7.7, 4.8 & 1.2 Hz, 1H, pyB).  
13C NMR (CDCl3) δ (ppm): 158.7; 154.8; 151.1; 149.7; 149.6; 149.56; 149.4; 
144.1; 137.1; 137.0; 124.5; 123.4; 121.3; 120.6; 119.6; 113.8; 110.7.  MS (ESI) 
m/z 323 (M+Na).  HRMS: calcd: 323.101566, found: 323.101593 
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2.2.16 Synthesis of 4-pyrid-2-yl-1-benzyl-1,2,3-triazole. (10) 
 
Bromomethylbenzene (0.88 mL, 11 mmol) and sodium azide (0.61 g, 9.38 mmol) 
were combined in dimethyl sulfoxide (15 mL) with one crystal of potassium 
iodide. The mixture was stirred at room temperature for two hours. The following 
reagents were then added to the reaction mixture in the following order: water (7 
mL), 2-ethynylpyridine (1.2 mL, 11 mmol), 1M sodium ascorbate solution (1.2 
mL, 1.2 mmol), copper sulfate pentahydrate (35 mg, 0.14 mmol) in water (0.3 
mL), 2,6-lutidine (1.28 mL, 11 mmol). The mixture was stirred at room 
temperature for 12 hours. The reaction mixture was then diluted with water (25 
mL) and the solid filtered and washed with water (25 mL) and dilute ammonia (25 
mL). The solid was air dried and washed with petroleum ether (40-60 °C, 25 mL). 
(1.96 g, 75%) 
1H NMR (400 MHz, CDCl3):  (ppm) 8.53 (ddd, J = 4.9, 1.8 & 1.0 Hz, 1H, 6-
pyH); 8.17 (dt, J = 7.9 & 1.1 Hz, 1H, 3-pyH); 8.04 (s, 1H, 5-triazole H); 7.76 (dt, 
J = 7.8 & 1.8 Hz, 1H, 4-pyH); 7.40–7.31 (m, 5H, PhH); 7.20 (ddd, J = 7.5, 4.9 & 
1.2 Hz, 1H, 5-pyH); 5.58 (s, 2H, CH2). 13C NMR (100 MHz, CDCl3):  (ppm) 
150.1; 149.2; 148.6; 136.8; 134.2; 129.1; 128.7; 128.2; 122.7; 121.7;  120.1; 54.45 
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2.2.17 Synthesis of di-([1-{2,2’-bipyrid-4-yl}-1,2,3-triazol-4-yl]methyl)ether  
(21) 
 
4-azido-2,2’-bipyridyl (0.25 g, 1.27 mmol) and propargyl ether (0.36 g, 3.83 
mmol) was dissolved in THF (30 mL) and water was added (30 mL). At 20 °C 
was added CuSO4 (1M aqueous solution 2.50 mL) was added followed by freshly 
prepared sodium ascorbate solution (1M aqueous solution 5.00 mL) dropwise. 
The solution was allowed to stir at room temperature for 1 hour. After removing 
the THF under vacuum, dichloromethane (30 mL) and concentrated ammonia 
solution (15 mL) were added to the solution. The solution was allowed to stir for a 
further 30 mins. at room temperature to remove any Cu(I) trapped as Cu(NH3)6+ 
ions. The organic phase was washed twice with water (30 mL) and once with 
brine (30 mL) and dried over MgSO4. The solvent was removed under vacuum 
and the product was recrystallised from dichloromethane and hexane to yield a 
white coloured solid. (0.97 g, 78.3 %) 
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1H NMR (CDCl3) δ (ppm): 8.83 (d, 5.5 Hz, 2H, bpy H-6); 8.76 (d, J = 2.2 Hz, 2H, 
bpy H-3); 8.70 (d, J = 5.1, 2H, bpy H-6’); 8.48 (d, J = 7.9 Hz, 2H, bpy H-3’); 8.35 
(s, 2H, Tz); 7.92 (dd, J = 5.5 & 2.2 Hz, 2H, bpy H-5); 7.87 (td, J = 7.6 & 1.8 Hz, 
2H, bpy H-4’); 7.37 (dd, J = 4.7 & 1.0 Hz, 2H, bpy H-5’); 4.91 (s, 4H, Tz-CH2-
O); 13C NMR (CDCl3) δ (ppm): 158.7; 155.0; 151.3; 149.5; 146.4; 144.3; 137.2; 
124.6; 121.5; 120.7; 114.2; 110.8; 63.9 MS (ESI) m/z 511.2  (M + Na) HRMS 
(ESI) calcd: 511.171376, found: 511.171819. 
  
 72 
2.2.18 Synthesis of 1,4-bis-({4-(pyrid-2-yl)-1,2,3-triazol-1-yl}methyl)benzene 
(22)  
 
1,4-dibromomethylbenzene (0.25 g, 0.947 mmol) and sodium azide (0.125 g, 1.92 
mmol) were combined in dimethyl sulfoxide (10 mL). The mixture was stirred at 
room temperature for two hours. The following reagents were then added to the 
reaction mixture in the following order:  water (4.7 mL), pyridyl acetylene (0.41 
g, 3.98 mmol), CuSO4 (1M aqueous solution 2.50 mL), sodium ascorbate solution 
(1M aqueous solution 3.98 mL), and 2,6-lutidine (0.3 mL). The mixture was 
stirred at room temperature for 12 hours. The reaction mixture was then diluted 
with water (25 mL) and the solid filtered and washed with water (25 mL) and 
dilute ammonia (25 mL) and the product was recrystallised from dichloromethane 
and hexane to yield a white coloured solid. (0.32 g, 86.8 %) 
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1H NMR (CDCl3) δ (ppm): 8.46 (d, 4.8 Hz, 2H, py H-6); 8.10 (d, J = 7.5 Hz, 2H, 
py H-3); 7.99 (s, 2H, Tz); 7.70 (td, J = 7.7 & 1.7 Hz, 2H, py H-4); 7.20 (s, 4H, 
benzyl); 7.15 (dd, J = 4.8 & 1.0 Hz, 2H, py H-5); 5.52 (s, 4H, CH2-Benzyl); 13C 
NMR (CDCl3) δ (ppm): 150.1; 149.4; 136.9; 135.3; 129.0; 122.9; 122.0; 120.3; 
53.9 MS (ESI) m/z 417.2 (M + Na) HRMS (ESI) calcd: 417.154664, found: 
417.154751. 
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2.2.19 Synthesis of 1,3,5-tris-({4-(pyrid-2-yl)-1,2,3-triazol-1-
yl}methyl)benzene (23) 
 
1,3,5-tribromomethylbenzene (0.1 g, 0.28 mmol) and sodium azide (0.055 g, 1.92 
mmol) were combined in dimethyl sulfoxide (10 mL). The mixture was stirred at 
room temperature for two hours. The following reagents were then added to the 
reaction mixture in the following order:  water (4.7 mL), pyridyl acetylene (0.095 
g, 0.92 mmol), CuSO4 (1M aqueous solution 2.50 mL), sodium ascorbate solution 
(1M aqueous solution 3.98 mL), and 2,6-lutidine (0.3 mL). The mixture was 
stirred at room temperature for 12 hours. The reaction mixture was then diluted 
with water (25 mL) and the solid filtered and washed with water (25 mL) and 
dilute ammonia (25 mL) and the product was recrystallised from dichloromethane 
and hexane to yield a white coloured solid. (0.098 g, 63.4 %) 
1H NMR (Me2SO-d6) δ (ppm): 8.67 (s, 3H, Tz); 8.57 (d, 4.5 Hz, 3H, py H-6); 
8.00 (d, J = 7.5 Hz, 3H, py H-3); 7.88 (td, J = 7.8 & 1.7 Hz, 3H, py H-4); 7.37 (s, 
3H, benzyl); 7.34 (dd, J = 4.7 & 1.1 Hz, 3H, py H-5); 5.69 (s, 6H, CH2-Benzyl); 
13C NMR (Me2SO-d6) δ (ppm): 149.7; 149.4; 147.3; 137.0; 136.9; 127.2; 123.3; 
122.8; 119.2; 52.3 MS (ESI) m/z 575.2 (M + Na) HRMS (ESI) calcd: 575.213910, 
found: 575.214384.  
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2.3 Synthesis of Rhenium Complexes 
2.3.1 Synthesis of [Re(bpy)(CO)3(1a)] (2a) 
AgPF6OC
OC
OCCO
OC
CO
 
[Re(bpy)(CO)3Cl] (0.1 g, 0.217 mmol) and silver hexafluorophosphate (0.06 g, 
0.237 mmol) was dissolved in dichloromethane (15 mL) and stirred at room 
temperature for 12 hour in the dark. 4-phenyl-1-methyl-1,2,3-triazole (0.0380 g, 
0.239 mmol) was added to the solution and the mixture was stirred at room 
temperature for 48 hours in the dark. The solution was then filtered over celite and 
the filtrate was then evaporated to dryness under reduced pressure. The resulting 
residue was recrystallised from dichloromethane/diethyl ether to yield a yellow 
solid. (87 mg, 69%) 
1H NMR (CD3CN)  (ppm) 8.70 (d, J = 5.5 Hz, 2H, bpy); 8.31 (d, J = 8.2 Hz, 2H, 
bpy); 8.14 (t, J = 7.8 Hz, 2H); 7.66 (s, 1H, Tz); 7.55 (tt, J = 7.6, 1.7 Hz, 1H, p-Ph); 
7.45 (ddd, J = 7.0, 5.5, 1.2 Hz, 2H, bpy); 7.43 (t, J = 7.6 Hz, 2H, m-Ph); 7.16 (d, J 
= 7.7 Hz, 2H, o-Ph); 3.77 (s, 3H, Me); 13C NMR (CD3CN)  (ppm) 153.3; 152.7; 
140.1; 138.9; 129.9; 128.9; 127.2; 126.8; 126.7; 124.8; 123.0; 38.1;  MS (ESI) 
m/z 586.1 (M+)  HRMS (ESI) calcd: 586.088342, found: 586.088352. 
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2.3.2 Synthesis of [Re(bpy)(CO)3(1b)] (2b) 
AgPF6OC
OC
OCCO
OC
CO



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
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[Re(bpy)(CO)3Cl] (0.1 g, 0.217 mmol) and silver hexafluorophosphate (0.06 g, 
0.237 mmol) was dissolved in dichloromethane (15 mL) and stirred at room 
temperature for 12 hour in the dark. 4-phenyl-1-propyl-1,2,3-triazole (0.045 g, 
0.239 mmol) was added to the solution and the mixture was stirred at room 
temperature for 48 hours in the dark. The solution was then filtered over celite and 
the filtrate was then evaporated to dryness under reduced pressure. The resulting 
residue was recrystallised from dichloromethane/diethyl ether to yield a yellow 
solid. (101 mg, 76%) 
1H NMR (CD3CN)  (ppm): 8.72 (d, J = 6.1 Hz, 2H); 8.32 (d, J = 8.1 Hz, 2H); 
8.14 (t, J = 8.1 Hz, 2H) 7.69 (s, 1H); 7.56 (t, J = 7.4 Hz, 1H); 7.49–7.40 (m, 4H); 
7.22 (d, J = 8.1 Hz, 2H); 4.05 (t, J = 6.1 Hz, 2H); 1.57 (sextet, J = 7.1 Hz, 2H); 
0.48 (t, J = 7.4 Hz, 3H); 13C NMR (CD3CN)  (ppm): 155.7; 152.7; 150.0; 140.2; 
129.9; 129.8; 128.9; 127.9; 126.9; 125.4; 124.8; 53.4; 31.0; 10.9. MS (ESI) m/z 
614.1 (M+). HRMS (ESI) calcd: 614.119642, found: 614.118959. 
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2.3.3 Synthesis of [Re(bpy)(CO)3(1c)] (2c) 
OC
OCCO
CO
OC
OC
AgPF6
 
[Re(bpy)(CO)3Cl] (0.1 g, 0.217 mmol) and silver hexafluorophosphate (0.06 g, 
0.237 mmol) was dissolved in dichloromethane (15 mL) and stirred at room 
temperature for 12 hour in the dark. 4-phenyl-1-benzyl-1,2,3-triazole (0.056 g, 
0.239 mmol) was added to the solution and the mixture was stirred at room 
temperature for 48 hours in the dark. The solution was then filtered over celite and 
the filtrate was then evaporated to dryness under reduced pressure. The resulting 
residue was recrystallised from dichloromethane/diethyl ether to yield a yellow 
solid. (109 mg, 76%) 
1H NMR (CD3CN)  (ppm) 8.69 (d, J = 5.5 Hz, 2H, bpy); 8.24 (d, J = 8.2 Hz, 2H, 
bpy); 8.11 (td, J = 7.8, 1.5 Hz, 2H, bpy); 7.80 (s, 1H, Tz); 7.56 (t, J = 7.6 Hz, 1H, 
p-Ph); 7.45 (t, J = 7.8, 2H, m-Ph); 7.42 (ddd, J = 7.6, 5.5, 1.2 Hz, 2H, bpy); 7.37 
(t, J = 7.4 Hz, 1H, p-Bz); 7.31 (t, J = 7.5 Hz, 2H m-Bz); 7.25 (d, J = 7.5 Hz, 2H o-
Ph); 6.94 (d, J = 7.7 Hz, 2H, o-Bz); 5.23 (s, 2H, CH2); 13C NMR (CD3CN)  
(ppm) 156.9; 154.7; 151.8; 141.4; 134.2; 131.2; 131.1; 130.0; 129.9; 129.9; 129.3; 
129.2; 128.7; 126.6; 124.9; 55.9; MS (ESI) m/z 662.1 (M+).  HRMS (ESI) calcd: 
662.119642, found: 662.118805.  
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2.3.4 Synthesis of [Re(bpy)(CO)3(1d)] (2d) 
AgPF6OC
OC
OCCO
OC
CO
 
[Re(bpy)(CO)3Cl] (0.1 g, 0.217 mmol) and silver hexafluorophosphate (0.06 g, 
0.237 mmol) was dissolved in dichloromethane (15 mL) and stirred at room 
temperature for 12 hour in the dark. 4-(p-tolyl)-1-propyl-1,2,3-triazole (0.048 g, 
0.239 mmol) was added to the solution and the mixture was stirred at room 
temperature for 48 hours in the dark. The solution was then filtered over celite and 
the filtrate was then evaporated to dryness under reduced pressure. The resulting 
residue was recrystallised from dichloromethane/diethyl ether to yield a yellow 
solid. (98 mg, 72%). 
1H NMR (CD3CN)  (ppm): 8.71 (d, J = 5.5 Hz, 2H, bpy); 8.30 (d, J = 8.3 Hz, 2H, 
bpy); 8.13 (t, J = 8.0 Hz, 2H, bpy); 7.66 (s, 1H); 7.44 (t, J = 6.6 Hz, 2H, bpy); 7.23 
(d, J = 7.9 Hz, 2H, Ar); 7.06 (d, J = 7.9 Hz, 2H, Ar); 4.05 (t, J = 6.7 Hz, 2H); 2.44 
(s, 3H); 1.58 (sextet, J = 7.1 Hz, 2H); 0.49 (t, J = 7.4 Hz, 3H); 13C NMR (CD3CN) 
 (ppm) 156.8; 154.7; 151.4; 141.4; 130.7; 130.4; 129.2; 128.6; 126.4; 126.3; 
124.8; 54.0; 23.4; 21.4; 10.8; MS (ESI) m/z 628.1 (M+). HRMS (ESI) calcd: 
628.135292, found: 628.135919. 
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2.3.5 Synthesis of (4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole)ReCl(CO)3 
(18) 
 
[Re(CO)5Cl] (0.1 g, 0.28 mmol) and ligand (0.092 g, 0.308 mmol) was refluxed in 
toluene (25 mL) for 4 hours. The reaction mixture was allowed to cool to room 
temperature, at which point a yellow solid precipitated. The solid was collected by 
filtration and washed with ether. (0.12 g, 75 %) 
1H NMR (CD3CN) δ (ppm): 9.72 (s, 1H, Tz); 9.24-9.20 (m, 2H, bpy H-3 & bpy 
H-6); 9.09 (d, J = 5.6 Hz, 1H, bpy H-3’); 8.95 (d, J = 8.2 Hz, 1H, bpy H6’); 8.46 
(t, J = 7.9 Hz, 1H, bpy H-5’); 8.36 (dd, J = 2.2 & 6.2 Hz, 1H, bpy H-5); 7.98 (d, J 
= 7.7 Hz, 2H, o-Ph); 7.85 (t, J = 6.6 Hz, 1H, bpy H-4’); 7.58 (t, J = 7.6 Hz, 2H, m-
Ph); 7.46 (t, J = 7.4 Hz, 1H, p-Ph)  
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2.3.6 Synthesis of (4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)ReCl(CO)3 (15) 
 
[Re(CO)5Cl] (0.1 g, 0.28 mmol) and ligand (0.125 g, 0.308 mmol) was refluxed in 
toluene (25 mL) for 4 hours. The reaction mixture was allowed to cool to room 
temperature, at which point a orange solid precipitated. The solid was collected by 
filtration and washed with ether. (0.15 g, 73 %) 
1H NMR (CD3CN) δ (ppm): 9.30 (s, 1H, Tz); 9.19-9.16 (m, 2H, bpy H-3 & bpy 
H-6); 9.09 (d, J = 5.5 Hz, 1H, bpy H-3’); 8.98 (d, J = 8.4 Hz, 1H, bpy H6’); 8.47 
(td, J = 1.2 & 7.8 Hz, 1H, bpy H-5’); 8.34 (dd, J = 2.2 & 6.4 Hz, 1H, bpy H-5); 
7.84 (t, J = 6.5 Hz, 1H, bpy H-4’); 4.84 (t, J = 2.6, 2H, C5H4Fe); 4.45 (t, J = 1.7, 
2H, C5H4Fe); 4.14 (s, 5H, Cp);  
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2.4 Synthesis of Ruthenium Complexes 
2.4.1 Synthesis of [(4-azido-2,2’-bipyridyl)RuCl(p-cymene)]PF6 (6a) 
PF6
 
[RuCl2(p-cymene)]2 (0.1 g, 0.16 mmol) and 4-azido-2,2’-bipyridyl (0.098 g, 0.5 
mmol) was reacted in methanol (30 mL) for 12 hours at room temperature. The 
orange solution was concentrated to half its volume and treated with excess NaPF6 
to yield an yellow-orange precipitate, which was collected by filtration and 
washed with diethyl ether. (0.15 g, 76 %) 
1H NMR (CD3CN) δ (ppm): 9.34 (ddd, J = 5.7, 1.3 & 0.7 Hz, 1H, bpy H-6’); 9.15 
(d, J = 6.3 Hz, 1H bpy H-6); 8.35 (d, J = 8.1 Hz, 1H, bpy H-3’); 8.19 (td, J = 8.0 
& 1.4 Hz, 1H, bpy H-4’); 7.92 (d, J = 2.5 Hz, 1H, bpy H-3); 7.72 (ddd, J = 7.6, 5.7 
& 1.4 Hz, 1H, bpy H-5’); 7.37 (dd, J = 6.3 & 2.5 Hz, bpy H-5); 5.91 (t, J = 5.7 Hz, 
2H, Cym CH-CiPr); 5.71 (m, 2H, Cym CH-CMe); 2.65 (sept, J = 7.0 Hz, iPr CH); 
2.21 (s, 3H, Cym Me); 1.04 (d, J = 7.0 Hz, 3H, iPr CH3); 1.03 (d, J = 7.0 Hz, 3H, 
iPr CH3).  13C NMR (CD3CN) δ (ppm): 159.9; 159.8; 156.6; 155.3; 154.1; 140.9; 
129.0; 125.0; 118.8; 115.4; 106.1; 104.6; 87.4; 85.2; 31.9; 22.2; 19.0 MS (ESI) 
m/z 468.1 (M+) HRMS: calcd: 468.052349, found: 468.054448.  IR (ATR) 2124 
cm-1.  
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2.4.2 Synthesis of [(4,4’-azido-2,2’-bipyridyl)RuCl(p-cymene)]PF6 (6b) 
PF6
 
[RuCl2(p-cymene)]2 (0.1 g, 0.16 mmol) and 4,4’-azido-2,2’-bipyridyl (0.120 g, 
0.5 mmol) was reacted in methanol (30 mL) for 12 hours at room temperature. 
The orange solution was concentrated to half its volume and treated with excess 
NaPF6 to yield an yellow-orange precipitate, which was collected by filtration and 
washed with diethyl ether. (0.14 g, 66 %) 
1H NMR (CD3CN) δ (ppm): 9.15 (d, J = 6.4 Hz, 2H, bpy H-6); 7.94 (d, J = 2.4 
Hz, 2H, bpy H-3); 7.37 (dd, J = 6.4 & 2.4 Hz, 2H, bpy H-5) 5.90 (d, J = 6.2 Hz, 
2H, Cym CH-CiPr); 5.69 (d, J = 6.2 Hz, 2H, Cym CH-CMe); 2.65 (sept, J = 7.0 
Hz, iPr CH); 2.21 (s, 3H, Cym Me); 1.05 (d, J = 7.0 Hz, 3H, iPr CH3); 13C NMR 
(CD3CN) δ (ppm): 157.0; 156.5; 154.3; 119.1; 115.7; 105.9; 104.6; 87.3; 85.0; 
31.9; 22.3; 19.0 MS (ESI) m/z 509.1 (M+) HRMS: calcd: 509.0537, found: 
509.0559.  IR (ATR) 2125 cm-1. 
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2.4.3 Synthesis of [(4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole)RuCl(p-
cymene)]PF6 (8a) 
Route A
PF6
Route B
PF6
 
Route A 
[RuCl2(p-cymene)]2 (0.1 g, 0.16 mmol) and 4-phenyl-1-(2,2’-bipyrid-2-yl)-1,2,3-
triazole (0.150 g, 0.5 mmol) was reacted in methanol (30 mL) for 12 hours at 
room temperature. The yellow solution was concentrated to half its volume and 
treated with excess NaPF6 to yield an orange precipitate, which was collected by 
filtration and washed with diethyl ether. (0.15 g, 66%) 
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Route B 
[(4-azido-2,2’-bipyridyl)RuCl(p-cymene)] (0.1 g, 0.214 mmol) and 
phenylacetylene (0.033 g, 0.321 mmol) was dissolved in THF (30 mL) and water 
was added (30 mL). At 20 °C was added CuSO4 (1M aqueous solution 0.214 mL) 
was added followed by freshly prepared sodium ascorbate solution (1M aqueous 
solution 0.428 mL) dropwise. The solution was allowed to stir at room 
temperature for 12 hours. After removing the THF under vacuum, 
dichloromethane (30 mL) and concentrated ammonia solution (15 mL) was added 
to the solution. The solution was allowed to stir for a further 30 mins. at room 
temperature to remove remaining Cu(I). The organic phase was washed twice 
with water (30 mL) and once with brine (30 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the product was recrystallised from 
acetonitrile and ether to yield an orange coloured solid. (0.097 g, 80 %) 
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1H NMR (CD3CN) δ (ppm): 9.47 (d, J = 6.5 Hz, 1H, bpy H-6); 9.39 (d, J = 5.8 
Hz, 1H, bpy H-6’); 8.99 (s, 1H, Tz); 8.78 (d, J = 2.4 Hz, 1H, bpy H-3); 8.52 (d, J 
= 8.1 Hz, 1H, bpy H-3’); 8.27 (td, J = 7.9 & 1.3 Hz, 1H, bpy H-4’); 8.21 (dd, J = 
6.3 & 2.4 Hz, 1H, bpy H-5); 8.00 (m, 2H, o-Ph); 7.78 (ddd, 7.6, 5.7 & 1.3 Hz, 1H, 
bpy H-5’); 7.57 (t, J = 7.8 Hz, 2H, m-Ph); 7.48 (tt, J = 7.4 & 1.2 Hz, 1H, p-Ph); 
5.98 (m, 2H, Cym CH-CiPr); 5.78 (d, J = 6.3 Hz, 2H, Cym CH-CMe); 2.71 (sept, 
J = 7.0 Hz, 1H, iPr CH); 2.25 (s, 3H, Cym CH3); 1.08 (d, J = 7 Hz, iPr CH3); 1.07 
(d, J = 7 Hz, iPr CH3). 13C NMR (CD3CN) δ (ppm): 157.9; 157.5; 156.7; 155.0; 
149.9; 146.3; 141.0; 130.5; 130.2; 130.0; 129.2; 126.7; 125.3; 120.1; 117.7; 
114.4; 106.5; 104.7; 87.5; 87.4; 85.5; 85.4; 31.8; 22.1; 18.9.  MS (ESI) m/z 570.1 
(M+) HRMS: calcd: 570.099300, found: 570.099993 
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2.4.4 Synthesis of [(4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole)RuCl(p-
cymene)]PF6 (8b) 
Route A
PF6
 
Route B 
PF6
 
Route A 
[RuCl2(p-cymene)]2 (0.1 g, 0.16 mmol) and 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-
1,2,3-triazole (0.204 g, 0.5 mmol) was reacted in methanol (30 mL) for 12 hours 
at room temperature. The red solution was concentrated to half its volume and 
treated with excess NaPF6 to yield an orange-red precipitate, which was collected 
by filtration and washed with diethyl ether. (0.21g, 79%) 
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Route B 
[(4-azido-2,2’-bipyridyl)RuCl(p-cymene)] (0.1 g, 0.214 mmol) and 
ethynylferrocene (0.067 g, 0.321 mmol) was dissolved in THF (30 mL) and water 
was added (30 mL). At 20 °C was added CuSO4 (1M aqueous solution 0.214 mL) 
was added followed by freshly prepared sodium ascorbate solution (1M aqueous 
solution 0.428 mL) dropwise. The solution was allowed to stir at room 
temperature for 12 hours. After removing the THF under vacuum, 
dichloromethane (30 mL) and concentrated ammonia solution (15 mL) was added 
to the solution. The solution was allowed to stir for a further 30 mins. at room 
temperature to remove remaining Cu(I). The organic phase was washed twice 
with water (30 mL) and once with brine (30 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the product was recrystallised from 
acetonitrile and ether to yield a red coloured solid. (0.10 g, 69 %) 
1H NMR (CD3CN) δ (ppm): 9.44 (d, 6.2 Hz, 1H, bpy H-6’); 9.38 (d, H = 5.5 Hz, 
1H, bpy H-6); 8.73 (bs, 1H, bpy H-3); 8.64 (s, 1H, Tz); 8.53 (d, J = 7.9 Hz, 1H, 
bpy H-3’); 8.27 (t, J = 7.9 Hz, 1H, bpy H-4’); 8.17 (d, J = 5.6 Hz, 1H, bpy H-5); 
7.77 (t, J = 6.5 Hz, 1H, bpy H-5’); 5.98 (t, J = 5.6 Hz, 2H, Cym CH-CiPr); 5.78 
(d, J = 6.5 Hz, 2H, Cym CH-CMe); 4.85 (s, 2H, Fc -C5H4); 4.42 (s, 2H, Fc -
C5H4); 4.13 (s, 5H, Cp); 2.70 (sept, J = 6.9 Hz, iPr CH); 2.24 (s, 3H, Cym Me); 
1.07 (d, J = 6.9 Hz, iPr CH3); 1.07 (d, J = 6.9 Hz, iPr CH3).  13C NMR (CD3CN) δ 
(ppm): 157.9; 157.5; 156.8; 155.2; 149.9; 146.4; 141.1; 129.3; 125.4; 118.8; 
117.6; 114.2; 106.5; 104.9; 87.6; 87.5; 85.5; 85.4; 70.8; 70.4; 68.0; 31.9; 22.3; 
19.0 MS (ESI) m/z . 678.1 (M+) HRMS: calcd: 678.065542 , found: 678.068143 
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2.4.5 Synthesis of [(4-pyrid-2-yl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole)RuCl(p-
cymene)]PF6 (8c) 
PF6
 
[(4-azido-2,2’-bipyridyl)RuCl(p-cymene)] (0.1 g, 0.214 mmol) and 2-
ethynylpyridine (0.033 g, 0.321 mmol) was dissolved in THF (30 mL) and water 
was added (30 mL). At 20 °C was added CuSO4 (1M aqueous solution 0.214 mL) 
was added followed by freshly prepared sodium ascorbate solution (1M aqueous 
solution 0.428 mL) dropwise. The solution was allowed to stir at room 
temperature for 12 hours. After removing the THF under vacuum, 
dichloromethane (30mL) and concentrated ammonia solution (15 mL) was added 
to the solution. The solution was allowed to stir for a further 12 hours. at room 
temperature to remove any remaining Cu(I). The organic phase was washed twice 
with water (30 mL) and once with brine (30 mL) and dried over MgSO4. The 
solvent was removed under vacuum and the product was recrystallised from 
acetonitrile and ether to yield an orange coloured solid. (0.057 g, 47 %) 
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1H NMR (CD3CN) δ (ppm): 9.45 (d, J= 6.4 Hz, 1H, bpy H-6); 9.36 (dd, J = 5.7 & 
1.0 Hz, 1H, bpy-H6’); 9.14 (s, 1H, Tz); 8.74 (d, J = 1.9 Hz, 1H; bpy-H3); 8.66 (s, 
1H, Py-H3); 8.50 (d, J = 7.6 Hz, 1H, bpy-H3’); 8.28-8.16 (m, 3H, bpy-H4’, bpy-
H5 & Py-H4); 7.91 (t, J = 7.7 Hz, 1H, Py-H5); 7.73 (td, J = 6.4 & 1.0 Hz, 1H, 
bpy-H5’); 7.39 (s, 1H, Py-H6); 5.9 (t, J = 6.3 Hz, 2H, Cym CH-CiPr); 5.76 (d, J = 
6.3 Hz, 2H, Cym CH-CMe); 2.68 (sept, J = 6.8 Hz, 1H, iPr CH); 2.16 (s, 3H, Cym 
CH3); 1.06 (d, J = 1.8 Hz, iPr CH3); 1.04 (d, J = 1.8 Hz, iPr CH3).   13C NMR 
(CD3CN) δ (ppm): 157.9; 157.6; 156.8; 155.0; 151.1; 150.9; 150.0; 146.3; 141.1; 
138.3; 129.3; 125.5; 124.9; 122.1; 121.3; 118.1; 114.6; 106.5; 104.8; 87.6; 87.5; 
85.5; 85.4; 31.9; 22.2; 19.0 MS (ESI) m/z . 571.1 (M+) HRMS: calcd: 
571.094548, found: 571.095033 
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2.4.6 Synthesis of [(4-pyridyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole)(RuCl(p-
cymene))2]2PF6 (9) 
2Cl 2PF6
 
[RuCl2(p-cymene)]2 (0.313 g, 0.5 mmol) and 4-pyridyl-1-(2,2’-bipyrid-4-yl)-
1,2,3-triazole (0.150 g, 0.5 mmol) was reacted in ethanol (50 mL) for 48 hours. 
Hexane was added under stirring to the orange-yellow solution until slight 
turbidity was achieved. The mixture was allowed to stand at 4 °C for 2 hours and 
then filtered. Evaporating the solution to dryness afford the product as an orange-
brown solid which was dissolved in acetonitrile (3 mL) and a solution of AgPF6 
(0.06 g, 0.22 mmol) in acetonitrile (2 mL) was added dropwise whilst stirring. 
The reaction mixture was stirred for a further 10 minutes and filtered through 
celite, and evaporated to dryness to yield an orange-brown solid. (0.22 g, 88 %) 
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1H NMR (CD3CN) δ (ppm): 9.58 (dd, J = 5.2 & 1.6 Hz, 1H, bpy H-6); 9.44 (d, J = 
9.6 Hz, 1H, Tz); 9.39 (dt, J = 5.6 & 1.3 Hz, 1H, bpy H-6’); 9.33 (d, J = 5.4 Hz, 
1H, Py H6); 8.34 (dd, J = 13.2 & 2.3 Hz, 1H, bpy H-3); 8.56 (t, J = 7.7 Hz, bpy H-
3’); 8.25 (m, 3H, bpy H-4’, bpy H-5 & Py H-4); 8.08 (d, J = 7.9 Hz, 1H, Py H-3); 
7.80 (m, 1H, bpy H-5’); 7.69 (t, J = 6.6 Hz, 1H, Py H-5); 6.09 (d, 6.0 Hz, 1H, 
cymene pytz); 6.00 (m, 3H, cymene bpy); 5.89 (dd, J = 6.0 & 2.5 Hz, 1H, cymene 
bpy); 5.81 (m, 3H, cymene pytz); 2.78 (sept, J = 6.4 Hz, 1H, iPr CH pytz); 2.69 
(m, 1H, iPr CH bpy); 2.23 (d, J = 3.6 Hz, 3H, Cym Me bpy); 2.21 (s, 3H, Cym Me 
pytz); 1.16 (dd, 6.4 & 1.6 Hz, 3H, iPr CH3 pytz); 1.11 (d, 6.8 Hz, 3H, iPr CH3 
pytz); 1.07 (d, J = 7.0 Hz, 6H, iPr CH3 bpy)  13C NMR (CD3CN) δ (ppm): 158.4; 
158.0; 156.9; 156.8; 154.7; 149.0; 148.0; 148.3; 145.3; 145.2; 141.7; 141.3; 
141.2; 129.7; 128.0; 125.7; 124.4; 124.3; 124.0; 118.6; 118.5; 118.3; 115.3;115.2; 
107.2; 107.2; 107.0; 106.9; 105.1; 105.1; 104.0; 103.9; 87.9; 87.8; 87.6; 87.2; 
87.2; 86.2; 85.8; 85.7; 85.7; 85.6; 85.6; 84.8; 32.0; 31.9; 22.5; 22.3; 22.3; 22.0; 
22.0; 19.0; 18.9  MS (ESI) m/z . 421.0 (M2+) HRMS: calcd: 421.038376, found: 
421.040178 
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2.4.7 Synthesis of [(4-pyrid-2-yl-1-benzyl-1,2,3-triazole)RuCl(p-
cymene)]PF6 (11) 
Cl PF6
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[RuCl2(p-cymene)]2 (0.313 g, 0.5 mmol) and 4-pyridyl-1-benzyl-1,2,3-triazole 
(0.223 g, 1.0 mmol) was reacted in ethanol (50 mL) for 48 hours. Hexane was 
added under stirring to the orange-yellow solution until slight turbidity was 
achieved. The mixture was allowed to stand at 4 °C for 2 hours and then filtered. 
Evaporating the solution to dryness afford an orange-brown solid which was 
dissolved in acetonitrile (3 mL) and a solution of AgPF6 (0.143 g, 0.564 mmol) in 
acetonitrile (2 mL) was added dropwise whilst stirring. The reaction mixture was 
stirred for a further 10 minutes and filtered through celite, and evaporated to 
dryness to yield an orange-brown solid. (0.34 g, 93%) 
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1H NMR (CD3CN) δ (ppm): 9.23 (d, J = 5.4 Hz, 1H, Py H-6); 8.56 (s, 1H, Tz); 
8.09 (td, J = 7.9 & 1.3 Hz, 1H, Py H-4); 7.92 (d, J = 7.9 Hz, 1H, Py H-3); 7.57 (td, 
J = 6.9 & 1.3, 1H, Py H-5) 7.46 (m, 5H, benzyl)  6.00-5.60 (m, 6H, Cym CH-
CiPr, Cym CH-Me & CH2-Benzyl); 2.63 (sept, J = 6.9 Hz, iPr CH); 2.16 (s, 3H, 
Cym Me); 1.09 (d, J = 6.9 Hz, iPr CH3); 0.94 (d, J = 6.9 Hz, iPr CH3)  13C NMR 
(CD3CN) δ (ppm):156.3; 149.1; 147.4; 141.1; 134.8; 130.2; 129.6; 127.0; 125.8; 
123.5; 106.1; 103.1; 86.5; 85.2; 85.1; 84.5; 56.9; 31.7; 22.4; 21.6; 18.7; MS (ESI) 
m/z . 507.1 (M+) HRMS: calcd: 507.088400 , found: 507.090438 
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2.4.8 Synthesis of [(di-([1-{2,2’-bipyrid-4-yl}-1,2,3-triazol-4-
yl]methyl)ether)(RuCl(p-cymene))2]2PF6 (12) 
PF6
2PF6
 
[(4-azido-2,2’-bipyridyl)RuCl(p-cymene)] (0.1 g, 0.214 mmol) and propargyl 
ether (0.012 g, 0.130 mmol) was dissolved in THF (30 mL) and water was added 
(30 mL). At 20 °C was added CuSO4 (1M aqueous solution 0.214 mL) was added 
followed by freshly prepared sodium ascorbate solution (1M aqueous solution 
0.428 mL) dropwise. The solution was allowed to stir at room temperature for 24 
hours. After removing the THF under vacuum, dichloromethane (30 mL) and 
concentrated ammonia solution (15 mL) was added to the solution. The solution 
was allowed to stir for a further 2 hours at room temperature to remove any 
remaining Cu(I). The organic phase was washed twice with water (30 mL) and 
once with brine (30 mL) and dried over MgSO4. The solvent was removed under 
vacuum and the product was recrystallised from acetonitrile and ether to yield a 
red coloured solid. (0.084 g, 60 %) 
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1H NMR (CD3CN) δ (ppm): 9.47 (dd, 6.3 & 1.3 Hz, 2H, bpy H-6); 9.39 (d, J = 5.7 
Hz, 2H, bpy H-6’); 9.30 (2 x s, 2H, Tz); 9.14 (dd, J = 2.2 & 7.2 Hz, 2H, bpy H-3); 
8.90 (t, J = 8.3 Hz, 2H, bpy H-3’); 8.37 (dt, J = 6.3 & 2.2 Hz, 2H, bpy H-5); 8.21 
(tt, J = 7.7 & 1.3 Hz, 2H, bpy H-4’); 7.76 (tt, J = 6.6 & 1.3 Hz, 2H, bpy H-4’); 
5.99 (t, J = 7.4 Hz, 4H, Cym CH-CiPr); 5.79 (d, J = 6.5 Hz, 4H, Cym CH-CMe); 
4.86 (s, 4H, Tz-CH2-O); 2.70 (sept, J = 6.8 Hz, 2H, iPr CH); 2.23 (s, 6H, Cym 
Me); 1.07 (d, J = 6.8 Hz, iPr CH3); 1.06 (d, J = 6.8 Hz, iPr CH3) 13C NMR 
(CD3CN) δ (ppm): 157.9; 157.8; 156.7; 155.4; 147.7; 147.7; 146.7; 141.1; 129.2; 
126.0; 123.9; 114.9; 106.5; 104.8; 87.6; 87.5; 85.6; 85.5; 64.1; 31.9; 22.3; 19.0 
MS (ESI) m/z . 515.1 (M2+) HRMS: calcd: 515.0733 , found: 515.0781 
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2.4.10 Synthesis of [Ru(bpy)2(4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6)2 (16) 
2PF6
 
[Ru(bpy)2Cl2] (0.1 g, 0.21 mmol) and ligand 5a (0.068 g, 0.231 mmol) were 
dissolved in ethanol (25 mL). The resulting solution was refluxed for 4 hours. The 
solution was allowed to cool to room temperature and was purified by column 
chromatography (silica gel, MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5)). The desired 
fraction was evaporated to dryness and then redissolved in ethanol, the product 
was precipitated as red crystals by addition of excess NaPF6. (0.13 g, 61 %) 
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1H NMR (CD3CN)  (ppm): 8.98 (s, 1H, Tz); 8.94 (d, J = 1.1 Hz, 1H, Tz sub-bpy 
H-3) 8.72 (d, J = 8.0 Hz, 1H, Tz sub-bpy H-3’); 8.52 (t, J = 8.5 Hz, 4H unsub-
bpy); 8.12 (t, J = 7.9 Hz, 1H, Tz sub-bpy H-4’) 8.10-8.04 (m, 4H, unsub-bpy); 
7.95 (d, J = 7.2, 2H, o-Ph); 7.89 (d, J = 1.3 Hz, 1H, Tz sub-bpy H-5 & Tz sub-bpy 
H-6); 7.85 (d, J = 5.2 Hz, 1H, unsub-bpy); 7.79 (t, J = 5.8 Hz, 2H, Tz sub-bpy H-
6’ & unsub-bpy); 7.75 (t, J = 6.4 Hz, unsub-bpy); 7.51-7.45 (m, 2H, m-Ph & 
unsub-bpy) 7.45-7.37 (m, 5H, Tz sub-bpy H-5’ & p-Ph & unsub-bpy); (CD3CN)  
(ppm): 160.0; 158.0; 157.9; 157.9; 157.4; 154.3; 152.9; 152.8; 152.7; 152.6; 
149.8; 144.8; 138.9; 130.6; 130.1; 129.9; 129.2; 128.7; 128.6; 128.6; 126.7; 
125.9; 125.3; 125.3; 119.9; 117.9; 115.0  (ESI) m/z 858.1 (M+ PF6-).  HRMS 
(ESI) calcd:, 858.122574 found: 858.1208 
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2.4.11 Synthesis of [Ru(bpy)2(4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6)2 (13) 
2PF6
 
[Ru(bpy)2Cl2] (0.1 g, 0.21 mmol) and ligand 5b (0.094 g, 0.231 mmol) were 
dissolved in ethanol (25 mL). The resulting solution was refluxed for 4 hours. The 
solution was allowed to cool to room temperature and was purified by column 
chromatography (silica gel, MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5)). The desired 
fraction was evaporated to dryness and then redissolved in ethanol, the product 
was precipitated as red crystals by addition of excess NaPF6. (0.17 g, 72 %) 
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1H NMR (CD3CN) δ (ppm): 8.89 (d, J = 2.0 Hz, 1H, Tz sub-bpy H-3); 8.69 (d, J = 
8.1 Hz, 1H, Tz sub-bpy H-3’) 8.60 (s, 1H, Tz); 8.51 (t, J = 8.0 Hz, 4H unsub-bpy); 
8.12 (t, J = 8.0, 1H, Tz sub-bpy H-4’); 8.09-8.04 (m, 4H, unsub-bpy); 7.88-7.81 
(m, 3H, Tz sub-bpy H-5 & unsub-bpy); 7.79-7.71 (m, 4H, Tz sub-bpy H-6’ & 
unsub-bpy); 7.45 (t, J = 6.5 Hz, sub-bpy H-5’); 7.43-7.38 (m, 4H, Tz sub-bpy H-6 
& unsub-bpy); 4.82 (t, J = 1.8 Hz, 2H, C5H4Fe); 4.39 (t, J = 1.6 Hz, 2H, C5H4Fe); 
4.14 (s, 5H, Cp); 13C NMR (CD3CN)  (ppm): 159.9; 158.0; 157.5; 154.3; 153.0; 
152.8; 152.7; 149.9; 144.9; 139.0; 129.2; 128.7; 128.6; 125.9; 125.4; 117.7; 
114.9; 75.1; 70.6; 70.2; 67.9  (ESI) m/z 966.1 (M+ PF6-).  HRMS (ESI) calcd: 
966.088816 found: 966.0797. 
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2.4.12 Synthesis of [{Ru(bpy)2}2(4-pyrid-2-yl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6)4 (24) 
 
Ru(bpy)2Cl2 (0.323 g, 0.666 mmol), ligand 5c (0.1 g, 0.333 mmol) and AgPF6 
(0.168 g, 0.666 mmol) were dissolved in ethanol (100 mL). The resulting solution 
was refluxed for 48 hours with exclusion of light. The solution was allowed to 
cool to room temperature and was filtered through celite to remove AgCl as a 
white solid and washed with acetonitrile (25 mL). The product was purified by 
column chromatography (silica gel, MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5)). The 
desired fraction was evaporated to dryness and then redissolved in ethanol, the 
product was precipitated as red crystals by addition of excess NaPF6. (0.22 g, 
39%) 
  
 101 
1H NMR (CD3CN) δ (ppm): 9.84 & 9.82 (2 x s, 1H, Tz); 8.84 (dd, J = 13.4 & 2.4 
Hz, 1H); 8.68 (t, J = 7.8 Hz, 1H); 8.55-8.39 (m, 8H); 8.30 (dd, J = 7.7 & 4.4 Hz, 
1H; 8.14-7.95 (m, 11H); 7.89 (t, J = 6.1 Hz, 1H); 7.85-7.80 (m, 2H); 7.79-7.73 (m, 
3H); 7.73-7.67 (m, 3H); 7.66 (d, J = 5.9 Hz, 1H); 7.61 (dt, J = 5.9 & 2.1 Hz); 
7.48-7.30 (m, 10H)  13C NMR (CD3CN) (ppm): 160.5; 160.4; 158.6; 158.6; 158.3;  
158.2; 158.0; 157.9; 157.1; 154.6; 153.3; 153.2; 153.2; 153.1; 153.0; 153.0; 
153.0; 152.8; 152.7; 151.0; 150.6; 150.5; 143.5; 139.7; 139.2; 139.2; 139.1; 
138.9; 129.5; 128.8; 128.7; 128.6; 127.9; 127.8; 126.2; 126.1; 125.4; 125.3; 
125.0; 125.0; 125.0; 124.6; 124.3; 124.3; 115.3 (ESI) m/z 282.1 (M4+) HRMS 
(ESI) calcd: 282.0485, found: 282.0503  
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2.4.13 Synthesis of [Ru(bpy)2(4-pyrid-2-yl-1-benzyl-1,2,3-triazole)](PF6)2 (26) 
2PF6
 
[Ru(bpy)2Cl2] (0.1 g, 0.21 mmol) and ligand 10 (0.055 g, 0.231 mmol) were 
dissolved in ethanol (25 mL). The resulting solution was refluxed for 4 hours. The 
solution was allowed to cool to room temperature and was purified by column 
chromatography (silica gel, MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5)). The desired 
fraction was evaporated to dryness and then redissolved in ethanol, the product 
was precipitated as red crystals by addition of excess NaPF6. (0.12 g, 61%) 
1H NMR (CD3CN) δ (ppm): 8.64 (s, 1H, Tz); 8.54 (dd, J = 8.1 & 3.0 Hz, 2H); 
8.46 (dd, J = 13.0 & 8.8 Hz, 2H); 8.12-8.06 (m, 4H); 8.03 (td, J = 7.8 & 1.3 Hz, 
1H); 7.98 (td, J = 7.8 & 1.3 Hz, 1H); 7.89 (d, J = 5.8 Hz, 2H); 7.83 (d, J = 5.2 Hz, 
1H); 7.76 (d, J = 5.6 Hz, 1H); 7.61 (d, J = 5.6 Hz, 1H); 7.48-7.34 (m, 6H); 7.30 
(td, J = 6.3 & 1.4 Hz, 1H); 7.18 (dd, J = 7.4 & 1.4 Hz, 2H); 5.54 (d, J = 2.5 Hz, 
2H, benzyl H) 13C NMR (CD3CN) (ppm): 158.7; 158.4; 158.3; 158.1; 153.2; 
153.1; 152.8; 152.7; 151.9; 148.9; 139.3; 138.8; 138.8; 138.8; 138.7; 134.7; 
130.1; 130.1; 129.2; 128.6; 128.5; 128.5; 127.8; 127.0; 126.7; 125.3; 125.2; 
124.8; 124.5; 123.8; 56.6 (ESI) m/z 325.1 (M2+) HRMS (ESI) calcd: 325.0735, 
found: 325.0738  
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2.5 Synthesis of Iridium Complexes 
2.5.1 Synthesis of [Ir(ppy)2(4,4’-azido-2,2’-bipyridyl)]PF6 (7).  
PF6
 
[Ir(ppy)2Cl]2 ( 262 mg, 0.24 mmol) and AgPF6 ( 140 mg, 0.55 mmol) were 
dissolved in acetonitrile (20 cm3) and stirred in the dark for 2 hours.  The mixture 
was then filtered through celite, the celite pad was washed with dichloromethane 
(40 cm3) and the combined filtrate and washing were reduced to dryness.  The 
residue was dissolved in dichloromethane (20 cm3) and 4b was added (117 mg, 
0.48 mmol) and the mixture stirred for 1 hour.  During this time, the reaction 
mixture turned dark brown.  The volume of solution was reduced by half and 
diethylether (50 cm3) was added with stirring to precipitate the complex as a 
brownish yellow powder which was filtered and washed with diethylether.  (376 
mg, 89 %) 
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1H NMR (CDCl3) δ 8.00 (d, J = X Hz, 2H, bpy(N3)2 H-3); 7.91 (d, J = X Hz, 2H, 
ppy H-X); 7.81 (d, J = X Hz, 2H, bpy(N3)2 H-6); 7.78 (t, J = X Hz, 2H, ppy H-X); 
7.67 (m, 4H, ppy H-X & H-X); 7.13 (d, J = X Hz, 2H, ppy H-X); 7.03 (m, 4H, 
ppy H-X & bpy(N3)2 H-5); 6.92 (t, J = X Hz, 2H, ppy H-X); 6.31 (d, J = X Hz, 
2H, ppy H-X).MS (ESI) m/z 739.2 (M+) HRMS: calcd: 739.165266, found: 
739.165101.  IR (ATR) 2119 cm-1. 
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2.5.2 Synthesis of [Ir(ppy)2(4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6) (17) 
PF6
 
[Ir(ppy)2Cl]2 (0.107 g, 0.10 mmol) and AgPF6 (0.053 g, 0.21 mmol) were 
dissolved in MeCN (25 mL) and stirred for 2 hours at room temperature in the 
dark. The yellow solution was filtered through celite to remove AgCl as a white 
solid and washed with acetonitrile (10 mL). To the resulting yellow solution, was 
added ligand 5a (0.063 g, 0.21 mmol) and the solution was stirred for a further 24 
hours at room temperature in the dark. The solvent was removed and the resulting 
orange solid was recrystallised to with dichloromethane/ether to yield yellow 
crystals. (0.11 g, 58 %) 
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1H NMR (CD3CN) δ (ppm): 8.99 (s, 1H, Tz); 8.97 (d, J = 2.7 Hz, 1H, Tz sub-bpy 
H-3) 8.73 (d, J = 8.2 Hz, 1H, Tz sub-bpy H-3’); 8.19 (t, J = 7.0 Hz, 1H, Tz sub-
bpy H-4’); 8.11 (d, J = 6.0 Hz, 1H, Tz sub-bpy H-6); 8.07 (t, J = 7.4 Hz, 2H, ppy); 
8.03 (d, J = 5.7 Hz, 1H, Tz sub-bpy H-6’); 7.99 (dd, J = 6.4 & 2.3 Hz, 1H, Tz sub-
bpy H-5); 7.96 (d, J = 7.0 Hz, 2H, o-Ph); 7.88-7.79 (m, 4H, ppy); 7.71 (d, J = 5.7 
Hz, 1H, ppy); 7.65 (d, J = 5.3 Hz, 1H, ppy); 7.56 (t, J = 6.4 Hz, 1H, Tz sub-bpy H-
5’); 7.52 (t, J = 7.4 Hz, 2H, m-Ph); 7.43 (t, J = 8.0 Hz, 1H, p-Ph); 7.09-7.01 (m, 
4H, ppy); 6.96-6.90 (m, 2H, ppy); 6.29 (t, J = 7.4 Hz, 2H, ppy) 13C NMR 
(CD3CN)  (ppm): 168.3; 159.1; 156.1; 153.3; 151.9; 150.9; 150.8; 150.3; 150.3; 
149.9; 145.9; 145.1; 145.0; 140.5; 139.6; 132.6; 132.5; 131.4; 131.4; 130.6; 
130.2; 130.0; 130.0; 126.7; 126.2; 125.9; 125.9; 124.6; 124.4; 123.7; 123.6; 
120.9; 120.0; 118.7; 115.4  (ESI) m/z 800.2 (M+)  HRMS (ESI) calcd: 
800.200819, found: 800.195416 
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2.5.3 Synthesis of [Ir(ppy)2(4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6) (14) 
PF6
 
[Ir(ppy)2Cl]2 (0.107 g, 0.10 mmol) and AgPF6 (0.053 g, 0.21 mmol) were 
dissolved in acetonitrile (25 mL) and stirred for 2 hours at room temperature in 
the dark. The yellow solution was filtered through celite to remove AgCl as a 
white solid and washed with acetonitrile (10 mL). To the resulting yellow 
solution, was added ligand 5b (0.063 g, 0.21 mmol) and the solution was stirred 
for a further 24 hours at room temperature in the dark. The solvent was removed 
and the resulting orange solid was recrystallised to with dichloromethane/ether to 
yield yellow crystals. The product was purified by column chromatography (silica 
gel, MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5)) and the desired fraction was evaporated 
to dryness and redissolved in dichloromethane and stirred with excess NaPF6 for 2 
hours. Water was added to the solution and the dichloromethane layer was kept, 
the aqueous layer was washed with dichloromethane (3 x 25 mL) and the 
combined dichloromethane fractions were evaporated to dryness to yield an 
orange solid. (0.13 g, 62 %)  
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1H NMR (CD3CN) δ (ppm): 8.90 (d, J = 2.0 Hz, 1H, Tz sub-bpy H-3); 8.71 (d, J = 
8.0 Hz, 1H, Tz sub-bpy H-3’) 8.59 (s, 1H, Tz); 8.20 (t, J = 8.4, 1H, Tz sub-bpy H-
4’); 8.11-8.05 (m, 4H, Tz sub-bpy H-3’ & ppy); 8.03 (d, J = 4.7 Hz1H, Tz sub-
bpy H-6’); 7.94 (dd, J = 6.4 & 2.0 Hz, 1H, Tz sub-bpy H-5); 7.88-7.79 (m, 4H, 
ppy); 7.70 (d, J = 6.4 Hz, 1H, ppy); 7.65 (d, J = 5.7 Hz, 1H, ppy); 7.56 (t, J = 6.4 
Hz, 1H, Tz sub-bpy H-5’) 7.10-7.01 (m, 4H, ppy); 6.96-6.90 (m, 2H, ppy); 6.29 (t, 
J = 7.0 Hz, 2H, ppy); 4.82 (t, J = 1.7 Hz, 2H, C5H4Fe); 4.39 (t, J = 1.7 Hz, 2H, 
C5H4Fe); 4.14 (s, 5H, Cp); 13C NMR (CD3CN) (ppm): 168.5; 159.1; 156.2; 153.3; 
151.9; 150.8; 150.4; 150.3; 149.9; 145.9; 145.1; 145.1; 140.5; 139.7; 132.6; 
132.6; 131.5; 131.5; 130.1; 126.2; 126.0; 126.0; 124.6; 124.5; 123.7; 123.7; 
121.0; 118.7; 118.6; 115.3; 75.1; 70.6; 70.2; 67.9  (ESI) m/z 908.2 (M+) HRMS 
(ESI) calcd: 908.177062, found: 908.1532 
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2.5.4 Synthesis of [{Ir(ppy)2}2(4-pyrid-2-yl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole)](PF6)2 (25) 
 
[Ir(ppy)2Cl]2 (0.356 g, 0.333 mmol) and AgPF6 (0.168 g, 0.666 mmol) were 
dissolved in MeCN (100 mL) and stirred for 2 hours at room temperature in the 
dark. The yellow solution was filtered through celite to remove AgCl as a white 
solid and washed with acetonitrile (25 mL). To the resulting yellow solution, was 
added ligand 5c (0.10 g, 0.333 mmol) and the solution was stirred for a further 48 
hours at reflux in the dark. The solvent was removed and the resulting orange 
solid was recrystallised to with dichloromethane/ether to yield yellow crystals. 
The product was purified by column chromatography (silica gel, MeCN/H2O/sat. 
KNO3 (aq.) (7:1:0.5)) and the desired fraction was evaporated to dryness and 
redissolved in dichloromethane and stirred with excess NaPF6 for 2 hours. Water 
was added to the solution and the dichloromethane layer was kept, the aqueous 
layer was washed with dichloromethane (3 x 25 mL) and the combined 
dichloromethane fractions were evaporated to dryness to yield an orange solid. 
(0.24 g, 45 %)   
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1H NMR (CD3CN) δ (ppm): 9.84 & 9.72 (2 x s, 1H, Tz); 9.51 & 9.42 (2 x d, 1H); 
9.47 (t, J = 8.9 Hz, 1H); 8.23-7.90 (m, 9H); 7.90-7.75 (m, 10H); 7.75-7.64 (m, 
3H); 7.62 & 7.58 (2 x d, 1H); 7.53 (t, J = 6.4 Hz, 1H); 7.42 (t, J = 6.8 Hz, 1H); 
7.11-6.87 (m, 11H); 6.85-6.80 (m, 1H); 6.28-6.23 (m, 4H) 13C NMR (CD3CN) 
(ppm): 167.3; 167.3; 167.1; 167.0; 167.0; 166.9; 166.7; 166.7; 158.7; 158.6; 
154.8; 152.3; 152.3; 150.4; 150.2; 150.1; 150.1; 149.6; 149.6; 149.4; 149.2; 
149.1; 149.0; 148.9; 148.5; 148.5; 145.4; 145.3; 144.1; 144.1; 144.0; 143.8; 
143.7; 143.7; 143.7; 139.8; 139.3; 138.4; 138.4; 138.3; 138.3; 138.2; 131.5; 
131.2; 131.1; 131.0; 130.9; 130.1 ;130.0; 129.3; 129.3; 128.8; 128.8; 127.0; 
126.5; 126.4; 126.2; 126.1; 124.6; 124.5; 124.0; 124.0; 123.3; 123.2; 123.2; 
123.2; 123.1; 123.1; 123.0; 122.5; 122.3; 122.0; 119.6; 119.6; 119.5; 119.4; 
119.3; 117.8; 117.7; 115.4; 115.3 (ESI) m/z 651.2 (M2+)  HRMS (ESI) calcd: 
651.149896, found: 651.1499 
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2.5.5 Synthesis of [Ir(ppy)2(4-pyrid-2-yl-1-benzyl-1,2,3-triazole)](PF6) (27) 
 
PF6
 
[Ir(ppy)2Cl]2 (0.107 g, 0.10 mmol) and AgPF6 (0.053 g, 0.21 mmol) were 
dissolved in acetonitrile (25 mL) and stirred for 2 hours at room temperature in 
the dark. The yellow solution was filtered through celite to remove AgCl as a 
white solid and washed with acetonitrile (10 mL). To the resulting yellow 
solution, was added ligand 10 (0.055 g, 0.21 mmol) and the solution was stirred 
for a further 24 hours at room temperature in the dark. The solvent was removed 
and the resulting yellow solid was recrystallised to with dichloromethane/ether to 
yield yellow crystals. The product was purified by column chromatography 
(alumina, 2% methanol in dichloromethane) and the desired fraction was 
evaporated to dryness and redissolved in dichloromethane and recrystallised with 
ether. (0.13 g, 74 %) 
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1H NMR (CD3CN) δ (ppm): 8.60 (s, 1H, Tz); 8.07 (t, J = 7.5 Hz, 2H); 8.01 (td, J = 
8.3 & 1.3 Hz, 2H); 7.85 (t, J = 7.5 Hz, 2H); 7.81 (d. J = 5.5 Hz, 1H); 7.77 (d, J = 
7.7 Hz, 1H); 7.73 (d, J = 6.8 Hz, 2H); 7.60 (d, J = 5.5 Hz, 1H); 7.41-7.36 (m, 3H); 
7.34 (dt, J = 7.0 & 1.7 Hz, 1H); 7.23 (dd, J = 7.6 & 1.7 Hz, 2H); 7.07 (t, J = 6.2  
Hz, 1H); 7.05-7.00 (m, 2H); 6.95 (t, J = 7.6 Hz, 1H); 6.90 (td, J = 7.4 & 1.1 Hz, 
1H); 6.82 (t, J = 7.4 Hz, 1H); 6.25 (t, J = 8.1 Hz, 2H); 5.58 (d, J = 2.27 Hz, 2H, 
benzyl H)  13C NMR (CD3CN) (ppm): 168.7; 168.3; 151.4; 150.7; 150.5; 150.4; 
150.3; 149.9; 147.5; 145.4; 145.3; 140.7; 139.6; 139.5; 134.6; 132.9; 132.5; 
131.4; 130.7; 130.2; 130.1; 129.3; 127.8; 127.2; 125.9; 125.4; 124.5; 124.3; 
123.9; 123.7; 123.3; 120.9; 120.7; 56.5 (ESI) m/z 737.2 (M+) HRMS (ESI) calcd: 
737.1999, found: 737.2000 
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3 ELECTRONIC AND 
PHOTOPHYSICAL EFFECTS OF 
1,2,3-TRIAZOLE BASED 
LIGANDS 
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3.1 Introduction 
In the last few decades rhenium(I) bipyridyl tricarbonyl complexes have attracted 
a great deal of interest for their luminescent and photophysical properties. These 
complexes have been used as photocatalysts for CO2 reduction, 169-173 emitters for 
electroluminescent devices, 174-176 biological imaging agents 177-180 and as 
supramolecular building blocks. 181, 182 Indeed, fac-[Re(bpy)(CO)3Cl] and its 
derivatives represent one of the most widely studied transition metal complex 
synthons. Luminescent emission, energy transfer, and electron transfer occur 
mainly through triplet metal-to-ligand-charge transfer (3MLCT) or triplet ligand-
centred (3IL) excited states. The chloride ion can readily be replaced with other 
ions or neutral ligands such as pyridine, acetonitrile and phosphines. Similarly the 
bipyridyl ligand can be replaced with other bidentate nitrogen donor ligands such 
as 1,10-phenanthroline, 2,2’-bipyrazine and 2,2’-bipyrimidine etc. The 1,2,3-
triazole moiety therefore has the potential to act as either an axial donor ligand in 
place of Cl- or form part of a bidentate donor ligand when coupled with another 
nitrogen donor moiety.  
In this chapter we explore the use of the 1,2,3-triazole ligand as a monodentate 
axial coordinating ligand and investigate the electronic and photophysical 
properties of the corresponding rhenium complexes. Similarly we explore the use 
of 4-(pyridyl)-1,2,3-triazole ligands and investigate the electronic and 
photophysical properties of the resultant rhenium complexes. 
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3.2 Synthesis and characterisation  
3.2.1 Ligand Synthesis for monodentate coordinating triazole ligands 
Ligands 1a-1d where prepared in a one-pot CuAAC synthetic procedure (Scheme 
3.1) starting from the corresponding alkyl halide and alkyne. All four of the 
starting azides were prepared in situ from corresponding alkyl halides by 
nucleophilic substitution with a slight excess of sodium azide in 
dimethylsulfoxide at room temperature for 2 hours. Warning: low molecular 
weight azides are often thermally and shock sensitive and may detonate, therefore 
they should not be isolated and should only be generated and used in situ.  Upon 
completion of the substitution reaction, the remainder of the starting material 
required for the CuAAC was added to the reaction; a slight excess of the alkyne 
was added in the presence of a catalytic quantity of CuSO4, sodium ascorbate and 
2,6-lutidine. The products were isolated by simple filtration of the reaction 
mixture and were further purified by recrystallisation from dichloromethane and 
hexane. All ligands were isolated in moderate to good yields.  
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X = R' = R =
1a
1b
1c
1d
 
Scheme 3.1 One-pot synthesis of 1,2,3-triazole ligands starting from 
corresponding halide. (i) dimethyl sulfoxide and NaN3 at room temperature; (ii) 
dimethyl sulfoxide/H2O, CuSO4 (aq.), sodium ascorbate (aq.) and 2,6-lutidene at 
room temperature.  
Ligand 1c was also prepared from isolated benzyl azide. Benzyl azide was 
prepared by reaction of benzyl bromide with an excess of sodium azide in 
dimethylsulfoxide. Upon completion, the reaction was quenched with water, and 
the azide extracted into diethyl ether. Benzyl azide was stored at -4°C and used in 
subsequent reactions. The benzyl triazole was formed by reaction of the azide 
with an excess of phenyl acetylene in the presence of one equivalent of CuSO4 
and two equivalents of sodium ascorbate in THF and water. After stirring at room 
temperature for 30 minutes, isolation of the product was achieved by partitioning 
between dichloromethane and aqueous ammonia to remove copper. Purification of 
the ligand was achieved by recrystallisation from dichloromethane and hexane. 
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Ligands 1a-1d have been fully characterised using 1H and 13C NMR spectroscopy 
and mass spectrometry. The 1H NMR spectra for the free ligands show a distinct 
diagnostic signal for the C-H proton of the triazole ring (Figure 3.1). These appear 
as singlet resonances over the range of  7.5-8.6. These signals show nOe 
interactions in their two dimensional NOESY spectra with the ortho-protons of 
the 4-aryl substituent and the -protons of the 1-alkyl group therefore confirming 
the 1,4-regiochemistry of the 1,2,3-triazole. Successful synthesis of 1a-1d was 
also confirmed using FT-IR spectroscopy where the lack of the azide and 
acetylene stretching modes at around 2100 to 2150cm-1 indicated that no starting 
materials were present and that the reactions had gone to completion. 
 
 
Figure 3.1 Aromatic region of the 1H NMR spectrumof ligand 1b (CDCl3). 
*CH proton of the triazole ring. 
 
7.17.27.37.47.57.67.77.87.9 ppm
* 
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3.2.2 Synthesis of cationic rhenium(I) triazole complexes 
The rhenium(I) complexes, were prepared by firstly isolating the starting material 
fac-[Re(bpy)(CO)3Cl] using a similar procedure to that of Meyer et al.163 by 
heating rhenium pentacarbonylchloride with a slight excess of 2,2’-bipyridyl at 
reflux in toluene. The yellow precipitate was collected and used without further 
purification. Stirring fac-[Re(bpy)(CO)3Cl] with an excess of silver 
hexafluorophosphate overnight in the dark and in the presence of slight excess of 
the appropriate triazole ligand in dichloromethane resulted in a green solution. 
The products were recrystallised from dichloromethane and ether to yield yellow 
solids in good yields. The complexes [Re(bpy)(CO)3(1a-1d)]PF6 (2a-2d) have 
been fully characterised using 1H and 13C NMR spectroscopy, mass spectrometry, 
high resolution mass spectrometry and FT-IR spectroscopy. The known pyridine 
complex [Re(bpy)(CO)3(Py)]PF6 (2e) was also prepared for comparison 163. 
AgPF6
[Re(bpy)(CO)3Cl]
PF6-
 
Scheme 3.2 Preparation of [Re(bpy)(CO)3(1a-1d)]PF6. (2a-2d) 
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1H and 13C NMR spectroscopy was used to confirm that all four triazole 
complexes had been successfully prepared. The 1H NMR spectra of 2a-2d each 
show four signals for the bipyridyl ligand along with the resonance for the proton 
of the triazole ring. These resonances for the triazole proton appear between  
7.66-7.80, and are shielded with respect to those of the free ligands.  
The infrared spectra of the complexes show two bands corresponding to the CO 
stretching modes with the symmetric stretches appearing at ~2035 cm-1 with the 
approximately coincident asymmetric stretches centred at ~1926 cm-1, slightly 
lower in energy than those observed for the pyridine complex. These data 
therefore suggest that the monodentate triazole ligands are perhaps marginally 
better but comparable donors to pyridine in agreement with binding competition 
experiments for their Pd and Pt 70 complexes and spectroscopic data from known 
Re pytz and btz complexes. 56, 96 FT-IR data for all complexes are shown in Table 
2.1  
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Table 3.1 Carbonyl stretching frequencies for complexes 
[Re(bpy)(CO)3(L)]+/0: [Re(bpy)(CO)3(1a-1d)]PF6 (2a-2d) and reference 
complexes [Re(bpy)(CO)3(Py)]PF6 and [Re(bpy)(CO)3Cl] 
Complex L CO (cm-1) 
2a 
 
2035, 1929 
2b 
 
2035, 1923 
2c 
 
2035, 1923 
2d 
 
2033, 1928 
2e 

 
2037, 1932 
2f Cl- 2024, 1928 & 1888 
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3.2.2.1 Crystallographic analysis 
Single crystals of X-ray diffraction quality of three of the complexes were 
obtained through slow diffusion of hexane into dichloromethane solutions of the 
complexes. The data obtained for complexes [Re(bpy)(CO)3(1a)]PF6 and 
[Re(bpy)(CO)3(1b)]PF6 were of good quality, however the X-ray crystal structure 
which was obtained for complex 2c [Re(bpy)(CO)3(1c)]PF6 showed disorder in 
the phenyl substituent of the triazole ligand which could not be successfully 
modelled. This structure is included here only for completeness. We were unable 
to grow any further crystals of diffraction quality for this complex and no suitable 
crystals of diffraction quality could be obtained for complex 2d. Figure 3.2, 
Figure 3.3 and Figure 3.4 depict the molecular structures of each of the cationic 
complexes, [Re(bpy)(CO)3(1a-1c)]+ whilst selected bond lengths and angles are 
provided in Table 3.2. 
 
Figure 3.2 ORTEP plot of the structure of the cation [Re(bpy)(CO)3(1a)]+(2a) 
(hydrogen atoms and PF6- counterion omitted for clarity, ellipsoids at 50% 
probability).  
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Figure 3.3 ORTEP plot of the structure of the cation [Re(bpy)(CO)3(1b)]+ 
(2b) (hydrogen atoms and PF6- counterion omitted for clarity, ellipsoids at 50% 
probability). 
 
Figure 3.4 ORTEP plot of the structure of the cation [Re(bpy)(CO)3(1c)]+ (2c) 
(hydrogen atoms and PF6- counterion omitted for clarity, ellipsoids at 50% 
probability).  
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Table 3.2 Selected bond lengths (Å) and angles (°) for single-crystal X-ray 
structures of [Re(bpy)(CO)3(1a)]PF6 (2a), [Re(bpy)(CO)3(1b)]PF6 (2b) and 
[Re(bpy)(CO)3(1c)]PF6 (2c) 
[Re(bpy)(CO)3(1a)]+ (2a) 
Re-N1 2.1733(13)  Re-C22 1.9176(18) 
Re-N2 2.1711(14)  C20-O1 1.150(2) 
Re-N3 2.2186(14)  C21-O2 1.154(2) 
Re-C20 1.9319(17)  C22-O3 1.152(2) 
Re-C21 1.9221(18)    
 
    
N1-Re-N2 74.80(5)  C22-Re-C21 87.69(8) 
N1-Re-N3 83.92(5)  C20-Re-C21 88.56(7) 
N2-Re-N3 78.82(5)  C20-Re-C22 89.16(7) 
C22-Re-N3 172.82(7)    
 [Re(bpy)(CO)3(1b)]+ (2b) 
Re-N2 2.164(4)  Re-C27 1.922(5) 
Re-N3 2.170(4)  C1-O2 1.150(6) 
Re-N4 2.198(4)  C24-O3 1.155(6) 
Re-C1 1.915(5)  C27-O1 1.145(6) 
Re-C24 1.930(5)    
     
N2-Re-N3 75.07(14)  C1-Re-C24 88.2(2) 
N2-Re-N4 82.70(14)  C1-Re-C27 88.1(2) 
N3-Re-N4 83.90(14)  C24-Re-C27 86.9(2) 
C1-Re-N4 174.50(18)    
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 [Re(bpy)(CO)3(1c)]+ (2c) 
Re-N1 2.1703(18)  Re-C13 1.917(2) 
Re-N2 2.1707(18)  C11-O1 1.149(3) 
Re-N3 2.2034(19)  C12-O2 1.155(3) 
Re-C11 1.924(2)  C13-O3 1.151(3) 
Re-C12 1.921(2)    
     
N1-Re-N2 74.87(6)  C24-Re-C26 89.00(9) 
N1-Re-N3 84.43(6)  C25-Re-C26 85.62(8) 
N2-Re-N3 83.43(6)  C24-Re-C25 89.36(9) 
C26-Re-N3 177.36(7)    
     
 
[Re(bpy)(CO)3(1a)]PF6 crystallises in the space group C2/c whilst 
[Re(bpy)(CO)3(1b)]PF6 and [Re(bpy)(CO)3(1c)]PF6 crystallised in the space 
groups Pbca and P-1 respectively. As can be seen in Figure 3.2, Figure 3.3 and 
Figure 3.4 all the complexes adopt distorted octahedral geometries with facial 
arrangements of the carbonyl ligands. It can also be seen that the triazole ligand 
coordinates to the rhenium metal centre through the N3 atom of the 1,2,3-triazole 
ring which would be expected as this is the more basic nitrogen of the two 
potential nitrogen donor atoms. The Re-N bonds to the 2,2’-bipyridyl ligands are 
all approximately the same length at ~2.17 Å. The Re-N bond lengths to the axial 
triazole ligands are 2.2186, 2.198 and 2.2034 Å for ligands 1a-1c respectively.  
These bond lengths are within the range observed for related tricarbonylrhenium 
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diimine complexes. For example the corresponding axial Re-N bond length in 
[Re(bpy)(CO)3(Py)]OTf 183 is 2.194(6) Å and in [Re(1,10-
phenanthroline)(CO)3(imidazole)]2SO4 184 the corresponding Re-N bond length is 
2.185(5) Å. 
 
 
The C-O bond lengths for the carbonyl ligands in all three of the complexes are 
unremarkable and vary between 1.145-1.155 Å. The Re-C bond lengths to the 
carbonyl which are trans to the triazole ligands are slightly shorter when 
compared to those trans to bpy and are 1.9176, 1.916 and 1.917 Å for complexes 
2a, 2b and 2c respectively. This shortening of the Re-C bond length is 
complementary to the results obtained from the infra-red experiments, and could 
be indicative of the slightly greater donor strength of the triazole ligands when 
compared to the pyridyl donors of the bipyridyl ligand. However this shortening 
isn’t significant with respect to experimental error and there is no accompanying 
elongation of the C-O bond length for the carbonyl trans to the triazole compared 
to those trans to the bipyridyl.  
Although there is only a slight difference in the chemical structures of complexes 
2a and 2b (in terms of the substituent at the 1-position of the triazole ligand 
changing from methyl to propyl respectively), the orientation of the triazole 
ligands in the solid state is quite different. For the 1-propyl-4-phenyl-1,2,3-
trialzole complex 2b , and indeed the 1-benzyl-4-phenyl-1,2,3-triazole complex 
2c, the Re-triazole bond lengths are ~2.20 Å and the triazole ligands are orientated 
in such a way that their respective phenyl groups lie over the carbonyl ligands. 
However, for the 1-methyl-4-phenyl-1,2,3-triazole complex 2a the Re-N(triazole) 
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bond length is elongated with respect to those in 2b and 2c, and is 2.2192 Å. Here, 
the triazole is orientated such that the phenyl group lies over one of the pyridyl 
rings of the bipyridyl ligand. The phenyl and pyridyl rings are almost coplanar 
and are separated by a distance of approximately 3.3 Å indicative of a -stacking 
interaction. The formation of this -stacking interaction leads to a significant twist 
in the bipyridyl ligand and a tilt in the triazole ligand. The plane of the triazole 
ring is tilted by 13 ° with respect to the Re-N(triazole) bond which compares to a 
much smaller tilt of only 5.2 ° for the propyl-substituted ligand.  As a result of the 
π-stacking interaction with the phenyl ring of the ligand 1a the participating 
pyridyl ring is twisted such that it is inclined by 3.4° with respect to the N1-Re 
bond and is twisted by 8.5° with respect to the plane defined by the Re atom and 
the carbonyl carbon atoms trans to bpy.  This twisting also results in an angle of 
8.5° between the planes of the two pyridyl rings and a more severe deviation in 
coplanarity of the second pyridyl ring with respect to the square plane about the 
Re centre.  Here, the ring has an inclination of the 15° with respect to the N2-Re 
bond and a twist of 21.2° relative to the same plane defined by the Re atom and 
carbonyl ligands.  Similar distortions of the bpy ligand have also been observed in 
related complexes with axial phosphine ligands due to π-π interactions between 
the bpy ligand and the aryl substituents of the phosphine. 185 In comparison, the 
propyl triazole complex (2b) experiences much less distortion.  The twist between 
rings of the bpy ligand of is only 5.3°, the rings have inclinations with respect to 
their Re-N bonds of only 1.9 and 3.2° and are twisted relative to the plane of the 
Re atom and the trans carbonyl carbon atoms by 2.7 and 2.6°. 
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The increase in steric bulk of the propyl and benzyl groups compared to that of 
the methyl substituent could explain the distortion observed in the geometry for 
the complex 2a. In the solid state, the methyl carbon of one [Re(bpy)(CO)3(1a)]+ 
cation comes within 3.0 Å of the carbonyl oxygen of one of the neighbouring 
cations. It maybe that the extra steric bulk of the propyl and benzyl groups of 
ligands 1b and 1c therefore hinder the adoption of the crystal packing 
arrangement that promotes the formation of this -stacking interaction which is 
observed for complex 2a. 
3.2.2.2 Photophysical studies 
UV-vis absorption spectra of complexes 2a-2d along with those of 
[Re(bpy)(CO)3Cl] and [Re(bpy)(CO)3(Py)]PF6 where recorded in acetonitrile. The 
UV-vis spectra that were obtained for complexes 2a-2d are almost identical to 
each other as can be seen in Figure 3.5. Photophysical data are summarised in 
Table 3.3 
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Figure 3.5 UV-vis absorption spectra for [Re(bpy)(CO)3(1a-1d)]PF6 in 
acetonitrile 
For these complexes the dominant absorption bands in the shorter wavelength 
region at 250-270 nm were assigned to the intraligand   * transitions. These 
assignments were made on assessment of closely related metal complexes in the 
literature. The low energy broad bands at approximately 325 nm are attributed to 
the metal to ligand charge-transfer (1MLCT) d(Re)  * (bpy) transitions. All 
the MLCT absorption bands of complexes 2a-2d are similar to those observed in 
related Re(I) carbonyl complexes 96, 184, 185 and exhibit a blue shift in absorption in 
comparison to the parent halide complex [Re(bpy)(CO)3Cl]. This is explained by 
replacement of the -donor chloride ligand with the -accepting triazole ligand 
which would therefore lead to a decrease in the energy of the d(Re) HOMO with 
respect to the LUMO, resulting in higher energy MLCT transitions.  
Luminescence measurements were recorded at room temperature in aerated 
dichloromethane and acetonitrile with an excitation wavelength of 400 nm. Figure 
3.6 shows the normalised emission spectra for the four triazole complexes 2a-2d 
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as well as the pyridine complex [Re(bpy)(CO)3(Py)]+ and the parent chloride 
complex [Re(bpy)(CO)3(Cl)]. 
 
Figure 3.6 Normalised luminescence spectra for the complexes 
[Re(bpy)(CO)3(L)]+/0 (L= 1a-d, Py, Cl-)  
Broad emission bands are observed with max appearing over a 10 nm range for 
the triazole complexes between 542 to 552 nm in dichloromethane solutions.  
These bands are assigned to phosphorescent emission from triplet metal-to-
ligand charge-transfer (3MLCT) excited states. These emission bands are 
significantly blue-shifted relative to that of the parent chloride complex 
[Re(bpy)(CO)3Cl] (612 nm) consistent with the replacement of a π-donor with 
a moderately π-accepting ligand leading to stabilisation of the HOMO relative 
to the LUMO.  The analogous pyridine complex [Re(bpy)(CO)3(Py)]+ exhibits 
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an emission band at 549 nm under the same conditions. This is consistent with 
observations of other cationic rhenium tricarbonyl complexes diimine 
complexes where changing the nature of the axial N-donor ligand has very 
little effect on the emission properties of the complexes. 96 Very little 
difference in the position of emission maximum is observed when changing 
solvent from dichloromethane to acetonitrile. 
Luminescence lifetime measurements were recorded for all complexes in aerated 
dichloromethane solutions at room temperature by time-correlated single photon 
counting spectroscopy. The decay traces for the emission from complexes 2a-2d 
are shown in Figure 3.7. Long luminescent lifetimes of between 475 and 513 ns 
were observed for the triazole containing complexes consistent with 
phosphorescent emission from the 3MLCT state. These lifetimes are significantly 
longer than that of the chloride complex (42 ns) and slightly longer than that 
measured for the pyridine complex [Re(bpy)(CO)3(Py)]+ measured under identical 
conditions (466 ns). When the lifetimes were measured in acetonitrile, much 
shorter lifetimes were determined of 130–140 ns. 
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Table 3.3 Photophysical properties for [Re(bpy)(CO)3(1a-1d)]PF6, 
[Re(bpy)(CO)3(Py)]PF6 and [Re(bpy)(CO)3(Cl)] in dichloromethane 
  
Complex abs / nm maxem / nm  / ns 
[Re(bpy)(CO)3(1a)]PF6 266, 298, 337 543 482 
[Re(bpy)(CO)3(1b)]PF6 266, 298, 338 552 475 
[Re(bpy)(CO)3(1c)]PF6 266, 301, 339 535 513 
[Re(bpy)(CO)3(1d)]PF6 265, 300, 340 542 477 
[Re(bpy)(CO)3(Cl)] 264, 300, 346 612 42 
[Re(bpy)(CO)3(Py)]PF6 266, 299, 345 549 466 
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Figure 3.7 Luminescent lifetime measurements for [Re(bpy)(CO)3(1a-1d)]PF6 
in dichloromethane. 
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A series of cationic bipyridyltricarbonylrhenium(I) complexes (2a-2d) with axial 
monodentate 1,2,3-triazole ligands have been prepared and fully characterised. It 
has been shown that subtle changes in the ligand scaffold can have an impact on 
the solid state structural properties of these types of molecules. This is evident in 
the single-crystal X-ray structure of 2a, the cation adopts a highly distorted 
structure due to the -stacking interaction between the triazole phenyl substituent 
and one ring of the bpy ligand. Infrared data suggest that the triazole ligands (1a-
1d) are slightly better donors than pyridine also the rhenium complexes of these 
ligands have long luminescent lifetimes in aerated dichloromethane at room 
temperature with maxem comparable to that of [Re(bpy)(CO)3(Py)]+. 
  
 134 
3.3 Rhenium tricarbonyl complexes with bidentate pyridyl-
1,2,3-triazole ligands 
Whereas replacing the Cl- ligand by the triazole modulates the energy of the 
HOMO with respect to the LUMO, changing the bidentate ligand by replacing the 
bipyridyl ligand by pyridine-triazole ligand would be expected to elevate the 
LUMO with respect to the HOMO.  
HOMO
LUMO
Energy
HOMO HOMO
LUMO
LUMO
OCOC
OC OCOC
COCO
OC
CO
 
Figure 3.8 Energy level diagram of rhenium tricarbonyl complexes showing 
modulation of the HOMO and LUMO on replacement of Cl- and bpy ligands 
respectively.  
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Described in this section of the chapter is the synthesis and characterisation of 1-
cyclohexyl-4-(pyrid-2-yl)-1,2,3-triazole and its corresponding rhenium complex. 
We had tried to probe the effects on the photophysical properties of the complex 
isomers of the ligand as the alternative isomer 4-cyclohexyl-1-(pyrid-2-yl)-1,2,3-
triazole should be accessible from ethynyl cyclohexane and 2-azidopyridine. 
Unfortunately the alternative isomer of this ligand could not be successfully 
isolated. Therefore we have studied these systems computationally and calculated 
the electronic and photophysical properties of these complexes.   
3.3.1 Synthesis and characterisation of [Re(1-cyclohexyl-4-(pyrid-2-yl)-
1,2,3-triazole)(CO)3Cl 
The ligand 1-cyclohexyl-4-(pyrid-2-yl)-1,2,3-triazole (3a) was prepared by a two 
step synthesis. (Scheme 3.3) Firstly cyclohexyl bromide was converted into 
cyclohexyl azide through a nucleophilic substitution reaction in the presence of 
excess of sodium azide in dimethylsulfoxide. Water was then added to quench the 
reaction after 12 hours and the cyclohexyl azide was isolated as a colourless oil in 
good yield after extraction with diethyl ether. 2-Ethynylpyridine was added to the 
azide with a catalytic quantity of CuSO4 with sodium ascorbate as a reducing 
agent in a 1:1 water/THF mixture. Ligand 3a was obtained as a white solid after 
purification by column chromatography in good yield (73%).  
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Scheme 3.3 Two step synthesis of 1-cyclohexyl-4-pyridyl-1,2,3-triazole (1e) (i) 
DMSO and NaN3 at room temperature;  (ii) THF/H2O, CuSO4 (aq.) and sodium 
ascorbate (aq.) at room temperature.  
Ligand 3a has been fully characterised using 1H and 13C NMR spectroscopy and 
mass spectrometry. The 1H NMR spectrum shows signals for the cyclohexyl 
group with the -proton at  4.53 and the remaining cyclohexyl protons as a series 
of multiplets in the region  2.40-1.20. The pyridyl protons appear at  8.57, 8.18, 
7.78 and 7.22 typical of a 2-substituted pyridyl ring. A distinct diagnostic signal 
for the triazole C-H proton appears as a singlet at  8.18. Successful synthesis of 
the ligands was also confirmed using infrared spectroscopy which shows a lack of 
the azide and alkyne stretching modes at ~2100cm-1 and ~2150cm-1 respectively 
indicating that no starting material was present and that the reaction had gone to 
completion.  
The ligand 3a was combined with rhenium pentacarbonyl chloride in toluene for 
12 hours at reflux resulting in the formation of a yellow solution which on cooling 
resulted in precipitation of the complex fac-[Re(3a)(CO)3Cl] (4a) as a pale yellow 
crystalline solid. A further crop of product was obtained by removing some 
toluene under reduced pressure and leaving the solution at 2 °C overnight.  
3a 
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The 1H NMR spectrum of 4a shows the pyridyl-triazole signals which are shifted 
downfield compared to the free ligand and appear at  9.05, 7.99, 7.79 and 7.44 
with the resonance for triazole C-H proton at  8.17. The complex exhibits three 
distinct bands in the carbonyl region of the infra red spectrum with the symmetric 
stretch at 2021 cm-1 and the asymmetric stretches at 1949 and 1874 cm-1. These 
are shifted with respect to the bpy analogue, which appear at 2024, 1928 and 1888 
cm-1 respectively. This is indicative of the triazole ligand is a marginally better 
donor than bpy. Luminescence measurements of complex 4a and 
[Re(bpy)(CO)3Cl] were recorded at room temperature in aerated acetonitrile with 
an excitation wavelength of 400 nm and are shown in Figure 3.9. A broad band is 
observed at 542 nm for complex 4a
 
which is significantly blue-shifted with 
respect to the bpy analogue (612 nm). This blue shift in emission maximum is 
explained due to the fact that the HOMO for both of these complexes is localised 
on the Re(I) and the Cl atoms where as the LUMO is localised on the pytz and 
bpy ligands respectively. Therefore approximately the same energy level would 
be observed for the HOMO for both complexes whereas the LUMO for complex 
4a would be at higher energy due to the smaller -system of the triazole ligand. 
Whilst this work was being undertaken Obata et al. 96 reported a similar rhenium 
complex with the ligand 1-benzyl-4-(pyrid-2-yl)-1,2,3-triazole, which exhibited 
similarly blue-shifted emission maximum which appeared at 538 nm. This is 
discussed further in the chapter. 
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Figure 3.9 Normalised luminescence spectra for [Re(3a)(CO)3Cl] (4a) and 
[Re(bpy)(CO)3Cl] 
3.3.2 Attempted synthesis of [Re(4-cyclohexyl-1-(pyrid-2-yl)-1,2,3 
triazole)(CO)3Cl] 
In order to fully investigate the electronic effects of the pyridyl triazole ligand on 
the properties of the metal we decided to prepare the alternative isomer of the 
ligand, 1-(pyrid-2-yl)-4-cyclohexyl-1,2,3-triazole (3b), which would coordinate to 
the metal by N2 of the triazole ring rather than N3. Three different synthese were 
explored: reacting the pyridyl halide with sodium azide, conversion of 2-amino 
pyridine to 2-azido pyridine using sodium nitrite and sodium azide in an acidic 
solution and finally reacting -amino pyridine with n-BuLi followed by an 
azidophosphonium salt, however no products could be isolated. 
After further examination of the literature it was noted that 2-azidopyridine exists 
in an equilibrium with its fused tetrazole form and that at temperatures between -
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10 °C and 150 °C the equilibrium lies greatly in favour of the tetrazole (Figure 
3.10 Equilibrium of 2-pyridyl azide with its fused tetrazole.). When 
subsequently used in an attempt to form the target ligand no product was formed. 
It is therefore possible that this isomerism inhibits the desired “click” reaction. 
 
Figure 3.10 Equilibrium of 2-pyridyl azide with its fused tetrazole. 
Others have since synthesised this ligand however this work was carried out at the 
beginning of the project and we had subsequently moved on to other areas and so 
we have not pursued it further.   
Due to these problems encountered in the synthesis of the second ligand, density 
functional theory (DFT) studies were undertaken in collaboration with an MSc 
student, Somaia Kamouka, and Paul Elliott in order to investigate the donor 
properties of these isomeric ligands and the electronic and photophysical 
properties of the complexes.   
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3.3.3 DFT Calculations 
We have carried out DFT calculations on the 4-(pyrid-2-yl)-1,2,3-triazole 
complex [Re(3a’)(CO)3Cl] (4a’) as well as the complex of the isomeric 1-(pyrid-
2-yl)-1,2,3-triazole complex, [Re(3b)(CO)3Cl] (4b). Additionally we have also 
carried out calculations on the complex of the further possible ligand isomer 2-
(pyrid-2-yl)-1,2,3-triazole, [Re(3c)(CO)3Cl] (4c). Structures of ligands 3a’, 3b 
and 3c are shown in Figure 3.11. Rhenium tricarbonyl chloride complexes are a 
good system for chelate ligand comparison, as the donor character can be assigned 
from the infrared data with electronic effects determined from the absorbance and 
emission data. Further, this particular ligand set allows us to look at ligand tuning 
and isolate electronic effects in ligands that are isosteric. For the computational 
calculations the cyclohexyl substituent was replaced by a methyl group because it 
is computationally less time consuming whilst being electronically almost 
identical. Firstly the geometries of the complexes were optimised using the 
B3LYP level of theory. 186 The Stuttgart relativistic small core potential 187 was 
used for rhenium and 6-311G* basis sets 188 were used for all the other atoms. 
Ground state geometry optimisations and molecular orbital analyses were carried 
out using the GAMESS-UK software package. 189 Excited state geometry 
optimisations, TDDFT and -SCF calculations were carried out using the 
NWChem 5.1 software package. 190  
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3a' 3b
3c
1-Methyl-4-(2-pyridyl)-1,2,3-triazole 4-Methyl-1-(2-Pyridyl)-1,2,3-triazole
4-Methyl-2-(2-pyridyl)-1,2,3-triazole
 
Figure 3.11 Isomers of methyl and pyridylsubstituted-1,2,3-triazoles. 
3.3.3.1 Optimised ground state and triplet excited state geometries 
Table 3.4 shows the selected calculated bond lengths for both the singlet ground 
state (S0) and the lowest triplet excited states (T1) for all three pyridyl triazole 
complexes and for the [Re(bpy)(CO)3Cl] parent complex. Molecular structures for 
the ground states are shown in Figure 3.12, with XYZ coordinates included in the 
appendix. All complexes exhibit a distorted octahedral geometry with the 
calculated Re-Cl bond lengths for all of the complexes within the range 2.520-
2.528 Å. The calculated Re-carbonyl bond lengths for the pyridyl triazole 
complexes are similar to those of the [Re(bpy)(CO)3Cl] parent complex with 
those trans to the chelating ligand ranging between 1.147 and 1.152 Å. The C-O 
bond length for the ligand trans to the chloride are comparatively elongated at 
1.155 to 1.157 Å consistent with the presence of the trans -donor. For the pytz 
complexes, the Re-C bonds are shorter and the C-O bonds longer for the carbonyl 
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ligands trans to the triazole ring compared to the ligands trans to pyridine expect 
for that of 3c suggesting that the triazole is a slightly better overall donor. The 
calculated Re-Ntz bond length for [Re(3b)(CO)3Cl] is slightly shorter at 2.184 Å 
than those for the other two pyridyl triazole complexes despite the N2 donor atom 
being expected to be less basic than the N3 atom. This may be due to the C-N 
bond length which connects the triazole to the pyridine within the ligand being 
shorter when compared to the corresponding bonds in the other two pyridyl 
triazole complexes.  
The geometries of the lowest triplet excited states for all complexes were 
calculated using the constraint of a triplet spin multiplicity. Differences are 
observed in the geometries when moving from the singlet ground state (S0) to the 
lowest triplet excited state (T1). The HOMO of all complexes is dRe-pCl 
antibonding in character whilst the LUMO is centred on the chelating ligand. The 
excitation of an electron from the largely metal-based HOMO with π*-
antibonding character to the chloride thereby results in a shortening of the Re-Cl 
bond by approximate 0.07 to 0.1 Å for all complexes (Table 3.4). Consistent with 
the loss of electron density from the rhenium tricarbonyl fragment in this 3MLCT 
state, Re-C bond lengths are elongated and C-O bonds shortened due to 
diminished back-bonding.  
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[Re(bpy)(CO)3Cl] [Re(3a’)(CO)3Cl] 
[Re(3b)(CO)3Cl] [Re(3c)(CO)3Cl] 
Figure 3.12 Optimised ground state geometries for the complexes 
[Re(L)(CO)3Cl], (L=3a’-c, bpy). 
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Table 3.4 Selected bond lengths for optimised singlet ground states and 
lowest lying triplet excited states for complexes [Re(L)(CO)3Cl], (L=3a’-c, bpy). 
 Re(bpy)(CO)3Cl Re(3a’)(CO)3Cl Re(3b)(CO)3Cl Re(3c)(CO)3Cl 
 
S0 T1 S0 T1 S0 T1 S0 T1 
Re-Cl 2.525 2.424 2.528 2.439 2.524 2.456 2.520 2.447 
Re-C(trans to Cl) 1.931 1.997 1.931 1.985 1.932 1.979 1.934 1.983 
Re-C(trans to 
Py) 
1.944 1.987 1.945 2.016 1.949 1.963 1.938 1.959 
Re-C(trans to 
Tz) 
na na 1.940 1.958 1.941 2.010 1.943 2.014 
C-O(trans to Cl) 1.156 1.141 1.157 1.144 1.155 1.145 1.155 1.144 
C-O(trans to Py) 1.151 1.144 1.148 1.141 1.147 1.143 1.150 1.145 
C-O(trans to Tz) na na 1.152 1.147 1.151 1.142 1.150 1.142 
Re-NPy 2.218 2.157 2.254 2.138 2.240 2.216 2.254 2.213 
Re-NTz na na 2.193 2.170 2.184 2.073 2.197 2.091 
 
3.3.3.2 IR Data 
Vibrational frequency calculations were carried out in order to determine relative 
carbonyl stretching frequencies. Table 3.5 shows the calculated carbonyl 
stretching frequencies for both the singlet ground state as well those for the lowest 
lying triplet excited state for all of the complexes studied. The calculated infrared 
data predicts that complexes [Re(3a’)(CO)3Cl] and [Re(3c)(CO)3Cl] have very 
similar electron donating properties due to the triazole being bonded to the metal 
centre through the outer N1 and N3 nitrogen atoms of the triazole respectively. 
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Complex [Re(3b)(CO)3Cl] has highest CO stretching frequencies suggesting that 
3b is the weakest donor. This would be expected due to the ligand being bonded 
to the metal centre through the less basic N2 atom of the triazole ring. 
As expected for generation of a MLCT state, decrease in electron density at the 
metal decreases back bonding leading to the carbonyl stretching frequencies being 
significantly shifted up in energy, when moving from a singlet ground state, to the 
T1 excited state. This increase in calculated frequency is of similar magnitude to 
those reported by George et al. 191 for [Re(bpy)(CO)3Cl]. Time-resolved infrared 
spectroscopy on the bpy complex showed that the carbonyl stretching frequencies 
shifted from 2024, 1921 and 1899 cm-1 to 2064, 1987 and 1957 cm-1 when 
moving from the ground state to the excited triplet state.  
Table 3.5 Calculated CO stretching frequencies for the singlet ground states 
and lowest triplet states for complexes [Re(L)(CO)3Cl], (L=3a’-c, bpy). 
 Re(bpy)(CO)3Cl Re(3a’)(CO)3Cl Re(3b)(CO)3Cl Re(3c)(CO)3Cl 
 
S0 T1 S0 T1 S0 T1 S0 T1 
 
1991 2051 1988 2040 1997 2047 1997 2046 
CO 2016 2060 2020 2060 2028 2065 2024 2060 
 
2090 2119 2095 2119 2101 2125 2097 2121 
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3.3.3.3 MO Energies 
Table 3.6 and Figure 3.13 Energy level diagram for the frontier molecular 
orbitals of the complexes [Re(L)(CO)3Cl], (L=3a’-c, bpy). shows the HOMO and 
LUMO energies along with the magnitude of the HOMO-LUMO gap for the four 
complexes investigated. The bipyridyl complex has the smallest HOMO-LUMO 
gap at 2.87 eV. [Re(3a’)(CO)3Cl] and [Re(3c)(CO)3Cl] have very similar HOMO-
LUMO gaps of 3.13 and 3.12 eV respectively. This is due to the raising in energy 
of the ligand centred LUMO relative to the HOMO by replacing one of the 
pyridine rings with the smaller -system of the triazole ring. Of the pyridyltriazole 
complexes, [Re(3b)(CO)3Cl] has the smallest HOMO-LUMO gap at 2.95 eV, 
some 0.08 eV larger than that of the bpy complex. The LUMO for complex 
[Re(3a’)(CO)3Cl] is destabilised with respect to the bpy analogue whereas the 
LUMO for complexes [Re(3b)(CO)3Cl] and [Re(3c)(CO)3Cl] are both stabilised 
with respect to the bpy complex. HOMO of 4c is stabilised to greater extent than 
the LUMO compared to the bpy complex leading to a larger HOMO-LUMO gap. 
Table 3.6 Calculated energies (eV) of the HOMO and LUMO and the 
HOMO-LUMO gap for the complexes [Re(L)(CO)3Cl], (L=3a’-c, bpy). 
 
Re(bpy)(CO)3Cl 
Energy / eV 
Re(3a’)(CO)3Cl 
Energy / eV 
Re(3b)(CO)3Cl 
Energy / eV 
Re(3c)(CO)3Cl 
Energy / eV 
LUMO -2.95 -2.50 -2.90 -2.83 
HOMO -5.81 -5.64 -5.85 -5.95 
HOMO-LUMO 2.87 3.13 2.95 3.12 
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Figure 3.13 Energy level diagram for the frontier molecular orbitals of the 
complexes [Re(L)(CO)3Cl], (L=3a’-c, bpy). 
The singly occupied molecular orbitals (SOMOs) of the T1 states for these 
complexes are similarly situated to the HOMOs and LUMOs of their singlet 
ground states confirming MLCT character  
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3.3.3.4 Time dependent DFT (TDDFT) Calculations 
Vertical excitation energies for the singlet ground state were calculated for each 
complex by TDDFT calculations and used to derive simulated optical absorption 
spectra. Calculated spectra are shown in Figure 3.14 and the wavelengths, 
energies, oscillator strengths and compositions of selected transitions are given in 
Table 3.7. The lowest energy singlet excitations (S1) for [Re(3a’)(CO)3Cl] and 
[Re(3c)(CO)3Cl], are almost entirely HOMOLUMO 1MLCT in character and 
appear at 520 and 526 nm respectively, blue-shifted by some 68 and 62 nm 
respectively to that of the parent bpy complex. These are of low oscillator strength 
and therefore will contribute little to the observed spectrum. The more intense 
HOMO-1LUMO 1MLCT transitions for these complexes appear at 484 and 487 
nm and are blue-shifted by 49 and 46 nm respectively relative to that of the bpy 
complex. Transitions between 250 and 350 nm are dominated by intraligand 
ππ* excitations. 
By comparison, for [Re(3b)(CO)3Cl] the corresponding S1 and S2 1MLCT 
transitions at 570 and 517 nm respectively are blue-shifted by only 18 and 16 nm 
respectively to those of [Re(bpy)(CO)3Cl].  These data suggest that despite the 
smaller π-system for the 3b ligand compared to bpy there is only a modest shift in 
the energies of the optical transitions for this complexes and that the complex will 
have comparable spectroscopic absorption properties to the bpy analogue. 
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Figure 3.14 Calculated UV-Vis absorption spectra from TDDFT derived 
vertical excitation energies for complexes [Re(L)(CO)3Cl], a) [Re(bpy)(CO)3Cl], 
b)  [Re(3a’)(CO)3Cl], c) [Re(3b)(CO)3Cl] and d)  [Re(3c)(CO)3Cl]. 
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Table 3.7 Selected energies (eV) (oscillator strength, f, in parentheses), 
wavelength (nm) and compositions of vertical excitations from TDDFT 
calculations 
Complex Transition Energy / eV / nm Composition/character 
Re(bpy)(CO)3Cl S1 2.11 (0.002) 588 HOMO  LUMO           MLCT 
 
S2 2.32 (0.042) 533 HOMO-1  LUMO       MLCT 
 
S9 3.51 (0.055) 353 HOMO-4  LUMO          -* 
 
S16 4.28 (0.052) 290 HOMO-3  LUMO         -* 
 
S18 4.45 (0.084) 278 HOMO-3  LUMO+1     -* 
 
S21 4.63(0.078) 268 HOMO-1  LUMO+5     -* 
 
S25 4.85 (0.159) 256 HOMO-2  LUMO+3    -* 
 
    
Re(3a’)(CO)3Cl S1 2.39 (0.002) 520 HOMO  LUMO           MLCT 
 
S2 2.56 (0.038) 484 HOMO-1  LUMO       MLCT 
 
S10 3.81 (0.058) 325 HOMO-4  LUMO         -*    
 
S25 4.93 (0.204) 252 HOMO-6 LUMO 
& HOMO-4  LUMO+2 -* 
 
    
Re(3b)(CO)3Cl S1 2.17 (0.002) 570 HOMO  LUMO           MLCT 
 
S2 2.40 (0.041) 517 HOMO-1  LUMO       MLCT 
 
S8 3.63 (0.069) 342 HOMO-4  LUMO          -*  
 
S19 4.75 (0.062) 261 HOMO-5  LUMO+1 
& HOMO-6  LUMO     -*     
 
S20 4.79 (0.045) 259 HOMO-5  LUMO         -*     
 
S21 4.88 (0.105) 254 HOMO-2  LUMO+3     -* 
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Re(3c)(CO)3Cl S1 2.36 (0.002) 526 HOMO  LUMO           MLCT 
 
S2 2.55 (0.039) 487 HOMO-1  LUMO       MLCT 
 
S7 3.80 (0.048) 326 HOMO-4  LUMO           -*   
 
S13 4.39 (0.043) 282 HOMO-5  LUMO           -*  
 
S16 4.53 (0.045) 274 HOMO  LUMO+3          -*  
 
S17 4.61 (0.133) 269 HOMO-1  LUMO+4 
& HOMO-5  LUMO       -*  
 
S18 4.64 (0.078) 267 HOMO-1  LUMO+4       -*   
 
S20 4.88 (0.074) 254 HOMO-2  LUMO+3       -*   
 
3.3.3.5 Calculated emission energies 
The theoretical emission energies cannot be directly derived from the calculations 
of the triplet excited state but are derived through -SCF calculations. Since 
emission under Frank-Condon emission conditions occurs without movement of 
the nuclei, the energies of the singlet ground states at the optimised T1 geometries 
calculated in single point calculations can be used to derive the emission energy. 
The corresponding difference in energy between the T1 states and these S0 states 
at the T1 geometries are therefore the calculated emission energies. These are 
presented in Table 3.8 along with the corrected values derived from the ratio of 
the theoretical and experimental values for the bpy complex. This ratio is then 
applied to all other complexes. The emission energies for the complexes 
[Re(3a’)(CO)3Cl] and [Re(3c)(CO)3Cl] are blue shifted by 84 nm and 69 nm 
respectively compared to [Re(bpy)(CO)3Cl], which would be expected on the 
basis of the blue shift in their absorption transitions. The blue shift in calculated 
emission observed in [Re(3a’)(CO)3Cl] when compared to that of 
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[Re(bpy)(CO)3Cl] is slightly greater than the experimentally observed blue-shift 
of [Re(3a)(CO)3Cl] (542 nm) when compared to [Re(bpy)(CO)3Cl] (612 nm). The 
emission wavelength for complex [Re(3b)(CO)3Cl] on the other hand is slightly 
red shifted with respect to the bpy analogue. Again, this shows 4b should have 
similar spectroscopic properties to its bpy analogue.  
The calculations show significant tuning of the spectroscopic properties through 
modulation of the frontier orbitals energies despite the ligands having the same 
size -system. 
Table 3.8 Calculated emission wavelengths for complexes [Re(L)(CO)3Cl], 
(L=3a-c, bpy). 
 Re(bpy)(CO)3Cl Re(3a’)(CO)3Cl Re(3b)(CO)3Cl Re(3c)(CO)3Cl 
 
    
T1 - S0 / eV 1.68 1.95 1.67 1.89 

em
 / nm 737 636 744 655 
Corrected 

em
 / nm 612 528 617 543 
 
3.4 Conclusions 
A series of cationic bipyridyltricarbonylrhenium(I) complexes 2a–d with axial 
monodentate 1,2,3-triazole ligands have been prepared and fully characterised. 
Single-crystal X-ray structures were determined for complexes 2a and 2b with 1-
methyl-4-phenyl-1,2,3 triazole and 4-phenyl-1-propyl-1,2,3-triazole ligands, 
respectively. Despite the small difference in the alkyl substituents between the 
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two complexes, significant differences in structure are observed in the solid state. 
The cation 2a is highly distorted due to the adoption of a -stacking interaction 
between the triazole phenyl substituent and one ring of the bpy ligand. This 
interaction results in a distortion in the complex, where the triazole ring is 
significantly tilted with respect to the metal ligand bond, and the bpy ligand is 
severely twisted with respect to the plane of the equatorial donor atoms around the 
metal centre. Infrared data suggest that the ligands are slightly better net donors 
than pyridine, through being worse -acceptors, confirming findings of others 
comparing the complexes [Re(bpy)(CO)3Cl] and [Re(pytz)(CO)3Cl] where a 
pyridine ring of the chelating diimine ligand is replaced by triazole. The 
complexes are luminescent with maxem comparable to that of [Re(bpy)(CO)3(Py)]+ 
with long luminescent lifetimes in aerated dichloromethane solutions at room 
temperature. Phosphorescent d6 metal complexes have attracted a large amount of 
interest as luminescent tags in biological imaging agents. The long luminescent 
lifetimes for complexes 2a–c, their cationic character which would increase 
solubility and the facile CuAAC derivatisation of many biologically relevant 
molecules might therefore allow complexes of this type to be utilised as time-
gated luminescent imaging agents as has been demonstrated with other cationic 
rhenium -based analogues (Figure 3.15). 178, 179 
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BIOMOLECULE
 
Figure 3.15 Rhenium polypyridine biological imaging agents 
Chelating pyridyl triazole ligand 3a and its rhenium complex 4a were prepared 
and characterised. A blue shift in emission maximum was experimentally 
observed for complex 4a, at (maxem 542 nm) and the emission maximum of 
[Re(bpy)(CO)3Cl] at 612 nm. Unfortunately we were unable to isolate the isomer 
of this bidentate ligand in which the ligand coordinates through the N2 atom of 
the triazole ring. However, through our computational calculations we have 
shown that replacing the chelating bipyridyl ligand with a pyridine triazole ligand, 
generally results in a blue shift of absorbance and emission energy. This blue shift 
is more evident for ligands 3a’ and 3c but not for 3b. Indicating that ligand 3b is 
more similar in character to bpy. The Re-C bonds are slightly shorter and the C-O 
bonds longer for the carbonyl ligands trans to the triazole ring compared to the 
ligands trans to pyridine suggesting that the triazole overall is a slightly better net 
donor. The data show that the small changes in these complexes due to these 
ligand isomers allows effective tuning of electronic and photophysical properties 
of their complexes.  
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4 SYNTHESIS AND 
CHARACTERIZATION OF 
AZIDOBIPYRIDYL RUTHENIUM 
COMPLEXES AND THEIR 
“CLICK” CHEMISTRY 
DERIVATIVES 
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4.1 Introduction 
The synthesis and preparation of supramolecular architectures containing photo- 
and redox- active transition metal complexes has become an area of intense 
interest. The traditional method for the preparation of such metallosupramolecular 
materials has relied on the formation of bridging ligands with multiple 
coordination sites into which metal centres can be subsequently incorporated.150 
However this approach has disadvantages in terms of controlling the selectivity of 
metal binding, when for example heterometallic structures are required and where 
the bridging ligand is non-symmetric. A more advantageous route would be to 
couple preformed complexes into supramolecular architectures using suitable, 
highly efficient coupling reactions.     
Described in this chapter are the syntheses and characterisation of mono- and 
bis(azido)bipyridyl and the click modification of these ligands. Also described are 
the results on the coordination of mono- and bis(azido)bipyridyl in their [Ru(	6-
cymene)Cl]+ complexes and the CuAAC modification thereof.  
+
+
 
Figure 4.1 ‘Click’ modification of [Ru(p-cymene)(4-azido-2,2’-
bipyridyl)Cl]+complex
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4.2 Synthesis and CuAAC reactions of azido bpy ligands 
The synthesis of two azido-bipyridyl ligands was carried out in a multi-step 
procedure starting from commercially available 2,2’-bipyridyl. Scheme 4.1 shows 
the multistep synthesis for the monoazido-substituted ligand 4-azido-2,2’-
bipyridyl (4a). Ligand 4a was prepared by slowly reacting 2,2’-bipyridyl with 1 
equivalent of meta-chloroperoxybenzoic acid (mCPBA) for 12 hours to form 2,2’-
bipyridyl-N-oxide. The C4 position of the oxidised pyridyl ring then underwent 
nitration in the presence of concentrated nitric acid and concentrated sulfuric acid 
to form 4-nitro-2,2’-bipyridyl-N-oxide which was isolated by adjusting the pH of 
the reaction mixture to 13. 4-nitro-2,2’-bipyridyl-N-oxide was then refluxed in 
phosphorus trichloride to remove the oxygen atom from the nitrogen to yield 4-
nitro-2,2’-bipyridyl. The monoazido-substituted ligand 4-azido-2,2’-bipyridyl (4a) 
was then prepared from this nitro-substituted analogue by reaction with sodium 
azide in dimethylformamide at 100 °C in a procedure modified from that reported 
previously by Al-Fallapour.167 After purification by flash chromatography 4a was 
isolated as a pale yellow solid in excellent yield (96 %). Ligand 4a was fully 
characterised by 1H and 13C NMR spectroscopy and mass spectrometry. The 1H 
NMR spectrum exhibits a total of seven resonances typical of a 4-substituted 2,2’-
bipyridyl ligand. The resonances of the azido substituted pyridine ring appear at  
8.58, 8.15, and 6.94 and are shifted relative to those of the precursor 4-nitro-2,2’-
bipyridyl which appear at  9.06, 8.84, and 7.91. The presence of the azide group 
was confirmed by the observation of a peak for the azide N-N stretch at 2115 cm-1 
in the infrared spectrum.  
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(i) (ii)
(iii)
(iv)
 
Scheme 4.1 The synthesis of 4-azido-2,2’-bipyridyl starting from 2,2’-bipyridyl. 
(i) mCPBA in DCM at room temperature, (ii) HNO3 and H2SO4 at 100 °C, (iii) 
PCl3 at reflux, (iv) NaN3 in DMF at 100 °C  
Scheme 4.2 outlines the multistep synthesis required for 4,4’-diazido-2,2’-
bipyridyl (4b). Ligand 4b was synthesised in a similar manner to 4a but with a 
differing initial N-oxidation step in which hydrogen peroxide and glacial acetic 
acid were used as oxidising agents. The remainder of the synthesis was very 
similar with only changes to the necessary equivalences of reactants. The product 
was isolated after purification as a yellow solid, again in excellent yield. 4,4’-
diazido-2,2’-bipyridyl was similarly fully characterised by 1H and 13C NMR 
spectroscopy and mass spectrometry. The 1H NMR spectrum exhibits three 
resonances at  8.58, 8.14 and 6.96. These peaks are characteristic of a 4,4’-
disubsituted-2,2’-bipyridyl which are again shifted relative to those of the dinitro 
precursor ( 9.22, 9.05 and 8.14). As with ligand 4a the presence of the azide 
4a 
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groups was confirmed by the diagnostic azide stretch at 2117 cm-1 in the infrared 
spectrum.  
(i) (ii)
(iii)
(iv)
 
Scheme 4.2 The synthesis of 4,4’-diazido-2,2’-bipyridyl starting from 2,2’-
bipyridyl. (i) H2O2 and glacial CH3COOH at 80 °C, (ii) HNO3 and H2SO4 at 
100°C, (iii) PCl3 at reflux, (iv) NaN3 in DMF at 100 °C 
Having isolated and fully characterised these two ligands, 4a and 4b, we decided 
to investigate the uses of these azido bipyridyl ligands in CuAAC reactions. We 
therefore reacted the azido ligands with a range of commercially available 
acetylenes, including phenylacetylene, ethynyl ferrocene and pyridylacetylene. 
Scheme 4.3 outlines the synthesis of 4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole 
(5a) and was carried out in a one pot CuAAC synthesis, starting from 4-azido-
2,2’-bipyridyl and excess phenylacetylene in the presence of copper sulfate and 
sodium ascorbate in a 1:1 mixture of tetrahydrofuran and water. Upon completion 
of the reaction the product was extracted from the reaction mixture by partitioning 
4b 
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it between dichloromethane and aqueous ammonia. The desired triazole ligand 
was then isolated in good yield (74%) after purification by recrystallisation from 
dichloromethane and hexane.  
(i)
 
Scheme 4.3 One-pot synthesis of 4-phenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole 
ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
Ligand 5a was fully characterised by 1H and 13C NMR spectroscopy, and mass 
spectrometry. In the 1H NMR spectrum the diagnostic singlet signal 
corresponding to the triazolyl proton is clearly observed and appears as a singlet 
at  8.48. This is accompanied by an upfield shift observed in resonances for the 
bpy protons of the triazole substituted pyridyl ring of the bpy compared to the 
azide analogue which now appear at  8.84, 8.75, and 7.99. This shift is indicative 
of the change from the electron donating azide substituent to a relatively electron 
withdrawing triazolyl substituent. The phenyl resonances are well resolved with 
the ortho- and meta-proton signals appearing at  7.94 and 7.48 respectively with 
the resonance for the para-position overlapping with one of the signals arising 
from the pyridyl protons at  7.39. Infra-red spectroscopy confirmed the lack of an 
5a 
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azide stretch at 2115 cm-1 indicating that no remaining 4-azido-2,2-bipyridyl was 
present.  
4-Ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5b) was prepared in a one-pot 
CuAAC synthesis in a similar fashion to that for the phenyl triazole substituted 
ligand. 4-Azido-2,2’-bipyridyl was reacted with ethynyl ferrocene in the presence 
of CuSO4 and sodium ascorbate (Scheme 4.4). Purification and work up of the 
reaction was exactly the same as that for ligand 5a and an orange solid was 
isolated as the product in moderate yield (43 %).   
(i)
 
Scheme 4.4 One-pot synthesis of 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
As for ligand 5a, ligand 5b was fully characterised using 1H and 13C NMR 
spectroscopy and mass spectrometry. The 1H NMR spectrum of the ligand shows 
a characteristic singlet resonance for the proton of the triazole ring at  8.18. 
Figure 4.2 shows selected regions of the 1H NMR spectrum for ligand 5b. The 
resonances of the bpy protons of the substituted pyridyl ring are again shifted 
upfield and appear at  8.83, 8.69, and 8.01 when compared to those of 4-azido-
5b 
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2,2’-bipyridyl. The resonances of the substituted cyclopentadienyl (Cp) ring of the 
ferrocene moiety appear at  4.82 and 4.37 whilst the protons of the unsubstituted 
Cp ring gives rise to a singlet at  4.12. Formation of the cycloaddition product 
was also confirmed by the absence of the azide stretch in the infrared spectrum.  
 
Figure 4.2 Selected regions of the 1H NMR spectrum for 4-ferrocenyl-1-(2,2’-
bipyrid-4-yl)-1,2,3-triazole.  
Scheme 4.5 shows the synthesis of 4-(pyrid-2-yl)-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole ligand (5c). Reaction of 4-azido-2,2’-bipyridyl with 2-ethynylpyridine 
resulted in the formation of the heteroditopic ligand with two potential metal 
binding sites; a bipyridyl domain, and a second pyridyl-triazole domain. 4-(Pyrid-
2-yl)-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5c) was fully characterised by 1H and 
13C NMR spectroscopy and mass spectrometry. Twelve clearly identifiable signals 
are visible in the 1H NMR spectrum within the region of  7-9 with the diagnostic 
triazole singlet resonance appearing at  8.92. The resonances for the triazole 
substituted pyridine ring of the bpy moiety appear at δ 7.97, 8.85 and 8.88. Two 
7.67.88.08.28.48.68.8 ppm
0.
97
1.
00
1.
01
1.
00
0.
97
1.
00
1.
01
0.
99
4.24.34.44.54.64.74.84.95.0 ppm
4.
79
1.
99
1.
96
 163 
sets of four signals for the other two pyridine rings are also observed. Infra-red 
spectroscopy confirmed no azide stretch at 2115cm-1 indicating that no 4-azido-
2,2-bipyridyl was present. 
(i)
 
Scheme 4.5 One-pot synthesis of 4-(pyrid-2-yl)-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
After having investigated the CuAAC coupling reactions of the mono-azido bpy 
4a it was decided to investigate the CuAAC chemistry of the diazido analogue 4b. 
The CuAAC coupling of 4b were attempted with phenylacetylene and 2-
ethynylpyridine and it appeared to result in their triazole products. However, these 
products proved to be rather insoluble and therefore very difficult to characterise 
and therefore the results are not discussed further. The reaction of 
ethynylferrocene with 4,4’-azido-2,2’-bipyridyl to produce the desired 
bis(ferrocenyltriazolyl)bpy ligand was also attempted however this proved 
unsuccessful with no product being isolable despite several attempts under various 
conditions. It is possible that the failure of this reaction is due to the 
decomposition of the diazido starting material. 
5c 
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4.3 Synthesis of complexes  
The coordination chemistry of these new azide substituted bpy ligands and their 
CuAAC derivatives were explored. Scheme 4.6 shows the formation of [Ru(p-
cymene)(4a)Cl]+ (6a) and [Ru(p-cymene)(4b)Cl]+ (6b). The starting material 
[Ru(p-cymene)(Cl)2]2 was stirred with ligand 4a or 4b in methanol at room 
temperature for 12 hours leading to a bright yellow solution with subsequent 
isolation of the complexes 6a and 6b respectively as their PF6- salts after 
treatment with NaPF6.  
+
(i)
(ii)
X
H
N3
6a
6b
 
Scheme 4.6 Synthesis of [Ru(p-cymene)(4a-4b)Cl]+ (i) [Ru(p-cymene)(Cl)2]2, 
MeOH at room temp. (ii) NaPF6  
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Both new complexes 6a and 6b were fully characterised by 1H and 13C NMR, 
mass spectrometry and high resolution mass spectrometry as well as infrared 
spectroscopy. The infrared spectrum of 6a shows a characteristic azide stretch at 
2124 cm-1 which is shifted to higher energy by 9 cm-1 relative to the non-
coordinated ligand. Similarly, complex 6b exhibits a similar stretching frequency 
for the azido substituents with a slightly broader band than that for complex 6a at 
2122 cm-1 and is shifted to higher energy by 5 cm-1 compared with the non-
coordinated ligand.  
For complex 6a the 1H NMR spectrum of the complex contains seven resonances 
in the aromatic region due to the aromatic protons of the bipyridyl ligand. The 
signals for the non-substituted pyridyl ring are all deshielded upon coordination as 
is the H-6 proton of the azide-substituted ring which appears at  9.15. The 
resonances for the arene protons of the cymene ligand appear at  5.91 and 5.71. 
These appear as apparent triplets rather than a pair of doublets as in the 1H NMR 
spectrum of the precursor [Ru(p-cymene)(Cl)2]2 showing that the symmetry of the 
cymene has been broken by the asymmetry of the coordinated ligand 4a. In 
addition, the 1H NMR spectrum exhibits two closely overlapping doublets 
corresponding to the methyl groups of the isopropyl substituent of the cymene 
ligand at  1.04 and 1.03. This is presumably due to the chirality of the ruthenium 
centre. These characteristics can be clearly observed in Figure 4.3. 
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Complex 6b exhibits three resonances in the aromatic region which are attributed 
to the symmetrical bipyridyl ligand. The resonances for the two protons ortho- to 
the azide group are both deshielded due to the change in environment. The 
resonances from the arene protons of the cymene ligand in complex 6b appear as 
two doublets at  5.88 and 5.67. The methyl groups of the isopropyl of the 
cymene ligand are magnetically equivalent and give rise to a doublet at  1.02 
(Figure 4.4).   
 
Figure 4.3 1H NMR of [Ru(p-cymene)(4a)Cl]PF6 (6a) with expanded regions 
in CD3CN * residual solvent signal ‡ solvent impurities. 
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Figure 4.4 1H NMR of [Ru(p-cymene)(4b)Cl]PF6 (6b) with expanded regions 
in CD3CN * residual solvent signal ‡ solvent impurities. 
Single crystals were obtained for complex 6b by slow diffusion of diethyl ether 
into an acetonitrile solution of the complex. Unfortunately the data was not of 
publishable quality and the structure is presented here only for information. Figure 
4.5 depicts the molecular structure of the cation [Ru(p-cymene)(4b)Cl)]+
 
whilst 
selected bond lengths and angles are provided in Table 4.1. [Ru(p-
cymene)(4b)Cl))]PF6 (6b) crystallises in the space group P-1. The C-N bonds 
between the bpy and the azide groups are 1.449 and 1.429 Å and the N-N bonds 
within the azide are between 1.143-1.128Å. These are similar to those reported by 
Constable et al. 150 in an iron azidoterpyridine complex where the corresponding 
C-N bonds are 1.419 and 1.423 Å and the azide N-N bond lengths are between 
1.135-1.239Å. The C-N-N bond angles between the carbon of the bpy and the 
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central nitrogen of the azide are 115.9 and 116.2°, and the N-N-N angles of the 
azide nitrogens are 172.1 and 172.9°, again very similar to those reported by 
Constable (171.4 and 170.3°). 
 
Figure 4.5 ORTEP plot of the structure of the cation [Ru(p-cymene)(4b)Cl]+ 
(hydrogen atoms and PF6- counterion omitted for clarity, ellipsoids at 50% 
probability) 
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Table 4.1 Selected bond lengths (Å) and angles (°) for single-crystal X-ray 
structures of [Ru(p-cymene)(4b)Cl]+ 
[Ru(p-cymene)(4b)Cl]+
 
(6a) 
     
C22-N14 1.449(16)  C27-N11 1.429(14) 
N14-N15 1.236(16)  N11-N12 1.219(15) 
N15-N16 1.128(17)  N12-N13 1.143(15) 
Ru-Cl 2.392(3)  Ru-N9 2.099(9) 
   Ru-N10 2.086(9) 
     
C22-N14-N15 116.2(11)  C27-N11-N12 115.9(10) 
N14-N15-N16 172.1(13)  N11-N12-N13 172.9(12) 
 
As a further example, the iridium complex [Ir(ppy)2(4b)]PF6 (7), was prepared 
(where ppy is 2-phenylpyridine). The dimer [Ir(ppy)2Cl]2 in acetonitrile was first 
treated with AgPF6 for the in situ generation of the cationic solvento complex 
followed by the addition of ligand 4b to yield the complex 7 (Scheme 4.7). The 
1H NMR spectrum of the complex shows the expected eight resonances for the 
cyclometallated ppy ligands along with a further three resonances for the 
bis(azido) bipyridyl ligand which appear at  7.98, 7.79 and 7.00. The proton 
resonances for the H-6 and H-6’ positions of ligand 4b are significantly shifted 
downfield to  7.79 due to the ring current effect of the adjacent phenyl ring of the 
cyclometallated ppy ligands over which they are situated. Confirmation of the 
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presence of the azide substitutued ligand was confirmed by observation of the 
azide stretch at 2119 cm-1 in the infrared spectrum. 
[Ir(ppy)2Cl]2 (i)(ii)
PF6-
 
Scheme 4.7 Synthesis of [Ir(ppy)2(4b)]+. (i) [AgPF6], MeCN at room temp. (ii) 
4b 
Having explored the coordination chemistry of the azide substituted bpy ligands 
we moved on to investigate the coordination chemistry of their triazole 
derivatives. 
Two further ruthenium cymene complexes were prepared by the same route as for 
those of 6a
 
and 6b. The addition of ligands 5a and 5b to [Ru(p-cymene)(Cl)2]2 led 
to the isolation of complexes [Ru(p-cymene)(5a)Cl]PF6 (8a) and [Ru(p-
cymene)(5b)Cl]PF6 (8b) respectively (Scheme 4.8). The 1H NMR spectrum of 8a 
displays a distinct triazole proton resonance at  8.99 and seven bpy resonances 
appearing at  9.47, 8.78 and 8.21 for the triazole substituted pyridyl ring and  
9.39, 8.52, 8.27 and 7.78 for the unsubstituted pyridyl ring. A further three 
resonances are observed for the phenyl ring at  8.00, 7.57 and 7.48 for the ortho-, 
7 
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meta-and para- protons respectively. The resonances for the arene protons of the 
cymene ligand appear at  5.98 and 5.78. In addition, the 1H NMR spectrum 
exhibits two closely overlapping doublets corresponding to the methyl groups of 
the isopropyl substituent of the cymene ligand at  1.08 and 1.07.  
The 1H NMR spectrum of 8b exhibits a resonance at  8.64 for the proton of the 
triazole ring, and a further seven protons for the bpy appearing at  9.38, 8.73 and 
8.17 for the triazole substituted pyridyl ring and  9.44, 8.53, 8.27 and 7.77 for the 
unsubstituted ring. The resonances of the substituted cyclopentadienyl (Cp) ring 
of the ferrocene moiety appear at  4.85 and 4.42 whilst the protons of the 
unsubstituted Cp ring gives rise to a singlet at  4.13. The resonances for the arene 
protons of the cymene ligand appear at  5.98 and 5.78 and those of the methyl 
groups of the isopropyl substituent are observed as two closely overlapping 
doublets centred at  1.07. 
The resonances for the arene protons adjacent to the i-propyl group appear as 
apparent triplets, whereas the resonance for the arene protons adjacent to the 
methyl substituent appear as doublets for both complexes 8a and 8b. 
 172 
+
(i)
(ii)
 
Scheme 4.8 Synthesis of [Ru(p-cymene)(5a-b)Cl]+. (i) [Ru(p-cymene)(Cl)2]2, 
MeOH at room temp. (ii) NaPF6 
When [Ru(p-cymene)(Cl)2]2 was allowed to react with an equivalent of the ditopic 
ligand 5c, in ethanol for 48 hours the dinuclear complex 9 was formed and 
isolated as its PF6- salt (Scheme 4.9).  
i)
ii)
2PF6-
 
Scheme 4.9 Synthesis of [{Ru(p-cymene)Cl}2(5c)](PF6)2.(9) (i) [Ru(p-
cymene)(Cl)2]2, MeOH at room temp. (ii) AgPF6 and MeCN 
a 
b 
9 
8 
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The resultant complex [{Ru(p-cymene)Cl}2(5c)](PF6)2 (9) was characterised by 
1H and 13C NMR spectrometry and mass spectrometry. The aromatic region of the 
1H NMR spectrum appears to show more signals than the twelve resonances 
required for the bridging ligand (Figure 4.6). Examination of the 1H NMR 
spectrum of the complex reveals two singlet resonances for the triazole ring 
proton at δ 9.45 and 9.43 indicating the formation of magnetically inequivalent 
“meso” and “rac” diastereoisomers. These are assigned due to their lack of 
coupling in the COSY spectrum (Figure 4.8). This would be expected in a 
dinuclear complex of this type due to the chirality of the ruthenium centres upon 
coordination in the asymmetric chelating domains of the bridging ligand 
(structures shown in Figure 4.7). Similar duplicate resonances centered at δ 8.83 
and 9.58 are also observed for the 3- and 6-position protons respectively of the 
pyridyl ring of the bpy domain to which the triazole ring is attached (Figure 4.6). 
The remaining resonances for the bridging ligand were assigned based on the two-
dimensional COSY and NOESY spectra (Figure 4.8 and Figure 4.9). Further 
overlapping signals from this mixture of isomers are observed for the aryl cymene 
proton at  6.15 and 5.75, the cymene methine proton at  2.78 and 2.69 and for 
the isopropyl methyl groups between  1.2 and 1.0. 
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Figure 4.6 Selected regions of the 1H NMR spectrum for [{Ru(p-
Cymene)Cl}2(5c)](PF6)2 (9) in CD3CN 
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Figure 4.7 Diastereoisomers of [{Ru(p-cymene)Cl}2(5c)](PF6)2 (9) (Cym= p-
cymene) 
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Figure 4.8 2D H-H COSY NMR spectrum of [{Ru(p-cymene)Cl}2(5c)](PF6)2 
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Figure 4.9 2D H-H NOESY NMR spectrum of [{Ru(p-cymene)Cl}2(5c)](PF6)2  
NOESY data was then used to assign the signals for the cymene methyl 
substituents in terms of which domain of the bridging ligand they are associated 
with. This was achieved through nOe cross peaks between resonances for the 
cymene substituent proton signals and those of the bridging ligand.  
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Figure 4.10 2D H-H NOESY NMR spectrum of [{Ru(p-cymene)Cl}2(5c)](PF6)2 
 
Using the ligand 1-benzyl-4-(pyrid-2-yl)-1,2,3-triazole (10), we also prepared the 
complex [Ru(p-cymene)Cl(10)]PF6 (11) as a spectroscopic model for the pytz 
domain of 9. Firstly 10 was prepared through a standard click procedure in which 
benzyl azide was prepared in situ and reacted with phenyl acetylene. 96 The ligand 
was characterised by 1H NMR spectroscopy, and the diagnostic signal for the 
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triazole proton is observed at  8.06. Four signals due to protons of the pyridyl 
ring appear at  8.56, 8.20, 7.79, and 7.23, whilst signals corresponding to the 
aromatic benzyl protons appear as a multiplet between  7.44-7.32. A further 
singlet corresponding to the methylene protons is observed at  5.61.  
Ligand 10 was stirred with [Ru(p-cymene)Cl2]2 in ethanol for 48 hours, after 
which the solvent was removed and the product was isolated as a chloride salt. 
The complex was converted into its PF6, by dissolving the complex in a small 
amount of acetonitrile and stirring with an equivalent of AgPF6. The solution was 
filtered to remove silver chloride and the solvent was removed. The complex 
[Ru(p-cymene)Cl(10)]PF6 was characterised by 1H NMR spectroscopy and 
exhibits a diagnostic triazole signal at  8.56, which is shielded by 0.87 ppm 
relative to that of the dinuclear complex (9). The shift in the triazole proton 
resonance is ascribed to the presence of the more electron donating benzyl 
substituent of the pytz ligand compared to the bpy moiety that is attached to the 
triazole in 9. Four signals arising from the pyridyl ring at  9.22, 8.08, 7.91 and 
7.57 are at positions close to those observed for the comparable protons in 9. 
Signals from the aromatic benzyl protons appear as a large multiplet between  
7.52-7.40 with an integration for five protons whilst the methylene protons for the 
benzyl group appear as a singlet  5.76 and overlaps with those of the arene 
protons of the cymene ligand. The 1H NMR spectrum exhibits two doublets 
corresponding to the methyl groups of the isopropyl group of the cymene ligand at 
 1.09 and 0.94, which are again shielded by 0.03 and 0.13 ppm respectively, with 
respect to 9, showing loss of magnetic equivalence.  
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Scheme 4.10 Synthesis of [Ru(p-cymene)Cl(10)]PF6 (11). (i) [Ru(p-
cymene)(Cl)2]2, MeOH at room temp. (ii) AgPF6 and MeCN 
After preparing the ruthenium cymene complexes with pre-clicked ligands 5a-c 
our attention turned to the ruthenium cymene complexes with azido substituted 
ligands and their reactivity with respect to CuAAC reactions. The complex (6a) 
was shown to undergo CuAAC modification of the outer coordination sphere with 
phenylacetylene and ethynylferrocene as an alternative route to the complexes 
[Ru(p-cymene)(5a-b)Cl]PF6 (8a-b). A THF/water mixture was decided upon as 
the most effective conditions and allowed for easy extraction of product resulting 
in the highest yields. [Ru(p-cymene)(4a)Cl]PF6 (6a)was dissolved in a 1:1 
mixture of THF and water and an excess of the appropriate alkyne was added 
along with copper sulfate and sodium ascorbate. The tetrahydrofuran was 
removed under reduced pressure and the complexes were extracted into 
dichloromethane and purified by recrystallisation with acetonitrile and ether 
(Scheme 4.11). Figure 4.11 and Figure 4.12 show that the 1H NMR spectra of 
complexes [Ru(p-cymene)(5a)Cl]PF6 (8a) and [Ru(p-cymene)(5b)Cl]PF6 (8b) 
11 
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prepared through the alternative route are identical to those of the same complexes 
prepared with the pre-clicked ligands. This therefore demonstrates the potential 
application of azide substituted metal complexes as supramolecular synthons 
through peripheral CuAAC modification. 
 
Scheme 4.11 Alternative synthesis of the complexes [Ru(p-cymene)(5a-b)Cl]+ 
(8a-b). (THF/water 1:1, CuSO4 and sodium ascorbate at room temp.) 
a 
b 
8 
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Figure 4.11 1H NMR spectra of [Ru(p-cymene)(5a)Cl]PF6 A) pre-clicked 
ligand complex
 
and B) clicked at the metal 
 
Figure 4.12 1H NMR spectra of [Ru(p-cymene)(5b)Cl]PF6 A) pre-clicked 
ligand complex
 
and B) clicked at the metal complex 
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When [Ru(p-cymene)(4a)Cl]PF6 was “click” coupled with 2-ethynylpyridine the 
complex [Ru(p-cymene)(5c)Cl]PF6 (8c) was formed (Scheme 4.12). The 1H NMR 
spectrum of the product shows signals characteristic of the 4-substitutued bpy 
ligand along with broad signals for the triazole ring proton and the protons of the 
third pendant pyridyl ring. The broad nature of these resonances is most likely due 
to the coordination and exchange of paramagnetic copper(II) remaining from the 
CuAAC reaction mixture in the pyridyl-triazole domain. After washing a 
dichloromethane solution of the product with aqueous ammonia solution in order 
to remove the remaining copper ions, the protons of the coordinatively vacant 
pyridyltriazole moiety sharpen in the 1H NMR spectrum (Figure 4.13).  
Resonances at δ 7.39 and 8.66 are still slightly broad in appearance and so we 
cannot rule out the presence of a small quantity of remaining Cu(II). 
(i)
(ii)
 
Scheme 4.12 Synthesis of [Ru(p-cymene)(5c)Cl]+. (i) THF/water 1:1, CuSO4 
and sodium ascorbate at room temp. (ii) NH4OH 
8c 
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Figure 4.13 1H NMR spectra of [Ru(p-cymene)(5c)Cl]+ a) prior to washing 
with conc. NH3, b) after washing (* triazole ring proton, ‡ pendant pyridyl ring 
protons). 
We then investigated the use of 6a as a potential building block for metallo-
supramolecular assemblies. Since we have successfully demonstrated that 6a can 
act as the azido component in a range of click reactions, this was therefore 
extended to investigate the reaction of this complex with a linker with multiple 
reaction sites. Therefore 6a
 
was dissolved in a 1:1 mixture of THF and water with 
half an equivalent of dipropargyl ether in the presence of 2 equivalents of copper 
sulfate and excess sodium ascorbate (Scheme 4.13). The product, [{Ru(p-
cymene)Cl}2{di([1-{2,2’-bipyrid-4-yl}-1,2,3-triazol-4-yl]methyl)ether}]2PF6 (12) 
was purified by extracting with dichloromethane solution and purified by column 
chromatography, using silica gel and MeCN/H2O/KNO3(aq.) 7:1:0.5 (v/v) and 
isolated as its PF6- salt after treatment with NaPF6.  
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Scheme 4.13 Synthesis of [{Ru(p-cymene)Cl}2{di([1-{2,2’-bipyrid-4-yl}triazol-
4-yl]methyl)ether}].2PF6 (12).(THF/water 1:1, CuSO4 and sodium ascorbate at 
room temp.) 
The new clicked complex 12 was fully characterised by 1H and 13C NMR along 
with mass spectrometry and high resolution mass spectrometry. The 1H NMR 
spectrum of the complex shows two signals for the triazole ring proton centered at 
δ 9.29 as does the resonance at δ 9.14 for the H-3 proton of the triazole 
functionalised pyridine ring. Again, we assign this as being due to the formation 
of meso- and rac- isomeric mixtures of complexes due to the chirality at each 
ruthenium site as observed in complex 9. There are 7 clearly defined signals in the 
aromatic region of the spectrum which arise from the two 4-substituted bipyridyl 
units. The resonances associated to the arene protons from the p-cymene ligand 
appear as an apparent triplet at  5.97 and a doublet at  5.77. A single resonance 
at  4.84 as a singlet is also observed which is due to the methylene protons from 
the ether bridge (Figure 4.14). Mass spectrometry data shows the detection the 
dication [{Ru(p-cymene)Cl}2(21)]2+ at m\z 515.1 with an isotope pattern 
consistent with the presence of two ruthenium centres. 
12 
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Figure 4.14 1H NMR of [{Ru(p-cymene)Cl}2{di([1-{2,2’-bipyrid-4-yl}-1,2,3-
triazol-4-yl]methyl)ether}].2PF6 (12). 
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4.4 Conclusion 
In conclusion, we have successfully developed new ‘clicked’ ligands from 4-
azido-2,2’-bipyridyl, with either single or multiple binding sites. We have shown 
successfully that these ligands can be successfully coordinated to [Ru(	6-
cymene)Cl]+
 
and a have fully characterised these complexes. In similar reactions 
we have shown that we can coordinate 4-azido-2,2’-bipyridyl and 4,4’-diazido-
2,2’-bipyridyl to [Ru(	6-cymene)Cl]+ and we have demonstrated that the azido 
unit remains intact upon coordination. Indeed this azido unit can undergo‘click’ 
reactions and provide an alternative method to synthesising the same complexes 
as those made with prepared ligands. Further we were able to introduce a second 
domain through this approach. Finally we have demonstrated that 6a and “click” 
chemistry can be used as a potential tool in building metallo-supramolecular 
species. We have therefore made some of the first steps towards the goal of the 
development of a general “click” chemistry-based methodology for the 
construction of functional supramolecular architectures via azide-functionalised 
transition metal complexes. 
Future work in this area could include preparation of hetereobimetallic complexes 
of the bridging ligand 5c through this “clicked at the complex” route. 
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5 1,2,3-TRIAZOLE BRIDGED 
LUMINESCENT REDOX 
SWITCHES 
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5.1 Introduction 
Molecular switches refer to molecules which can be reversibly shifted between 
two or more stable states in response to various external triggers. 192 These 
molecules can respond to a range of different stimuli, for example pH, light, 
temperature, electrical current or the presence of a ligand. 192-195 One of the most 
attractive fields of research within molecular switches is the redox switching of 
fluorescence due to the interest in designing reversible luminescent sensors for the 
determination of local environmental redox properties and as bio-sensor elements 
to study electron and energy transfer mechanisms. 195 Aukauloo 196 and Galoppini 
197
 have used the mono azido bpy and bis azido ligand precursors respectively and 
showed that both of these ligands can be ‘click’ modified and can be used for the 
preparation of ruthenium complexes. Both groups note efficient electron transfer 
across the triazole ring. The group of Molina and Tárraga have shown that 
luminescent properties of ruthenium and iridium complexes with tethered 
ferrocene can be manipulated by a reversible process between the oxidized and 
reduced states of the ferrocene unit. 195, 198, 199 These results encouraged us to 
pursue complexes of 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole (5c) as 
potential luminescent switches. 
Described in this chapter is the synthesis and characterisation of metal complexes 
of ferrocenyl-bipyridyl ligand in which the ferrocene unit is tethered to the 
bipyridyl through a 1,2,3-triazole linkage. The photophysical properties of these 
complexes are reported along with efforts to use these as reversible luminescent 
switches. 
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5.2 Ligand Synthesis  
The synthesis of ligand 5b was carried out in a one-pot CuAAC synthesis as 
described previously. Briefly, 4-azido-2,2’-bipyridine was mixed with a slight 
excess of ethynylferrocene in the presence of copper sulfate and sodium ascorbate 
in a 1:1 mixture of THF and water at room temperature (Scheme 5.1). Upon 
completion of the reaction the product was isolated from the reaction mixture by 
portioning it between dichloromethane and aqueous ammonia and the desired 
triazole substituted ligand was purified by recrystallisation from dichloromethane 
and hexane and isolated in excellent yields. Ligand 5b was fully characterised 
using 1H and 13C NMR spectroscopy and mass spectrometry. 
(i)
 
Scheme 5.1 Synthesis of 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole 
ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
5b 
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5.3 Synthesis of ferrocenyltriazolyl-bipyridyl complexes 
5.3.1 Synthesis of [Ru(bpy)2(5b)][PF6]2 (13) 
Ligand 5b was reacted with one equivalent of [Ru(bpy)2Cl2] in EtOH and the 
mixture stirred at reflux for 4 hours under an inert atmosphere (Scheme 5.2). 
Upon cooling the resulting purple solution was passed through a silica column and 
MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5) was used to elute the desired fraction. The 
product was then isolated as its PF6- salt after treatment with NaPF6. The ESI-MS 
and high resolution ESI-MS spectra confirmed the resulting solid as 
[Ru(bpy)2(5b)](PF6)2 (13) with a signal at m/z 966.1 corresponding to the ion-pair 
[Ru(bpy)2(5b)](PF6)+ showing the expected isotope pattern for a Ru complex. The 
identity of the complex was also confirmed by 1H and 13C NMR studies in 
deuterated acetonitrile. The diagnostic singlet resonance corresponding to the 
triazole ring proton is clearly observed at  8.63 (Figure 5.1). Peaks which relate 
to both the substituted and unsubstituted Cp rings are clearly defined as a set of 
two triplet signals for the substituted Cp ring at  4.85 and 4.42, each with an 
integration of two protons and a large singlet at  4.12 for the unsubstituted ring 
with an integration of five protons. A number of multiplets are observed in the 
aromatic region of the spectrum, some of which overlap, and are associated with 
substituted and un-substituted bpy ligands. The signals for the ferrocenyl triazole 
substituted ligand are easily identifiable through two dimensional NOESY and 
COSY NMR spectroscopy. The protons for the 4-substituted pyridyl ring of 
ligand 5b in the complex are observed at  8.89, 7.84 and 7.41 whilst the protons 
for the unsubstituted pyridyl appear at  8.70, 8.12, 7.34 and 7.45. The remaining 
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resonances, some of which overlap, are assigned to the two remaining bpy ligands 
of the complex.  
(ii)
(i)
2PF6
 
Scheme 5.2 Synthesis of [Ru(bpy)2(5b)](PF6)2 (i) EtOH at reflux (ii) NaPF6. 
 
Figure 5.1 Selected regions of the 1H NMR spectrum for [Ru(bpy)2(5b)]PF6 
showing the aromatic region and the Cp ring region for the ferrocene sub unit. 
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5.3.2 Synthesis of [Ir(ppy)2(5b)][PF6] (14) 
Ligand 5b was reacted with half an equivalent of the iridium dimer [Ir(ppy)2Cl]2 
in the presence of silver hexafluorophosphate in acetonitrile with the exclusion of 
light.  The resulting orange solution was passed through a silica column and 
MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5) was used to elute the desired fraction. 
Fractions containing the product were evaporated to dryness and redissolved in 
dichloromethane and stirred with excess NaPF6 for 2 hours (Scheme 5.3). Water 
was added to the solution and the product was extracted as the PF6- salt into 
dichloromethane. Further purification was carried out by recrystallisation from 
dichloromethane and ether resulting in [Ir(ppy)2(5b)]PF6 (14). ESI-MS was used 
to confirm identity of the product and a molecular ion was observed with m/z 
908.2 corresponding to [Ir(ppy)2(5b)]+ with the expected isotope pattern for an 
iridium complex. NMR studies were also carried out in deuterated acetonitrile and 
a few similarities were observed between iridium complex and the corresponding 
ruthenium bipyridyl complex. The distinct signal for the triazolyl proton was 
clearly defined at  8.60 and the ferrocenyl signals were also clearly observed 
with two triplet resonances at  4.82 and 4.40 for the substituted Cp ring and a 
singlet at  4.10 for the unsubstituted Cp ring. As with the ruthenium complex 
there are also another 15 signals in the aromatic region which correspond, with 
some overlap, to the 23 protons of the bpy and ppy ligands. The protons of the 
substituted pyridyl ring of ligand 5b in the complex appear at  8.90, 8.09 and 
7.94 and those of the unsubstituted ring appear at  8.71, 8.19, 8.03 and 7.56.  
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(i)
PF6
 
Scheme 5.3 Synthesis of [Ir(ppy)2(5b)](PF6) (AgPF6, MeCN in the dark at 
room temperature) 
5.3.3 Synthesis of [Re(5b)(CO)3Cl] (15) 
Ligand 5b was refluxed with an equivalent of [Re(CO)5Cl] in toluene and upon 
cooling [Re(5b)(CO)3Cl] (15) was collected as an orange-brown solid (Scheme 
5.4). Mass spectrometry indicated that this synthesis had been successful with an 
ion with m/z 678.0 being observed corresponding to [Re(5b)(CO)3]+ through loss 
of the Cl- ligand. The 1H NMR spectrum in deuterated acetonitrile of the complex 
contains all of the expected signals arising from the ferrocenyl triazolyl bpy ligand 
which are shifted relative to those of the free ligand in the same solvent. The 
triazole proton gives rise to a singlet resonance at  9.31 which is deshielded by 
1.1 ppm on coordination. The signals for the substituted ring of the bpy appear at 
 9.18, 9.17 and 8.34 and those of the unsubstituted ring appear at  9.09, 8.98, 
8.47 and 7.85. Again, ferrocenyl signals were also clearly observed with two 
triplet resonances at  4.84 and 4.44 for the substituted ring and a singlet at  4.14 
for the unsubstituted ring. The infrared spectrum of complex 15 was recorded 
14 
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using ATR. The complex exhibits three distinct bands in the carbonyl region of 
the infrared spectrum with the symmetric stretch at 2019 cm-1 and the asymmetric 
stretches at 1934 and 1909 cm-1. The carbonyl stretching frequencies shift to 
higher wavenumbers with respect to the bpy analogue, which appear at 2010, 
1890 and 1870 cm-1 respectively using the same technique, which is indicative of 
a greater -accepting character for the ligand 5b compared to bpy. 
(i)
 
Scheme 5.4 Synthesis of [Re(5b)(CO)3Cl] (i) Toluene at reflux. 
5.4 Synthesis of phenyltriazolyl-bipyridyl complexes 
In order to probe the effect of the ferrocene moiety on the photophysical 
properties of the ruthenium and iridium complexes of ligand 5b we have prepared 
the analogous series of complexes bearing the ligand 5a, 4-phenyl-1-(2,2’-
bipyrid-4-yl)-1,2,3-triazole. Further, comparison of these complexes to the 
analogous unsubstituted bpy parent complexes will allow us to gauge the effects 
of the triazole linker on the photophysical properties. 
15 
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The synthesis of ligand 5a has been reported in a previous chapter. Briefly, 4-
azido-2,2’-bipyridyl was reacted with phenylacetylene in the presence of CuSO4 
and sodium ascorbate (see chapter 4). 
(i)
 
Scheme 5.5 Synthesis of 4-phenyl-1-(2,2’-bipyridyl)-1,2,3-triazole ligand. (i) 
THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
5.4.1 Synthesis of [Ru(bpy)2(5a)][PF6]2 (16) 
Ligand 5a was reacted with an equivalent of [Ru(bpy)2Cl2] in ethanol and the 
mixture was stirred at reflux for 4 hours under an inert atmosphere (Scheme 5.6). 
Upon cooling the resulting purple solution was passed through a silica column and 
MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5) was used to elute the desired fraction. The 
complex [Ru(bpy)2(5a)](PF6)2 (16) was isolated as its PF6- salt as a red solid. ESI-
MS was used to identify the product and a peak was observed at m\z 858.1108 
corresponding to the ion-pair [Ru(bpy)2(5a)]PF6+. The complex was also 
characterised by NMR spectroscopy and as with the other complexes of this sort a 
singlet signal is observed at  8.98 for the triazole ring proton all other resonances 
associated with the bipyridyl protons are observed in the region  7.36-8.96. The 
5a 
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resonances which correspond to the ligand 5a were distinguished by two-
dimensional NMR spectroscopy. The phenyl resonances are well resolved with 
the ortho- and meta-proton signals appearing at  7.94 and 7.48 respectively with 
the resonance for the para-position overlapping with one of the signals arising 
from the unsubstituted bpy ligands at  7.42. The resonances for the protons of the 
triazole substituted pyridyl ring are observed at  8.94 for the proton at 3-position 
and the signals for the 5- and 6- positions appear coincident at  7.89. The 
resonances for the unsubstituted pyridyl ring protons of ligand 5a appear at  8.72, 
8.12, 7.79 and 7.42. 
i)
ii)
2PF6
 
Scheme 5.6 Synthesis of [Ru(bpy)2(5a)](PF6)2 (i) EtOH at reflux (ii) NaPF6. 
5.4.2 Synthesis of [Ir(ppy)2(5a)][PF6] (17)  
In a similar procedure to that for the iridium ferrocene substituted complex 14, 
ligand 5a was reacted with half an equivalent of the iridium dimer [Ir(ppy)2Cl]2 in 
the presence of silver hexafluorophosphate in MeCN with the exclusion of light.  
The resulting orange solution was passed through a silica column and 
MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5) was used to elute the desired fraction.  
16 
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Further purification was carried out by recrystallisation from dichloromethane and 
diethyl ether and metathesis to the PF6 to yield [Ir(ppy)2(5a)]PF6 (17). The 
complex was characterised by NMR spectroscopy and as with the other 
complexes in this series a singlet signal is observed at  8.99 assigned to the 
triazolyl ring proton. All other resonances associated with the cyclometallated 
bipyridyl protons are observed in the region  6.20-9.00 with the ortho, meta and 
para protons of the phenyl ring appearing at  7.96, 7.52 and 7.43 respectively. 
The resonances for the bpy protons of the triazole substituted pyridyl ring of 
ligand 5a are observed at  8.97, 8.11 and 7.99, and those of the unsubstituted 
pyridyl ring of 5a are observed at  8.74, 8.19, 8.03 and 7.56.  
i)
ii)
PF6
 
Scheme 5.7 Synthesis of [Ir(ppy)2(5a)](PF6) (i) MeCN and AgPF6 (ii) NaPF6. 
5.4.3 Synthesis of [Re(5a)(CO)3Cl] (18) 
Ligand 5a was also coordinated to rhenium by reaction with [Re(CO)5Cl] in 
refluxing toluene. The complex [Re(5a)(CO)3Cl] (18) was characterised by 1H 
NMR spectroscopy and the spectrum shows the same number of signals as for the 
uncomplexed ligand but which appear shifted relative to those of the free ligand. 
The triazole ring proton is observed as a characteristic singlet resonance at  9.72, 
17 
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which is deshielded by 1.5 ppm compared to that of the free ligand. The 
resonances for the substituted pyridyl ring of the bpy have characteristic 
resonances at  9.23, 9.21 and 8.36 and those of the unsubstituted ring appear at δ 
9.09, 8.95, 8.46 and 7.85. This complex proved rather insoluble and so obtaining 
mass spectrometry data for this complex was not possible. The infrared spectrum 
of complex 18 shows three distinct carbonyl stretching frequencies at 2019 cm-1 
and the asymmetric stretches at 1926 and 1890 cm-1 again at higher wavenumbers 
compared to the bpy analogue. 
i)
 
Scheme 5.8 Synthesis of [Re(5a)(CO)3Cl](i) Toluene at reflux. 
  
18 
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5.5 Photophysical Studies 
UV-vis absorption and luminescence data for [Ru(bpy)2(5a)](PF6)2, 
[Ru(bpy)2(5b)](PF6)2, [Ru(bpy)3](PF6)2 [Ir(ppy)2(5a)](PF6), [Ir(ppy)2(5b)](PF6) 
and [Ir(ppy)2(bpy)](PF6) are summarised in Table 5.1 UV-vis absorption spectra 
of ruthenium complexes 13 and 16 along with that of [Ru(bpy)3](PF6)2 (19) were 
recorded in acetonitrile and are shown in Figure 5.2. The spectra for complexes 
13, 16 and 19  all show an intense absorption band at approximately 290 nm, 
assigned to bpy-centred   * excitations. The complexes also exhibit a broad 
band between 400–500 nm, assigned to 1MLCT-based transitions. On replacing 
one of the bpy ligands in [Ru(bpy)3]2+ with a triazole substituted bpy ligand these 
MLCT bands are observed to redshift appearing at 460 nm for 13 and 461 nm for 
16, compared to 452 nm for 19. This is explained by the extended -system in the 
derivatised bpy ligand which will result in a lowering of the energy of the LUMO 
and hence the 1MLCT state relative to the ground state. 
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Figure 5.2 UV-vis absorption spectra  for [Ru(bpy)2(5a)](PF6)2, 
[Ru(bpy)2(5b)](PF6)2 and [Ru(bpy)3](PF6)2 
UV-vis absorption spectra of the iridium complexes 14 and 17 were also recorded 
in acetonitrile, along with that of the bpy analogue [Ir(ppy)2(bpy)](PF6) (20), and 
are presented in Figure 5.3. The compounds show absorption features similar to 
those reported for other [Ir(ppy)2] complexes with typical strong   * 
transitions in the UV region below 300 nm localized on the ppy and the bpy 
ligands. Weaker 1MLCT bands are observed at lower energies between 370 and 
470 nm. On replacing one of the bpy ligand in 20 with a triazole substituted bpy 
ligand these weak 1MLCT bands are observed to very slightly blueshift appearing 
at 468 nm for 14 and 466 nm for 17, compared to 470 nm for 20. 
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Figure 5.3 UV-vis absorption spectra  for [Ir(ppy)2(5a)](PF6), 
[Ir(ppy)2(5b)](PF6) and [Ir(ppy)2(bpy)](PF6) 
Luminescence measurements were recorded at room temperature in aerated 
acetonitrile with an excitation wavelength of 400 nm. Figure 5.4 and Figure 5.5 
shows the emission spectra for truthenium complexes 13, 16 and 19 and the 
iridium complexes 14, 17 and 20 respectively.. Figure 5.4 shows broad emission 
bands with max of 639 and 611 nm for complexes 16 and 19 respectively, which 
are assigned to phosphorescent emission from triplet metal-to-ligand charge-
transfer (3MLCT) excited states. The ferrocene containing complex 13 shows 
largely quenched room temperature emission compared to emission from 14 and 
16. The emission profile of both the triazole containing complexes is red-shifted 
relative to that of the homoleptic bpy complex 19 (611 nm) and is observed at 639 
nm for 16 and very weak emission at 642 nm for 13. The red-shift in the emission 
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band reflects the shift observed in the absorption spectra showing a stabilisation of 
the 3MLCT state due to the extended -system of the triazole substituted ligands. 
 
Figure 5.4 Equimolar luminescence spectra for[Ru(bpy)2(5a)](PF6)2, 
[Ru(bpy)2(5b)](PF6)2 and [Ru(bpy)3](PF6)2 (* 2nd harmonic scattering) 
Figure 5.5 shows the emission profiles for the iridium complexes 15, 17 and 20. 
As with the ruthenium complexes, broad emission bands are observed for the 
unsubstituted bpy complex (20) and the phenyl-triazole substituted bpy complex 
(17). Similarly to the ruthenium analogue, the ferrocene containing iridium 
complex (15) shows largely quenched room temperature emission. The emission 
profiles of both the triazole containing complexes are again red-shifted relative to 
that of the bpy complex (590 nm) and are observed at 624 nm for 17 and 640 nm 
for 14. This is indicative of a lowering of the bpy-centered LUMO and hence 
stabilisation of the 3MLCT state.  
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Figure 5.5 Equimolar luminescence spectra for[Ir(ppy)2(5a)](PF6), 
[Ir(ppy)2(5b)](PF6) and [Ir(ppy)2(bpy)](PF6) (* 2nd harmonic scattering) 
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Table 5.1 UV-vis absorption and luminescence data for 
[Ru(bpy)2(5a)](PF6)2, [Ru(bpy)2(5b)](PF6)2, [Ru(bpy)3](PF6)2 
[Ir(ppy)2(5a)](PF6), [Ir(ppy)2(5b)](PF6) and [Ir(ppy)2(bpy)](PF6) 
Complex abs / nm maxem / nm 
[Ru(bpy)2(5a)](PF6)2 (16) 288, 461 639 
[Ru(bpy)2(5b)](PF6)2 (13) 287, 460 642  
[Ru(bpy)3](PF6)2 (19) 286, 452 611 
[Ir(ppy)2(5a)](PF6) (17) 250, 315, 373, 466 624 
[Ir(ppy)2(5b)](PF6) (14) 250, 314, 378, 468 640 
[Ir(ppy)2(bpy)](PF6) (20) 258, 310, 379, 470 590 
 
5.6 Complex Stability 
After a period of six months the complex [Ru(bpy)2(5b)](PF6)2 appears to 
undergo oxidation of the ferrocene moiety to ferrocenium. This is characterised by 
a broadening of the resonances for the substituted bpy ligand and absence of the 
signals for the Cp rings of the ferrocene due to the paramagnetic effects. The 
signals for the unsubstituted bpy ligand can still be seen however.  
Sodium ascorbate and N-ethylmorpholine were used to effect reduction of the 
ferrocene back to Fe(II). Treatment with sodium ascorbate was not successful, 
however, treatment with N-ethylmorpholine in acetonitrile results in restoration of 
the ferrocene and the substituted bpy ligand signals (Figure 5.6).  
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Figure 5.6 1H NMR spectra for [Ru(bpy)2(5b)]PF6 showing the aromatic 
region and the Cp ring region before and after treatment with N-ethylmorpholine. 
The same oxidation was observed for the iridium complex however the 
broadening of the peaks were less pronounced and the iridium complex was 
reduced and purified in the same way and all complexes were subsequently kept 
at -18 °C under nitrogen. 
5.7 Cyclic Voltammetry Studies 
Cyclic voltammetry was carried on 0.9-1.0 mM solutions of the complexes in 
acetonitrile using tetrabutylammonium tetrafluoroborate as the electrolyte and a 
silver/silver chloride reference electrode referenced to ferrocene/ferrocenium (0 
V). Cyclic voltammetry experiments were carried out on the ligand and its 
complexes to probe their electrochemical properties. The redox data for all ligands 
and complexes are summarised in Table 5.2. Firstly the cyclic voltammogram of 
3.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
3.54.04.55.05.56.06.57.07.58.08.59.09.5 ppm
Before treatment 
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commercially available ferrocene was obtained to optimise the equipment and 
provide a reference potential, after which 4-ferrocenyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole (5b) was scanned using the same procedure. Figure 5.7 shows a 
comparative trace of ferrocene and ligand 5b. Ligand 5b exhibits a reversible 
oxidation curve at a potential of 0.074 V relative to Fc/Fc+ E=0.0 V. The data 
suggests that the Fe dz2 centred HOMO of ligand 5b is slightly stabilised 
compared to that of ferrocene.  
 
Figure 5.7 Cyclic voltammogram traces of ferrocene and ligand 5b  
Upon determining the redox potential for the ferrocene substituted ligand 5b in 
isolation the oxidation potential for the ruthenium complex [Ru(bpy)2(5a)](PF6)2 
(16) was determined. The cyclic voltammogram of complex 16 is shown in Figure 
5.8 in which clearly defined reversible oxidation is observed at 0.9 V. Upon 
comparing the redox potentials of the ferrocene and ruthenium of the complexes it 
can be seen that the ferrocene moiety redox potential of [Ru(bpy)2(5b)](PF6)2 
appears at 0.14 V which is shifted by +0.066 V compared to that of the free 
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ligand. The redox potential for the ruthenium centre of complex 
[Ru(bpy)2(5b)](PF6)2 (13) is shifted by +0.035 eV compared to those of 
[Ru(bpy)2(5a)](PF6)2 (16). The redox wave for the ruthenium metal centre in 
complex 13 is not as well resolved as it is in complex 16, and appears only 
partially reversible. 
 
 
Figure 5.8 Overlay of cyclic voltammogram traces of [Ru(bpy)2(5b)]PF6, 
[Ru(bpy)2(5a)]PF6 and ligand 5b. 
Similar experiments were also carried out for the iridium and rhenium complexes. 
Figure 5.9 shows the overlay of the traces obtained for the iridium complexes 14 
and 17. [Ir(ppy)2(5a)]+ exhibits a partially reversible oxidation centred at 0.90 V. 
The ferrocenyl appended complex [Ir(ppy)2(5b)]+ shows a reversible Fc/Fc+ 
oxidation potential at 0.095 V which is shifted to more positive potential when 
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compared to that of the free ligand as well as largely irreversible oxidation at 0.91 
V.   
 
Figure 5.9 Overlay of cyclic voltammogram traces of [Ir(ppy)2(5b)]PF6, 
[Ir(ppy)2(5a)]PF6 and ligand 5b.  
The rhenium complex [Re(CO)3(5b)Cl] exhibits a partially reversible Fc/Fc+ 
oxidation potential at 0.18 V (Figure 5.10) which is again at a more positive 
potential when compared to that of the free ligand, however there is a greater 
separation of the oxidation and reduction potentials. The redox wave for the 
rhenium is not well defined for either of the complexes with possible irreversible 
oxidations appearing at 0.95 V and 1.06 V for the complexes [Re(CO)3(5b)Cl] 
and [Re(CO)3(5a)Cl] respectively. Studies on these complexes were hampered 
due to low solubility of the complexes which may have adversely affected the 
cyclic voltammetry measurements.  
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Figure 5.10 Overlay of Cyclic voltammogram of [Re(CO)3(5b)Cl], 
[Re(CO)3(5a)Cl] and Ligand 5b. 
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Table 5.2 Redox data for [Ru(bpy)2(5a)](PF6)2, [Ru(bpy)2(5b)](PF6)2,  
[Ru(bpy)3](PF6)2 [Ir(ppy)2(5a)](PF6), [Ir(ppy)2(5b)](PF6), [Ir(ppy)2(bpy)](PF6), 
[Re(CO)3(5b)Cl], [Re(CO)3(5a)Cl] and Ligand 5b ( a Ferrocenyl redox potential, 
b
 
ruthenium redox potential, c
 
iridium redox potential and d
 
rhenium redox 
potential) 
Complex Redox Potential / eV vs. Fc/Fc+ 
Ligand 5b 0.074 
[Ru(bpy)2(5b)](PF6)2 (13) 0.14a, 0.96b 
[Ru(bpy)2(5a)](PF6)2 (16) 0.93b 
[Ir(ppy)2(5b)](PF6) (14) 0.095a, 0.91c 
[Ir(ppy)2(5a)](PF6) (17) 0.90c 
[Re(CO)3(5b)Cl] (15) 0.18a, 0.95d 
[Re(CO)3(5a)Cl] (18) 1.06d 
 
5.8 Luminescent Switching Studies 
Electrochemical luminescence switching studies were carried out on the ferrocene 
appended metal complexes, in an attempt to turn on the emission through 
oxidation of the ferrocene moiety. Molina 199 had previously reported that such 
oxidative turning on of luminescent emission could be achieved in [Ru(bpy)2] 
complexes of a ferrocene appended imidazophenanthroline ligand. 
Initial work was carried out, using voltammetric methods for switching the 
oxidation state of the ferrocene. From the cyclic voltammetry experiments 
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discussed earlier, the oxidation potentials of the ferrocene and metal moieties had 
been determined. A potential was applied to a solution containing the Ru 
complex, more positive than that required for the oxidation of the ferrocene, but 
lower than that of the ruthenium redox couple. It was hoped that this would 
selectively oxidise the ferrocene moiety thereby switching on luminescent 
emission. Therefore a potential of 0.57 V with respect to Fc/Fc+ was applied to a 1 
mM solution of [Ru(bpy)2(5b)](PF6)2 for 120 minutes and aliquots were taken out 
at regular intervals at which point the luminescent emission of the aliquot was 
recorded. The luminescent intensities of the samples did not differ from that of the 
original solution and could be due to the limitations of our cyclic voltammetry 
instrumentation. 
Through our stability work we successfully showed that the use of a mild 
reducing agent could regenerate the ferrocene from ferrocenium. Therefore, if the 
complex could be reduced chemically, then the use of a mild chemical oxidising 
agent should oxidise the ferrocene and increase the luminescent intensity of the 
complex. Molina et al. 198 had shown that Cu(II) triflate could be used to increase 
the luminescent intensity of ferrocene containing ruthenium complexes and we 
therefore carried out a similar experiment. Figure 5.11 shows spectra before and 
after reaction with 1 equivalent of copper(II) trifluoromethanesulfonate for a 
solution of the [Ru(bpy)2(5b)](PF6)2 in acetonitrile. As can be seen luminescence 
intensity increases by greater than 20 fold demonstrating electrochemical switch 
on of emission through chemical oxidation.  
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Figure 5.11 Fluorescence intensity of [Ru(bpy)2(5b)]PF6 before and after the 
addition of 1 equivalent of copper(II)triflate.  
After this encouraging initial result the effect on luminescent intensity with 
respect to the amount of copper triflate was also investigated. Figure 5.12 shows 
the change in luminescence intensity with increasing copper triflate concentration. 
The data shows a general correlation with luminescence intensity to copper triflate 
added, however the results obtained did not show a linear relationship.  
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Figure 5.12 Fluorescence intensity of [Ru(bpy)2(5b)]PF6 with respect to the 
amount of copper(II)triflate added. 
A solution of one equivalent of copper triflate and ruthenium complex was kept 
for a period of one week. The fluorescence intensity was recorded immediately 
upon addition of [Cu(OTf)2], then after 24 hours and then again after 1 week. 
Figure 5.13 shows that the luminescent intensity of the ruthenium complex 
increases with time. We are uncertain why the oxidation appears slow but could 
be due to solubility, though no precipitation of [Cu(OTf)2] was noticed. 
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Figure 5.13 Fluorescence intensity of [Ru(bpy)2(5b)]PF6 with 1 equivalent of 
copper(II)triflate added over time. 
Our investigation was extended and bromine was used as chemical oxidising 
agent in the hope that the reaction would be faster. Bromine was added to an 
acetonitrile solution of the complex [Ru(bpy)2(5b)](PF6)2 in 0.1 equivalent 
aliquots. Figure 5.14 shows the luminescent intensity of the ruthenium complex 
with respect to the amount of bromine added. The data show that increase in Br2 
concentration yields increased luminescent intensity. 
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Figure 5.14 Luminescence spectra of [Ru(bpy)2(5b)]PF6 with increasing 
bromine concentration. 
The bromine switching experiment was also carried out on the iridium complex 
14 with similar results (Figure 5.15). Again the luminescence intensities of the 
complex increase with the amount of bromine added. Unfortunately due to the 
solubility of the rhenium complex 15 this switching experiment could not be 
carried out.  
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Figure 5.15 Fluorescence intensity of [Ir(ppy)2(5b)]PF6 with respect to the 
amount of bromine added. 
5.9 Conclusion 
In conclusion we have developed two potential luminescent switches with 
ferrocene tagged bipyridyl ligands containing a CuAAC derived triazole linker. 
The ferrocene moiety quenches the Ru/Ir based luminescent emission, presumably 
by electron transfer across the triazole bridge. The complexes undergo slow 
oxidation on standing in air therefore the complexes must be stored under nitrogen 
at -18 °C, however the complexes can be regenerated through N-ethylmorpholine. 
We have demonstrated that the luminescent emission can be switched on by 
oxidation of the Fc moiety to Fc+.  
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The quenching of emission shows that there is good electronic communication 
across the triazole bridge in agreement with recently reported systems. Ruthenium 
and iridium conjugates with ferrocene linked by a triazole moiety have been 
shown to yield luminescent emission intensity that can be modulated by oxidation 
of the ferrocene. Unfortunately this oxidation and the switching on of 
luminescence is not terribly well controlled and this will be a focus of further 
work in this area. 
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6 TRIAZOLE BASED BRIDGING 
LIGANDS: PHOTOPHYSICS OF 
DINUCLEAR RU AND IR 
COMPLEXES 
  
 220 
6.1 Introduction 
Oligonuclear complexes involving polypyridyl ligand moieties have attracted a 
great deal of recent attention, largely due to their potential as the basis of novel 
functional materials.200-202 In particular polymetallic assemblies based on 
ruthenium, iridium and rhenium have been widely studied due to their 
electrochemical, photochemical and photophysical properties.203-206 For the 
majority of the complexes studied, the metal centres are linked by a ligand bridge, 
with the nature of the bridge having a fundamental influence on the electronic 
interaction between the metal centres and therefore on the characteristics of the 
material.150, 207 A wide range of bridging ligands have been used in recent years. 
In most cases the bridging ligands contain pyridine-type coordinating units 
(particularly chelating sites like bpy) either directly connected or separated by a 
variety of spacers. Non-rigid bridging ligands have limitations, in terms of energy 
and electron transfer, as the geometry (metal-to-metal distance) of the system is 
not defined, therefore rigid spacers are much preferred.204 
Jean-Pierre Sauvage has studied the electrochemical and photophysical properties 
of ruthenium(II) and osmium(II) bis(terpyridine) linked by a rigid spacer attached 
at their 4’-postion (Figure 6.1a). 208-210 Both homo- and heteronuclear complexes 
were prepared and it was found that the strong electronic interaction observed 
when the two metal ions are separated by the tpy-tpy bridge decreases upon 
introduction of one or two phenylene spacers but remains large enough to allow 
fast energy transfer. The same group have also prepared ruthenium and osmium 
complexes with biscyclometalating bridging ligands (Figure 6.1b). 210, 211  
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In comparison with analogous complexes containing non-cyclometallating 
bridging ligands, where the MLCT excited states involved in the energy transfer 
step are localized in the bridge and very fast energy transfer takes place, energy 
transfer in the cyclometalated complexes is slower because the involved MLCT 
excited states are directed toward the terminal ligands. 
a)
b)
 
Figure 6.1 Ruthenium-osmium terpyridine bridged complexes.  
Bipyridyl-based bridging ligands have also been prepared. The simplest of which 
are 2,3-bis(dipyridyl)pyrazine or 2,5-bis(dipyridyl)pyrazine (dpp). Very high 
nuclearity structures have been developed based on ruthenium(II) and osmium(II) 
centres connected by these ligands (Figure 6.2). 204, 212 
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Figure 6.2 Decanuclear species bridged by 2,3-bis(dipyridyl)pyrazine .212 
Ward and co-workers have also used the asymmetric bis(bipyridyl) bridging 
ligand 2,2’:3’,2’’:6’’,2’’’-quaterpyridine ligand 213 and prepared mononuclear 
ruthenium complexes and heterodinuclear ruthenium-rhenium complexes (Figure 
6.3). 214, 215 They found that that the pendant [Re(CO)3Cl] fragments exert an 
electron-withdrawing effect on the [Ru(bpy)3]2+ core such that the Ru(II)/Ru(III) 
redox couple moves to more positive potentials as the number of pendant 
[Re(CO)3Cl] fragments increases. They also showed that Re-Ru energy transfer 
takes place with 100% efficiency in all cases. Ishitani and co-workers have shown 
that ruthenium–rhenium bridged complexes act as efficient photocatalysts for the 
reduction of CO2.169, 171, 216, 217 
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Figure 6.3 Ruthenium-rhenium complex bridged by 2,2’:3’,2’’:6’’,2’’’-
quaterpyridine ligand 
Described in this chapter is the synthesis and characterisation of a range of 
ligands, incorporating the 1,2,3-triazole moiety, which have designed to act as 
bridging ligands for the construction of supramolecular assemblies. Also 
described in this chapter is synthesis, characterisation and photophysical study of 
ruthenium and iridium complexes utilising some of these ligands. 
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6.2 Ligand Synthesis 
In order to explore the versatility of the CuAAC reaction for the preparation of 
novel bridging ligands for supramolecular architectures a number of new triazole 
containing oligotopic ligands were prepared and characterised and are described 
below. 
The synthesis and characterisation of ligand 5c has been discussed in a previous 
chapter, and was prepared from 4-azido-2,2-bipyridyl and 2-ethynlypyridine in 
the presence of copper(I) under standard click reaction conditions (Scheme 6.1). 
This resulted in the formation of a heteroditopic ligand with two potential metal 
binding domains; a bipyridyl moiety, and a second pyridyl-triazole domain.  
(i)
 
Scheme 6.1 Synthesis of 4-pyrid-2-yl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole 
ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room temperature. 
The ether-bridged ditopic bidentate ligand, 21 (Scheme 6.2) was prepared through 
a similar procedure, starting from 4-azido-2,2-bipyridyl and half an equivalent of 
dipropargyl ether in the presence of copper sulfate and sodium ascorbate in a 1:1 
mixture of THF and water. The bridging ligand has been reported in a previous 
5c 
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chapter however this was constructed from the ligated azido bpy ligands using the 
complex [Ru(p-cymene)(4a)Cl]+. 
(i)
 
Scheme 6.2 Synthesis of di-([1-{2,2’-bipyrid-4-yl}-1,2,3-triazol-4-
yl]methyl)ether ligand. (i) THF/H2O, CuSO4 and sodium ascorbate at room 
temperature. 
Ligand 21 was fully characterised by 1H and 13C NMR spectroscopy, along with 
mass spectrometry. Due to the symmetry of this ligand, across the ether linkage, 
the 1H NMR spectrum exhibits a total of nine resonances for the bpy, triazole and 
methylene protons. A diagnostic singlet signal for the triazole ring protons 
appears at  8.36. There are seven clearly defined signals within the aromatic 
region of the spectrum arising from the bipyridyl moieties, with the protons of the 
substituted pyridyl ring appearing at  8.83, 8.76 and 7.92 and resonances at  
8.70, 8.48, 7.87 and 7.37 arising from the unsubstituted pyridyl rings. A single 
resonance at  4.92 which appears as a singlet is also observed and corresponds to 
the methylene protons from the ether bridge. Formation of the product was also 
confirmed by the absence of the azide stretch in the infrared spectrum, ESI-MS 
was also used to confirm the successful synthesis of the ligand and a sodium 
adduct is observed with m/z 511.2. 
21 
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The synthesis of the ligands 1,4-bis-{4-(pyridi-2-yl)-1,2,3-triazol-1-
yl}methylbenzene and 1,3,5-tris-{4-(pyridi-2-yl)-1,2,3-triazol-1-
yl}methylbenzene (22 and 23 respectively) were both prepared in a simple two-
step/one-pot synthesis. Scheme 6.3 and Scheme 6.4 shows the CuAAC procedure 
starting from the corresponding halide and acetylene starting materials. The azides 
were prepared in situ from their corresponding bromomethyl-substituted benzene 
analogues by nucleophilic substitution with a slight excess of NaN3 in 
dimethylsulfoxide at room temperature for 2 hours. Upon completion of the 
substitution reaction, 2-ethynylpyridine was added to the reaction vessel along 
with catalytic quantity of CuSO4 and excess sodium ascorbate along with an 
equivalent of 2,6-lutidine per acetylene. The compounds 22 and 23 were purified 
by recrystallisation from dichloromethane and hexane and isolated in good yields. 
(i) (ii)
 
Scheme 6.3 One-pot synthesis of 1,4-bis-({4-(pyrid-2-yl)-1,2,3-triazol-1-
yl}methyl)benzene ligands (22) starting from corresponding halide. (i) 
dimethylsulfoxide and NaN3 at room temperature; (ii) dimethylsulfoxide/H2O, 
CuSO4, sodium ascorbate and 2,6-lutidine at room temperature. 
22 
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(i) (ii)
 
Scheme 6.4 One-pot synthesis of 1,3,5-tris-({4-(pyrid-2-yl)-1,2,3-triazol-1-
yl}methyl)benzene (23) ligands starting from corresponding halide. (i) 
dimethylsulfoxide and NaN3 at room temperature; (ii) dimethylsulfoxide/H2O, 
CuSO4, sodium ascorbate and 2,6-lutidine at room temperature. 
Both polytypic ligands 22 and 23 where fully characterised 1H and 13C NMR 
spectroscopy. The symmetrical nature of the bis-triazole ligand 22 results in a 
simple set of resonances in the 1H NMR spectrum. A characteristic singlet 
resonance arising from the triazole protons is observed at  8.07, and is clearly 
distinguishable as with other triazole signals as there is no coupling to any other 
protons evident in the COSY spectrum. Four signals for the pyridyl rings are also 
observed at  8.46, 8.10, 7.70 and 7.15 and a singlet at  7.37 arises from the four 
aromatic protons of the benzyl ring. A singlet at  5.60 is assigned to the 
methylene protons. These singlet resonances are assigned on the basis of NOESY 
data. 
 Similarly the tris triazole derivative 23 was also characterised by 1H NMR 
spectroscopy and the diagnostic signal for the triazole protons is observed at  
8.65. Four signals for the tethered pyridine units were also observed in the 
23 
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aromatic region of the spectrum at δ 8.57, 8.00, 7.88 and 7.34. Finally a singlet at 
 7.36 was also observed corresponding to the three protons of the benzene ring 
whilst the resonances for the methylene protons appear at  5.68 and were 
assigned through the NOESY interaction with the benzene ring and triazole ring 
protons.  
Both ligands were also characterised by ESI-MS, with the ditopic ligand (22) 
having a m/z peak at 417.2 and the tritopic ligand (23) having a m/z peak at 575.2 
corresponding to their sodium adducts. Elemental composition was confirmed 
using high resolution mass spectrometry.  
The intention was to use these ligands for metal complexation. However the pytz 
appended benzene ligands 22 and 23 appeared in the literature whilst we were 
carrying out this work 11 and we therefore decided to concentrate our efforts on 
the coordination chemistry and photophysical properties of ligand 5c as we 
anticipated further publications appearing on these already published ligands.  
We also felt that complexes of ligand 5c would be more interesting, due to the fact 
that there is direct -conjugation between the two coordinating domains and thus 
the potential for good metal to metal communication. 
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6.3 Synthesis and Characterisation of Dinuclear Ruthenium 
and Iridium Complexes 
Bis-ruthenium and bis-iridium complexes utilising the heteroditopic ligand 5c 
were prepared. The bis-ruthenium complex [{Ru(bpy)2}2(5c)](PF6)4 (24) was 
prepared by refluxing two equivalents of [Ru(bpy)2Cl2] with ligand 5c in ethanol 
under nitrogen atmosphere for 48 hours, after which time the mixture was passed 
through a column containing silica gel using MeCN/H2O/sat. KNO3 (aq.) (7:1:0.5) 
as a eluent (Scheme 6.5). A deep-red luminescent fraction was eluted and the 
product was crystallised as the hexafluorophosphate salt by adding excess NaPF6. 
4PF6-
4+
(i)
 
Scheme 6.5 Synthesis of [{Ru(bpy)2}2(5c)](PF6)4 (i) Ethanol at reflux under N2 
for 48 hours. 
The bis-iridium complex [{Ir(ppy)2}2(5c)](PF6)2 (25) was prepared by reacting 
ligand 5c with an equivalent of the dimer [Ir(ppy)2Cl]2 in the presence of AgPF6 
in dichloromethane under an inert atmosphere of nitrogen and exclusion of light 
(Scheme 6.6). Purification of the product was carried out in a similar manner to 
that for the bis-ruthenium complex and a yellow/orange luminescent fraction was 
eluted from the column. Isolation of the product was carried out by removing the 
24 
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solvent by rotary evaporation, adding water and extracting the product into 
dichloromethane, and adding NaPF6 in methanol. Further purification of both the 
homoleptic complexes was carried out through recrystallisation from acetonitrile 
and diethylether.  
2+
2PF6-
(i)
 
Scheme 6.6 Synthesis of [{Ir(ppy)2}2(5c)](PF6)2 (i) AgPF6 in DCM at reflux 
under N2 with light exclusion. 
1H NMR characterisation of the ditopic complexes is problematic due to the large 
number of aromatic resonances that are present which result in significant 
overlapping of signals. The asymmetery of the bridging ligand renders every 
proton magnetically unique. This is further complicated by the presence of two 
sets of signals corresponding to the two sets of meso- and rac- diastereoisomers 
due to the  and 
 stereochemistry at the coordinated metal centres (Figure 6.4). 
This is highlighted by the observation of two triazole signals in each of the 
complexes. The ruthenium complex 24 exhibits two triazole signals at  9.90 and 
9.85 and similarly the iridium complex 25 exhibits two triazole signals at  9.84 
and 9.72. Each complex has 13 signals arising from ligand 5c as well as 32 
bpy/ppy protons, each of which are magnetically unique, hence (13 + 32) × 2= 90 
resonances, therefore making it difficult to fully characterise. However mass 
25 
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spectrometry and high resolution mass spectrometry were used to confirm the 
identity of the complexes as well as their elemental composition, with complex 24 
giving a molecular ion at m/z 282.1 for the 4+ species, [{Ru(bpy)2}2(5c)]4+, and 
complex 25 giving a molecular ion at m/z 651.2 for the 2+ species, 
[{Ir(ppy)2}2(5c)]2+. 
 
Figure 6.4 Diastereoisomers of [{Ru(bpy)2}2(5c)].4 PF6 (24) 
  
   
 
 
 
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Figure 6.5 1H NMR spectrum for [{Ru(bpy)2}2(5c)](PF6)4 (* triazole 
resonance) 
 
Figure 6.6 1H NMR spectrum for [{Ir(ppy)2}2(5c)](PF6)2 (* triazole 
resonance) 
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To aid with the photophysical studies of these dinuclear species, mono nuclear 
model analogues of the bipyridyl and the pyridyl-triazole domains of the dinuclear 
complexes were prepared. To model the bipyridyl domain the Ru(bpy)2 and 
Ir(ppy)2 complexes of ligand 5a were used (Figure 6.7). The synthesis and 
characterisation of the these complexes have been discussed in the previous 
chapter. To model the pyridyl-triazole domain the Ru(bpy)2 and Ir(ppy)2 
complexes of the 1-benzyl-4-pyrid-2-yl triazole ligand (10) were prepared.  
 
(a) (b) PF62PF6
 
Figure 6.7 Mononuclear species to model the bipyridyl domain of the 
bimetallic species (a) [Ru(bpy)2(5a)](PF6)2 and (b) [Ir(ppy)2(5a)](PF6).  
During the course of this work the Ru(bpy)2 and Ir(ppy)2 complexes of ligand 10 
have also been independently prepared and characterised by the groups of 
Schubert 10, 99 and De Cola. 98, 101, 102, 124 The synthesis of [Ru(bpy)2(10)](PF6)2 
(26) was carried out by refluxing [Ru(bpy)2Cl2] with 10 in ethanol under an 
atmosphere of nitrogen for 4 hours. The resultant solution of the complex was 
16 17 
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passed through a column containing silica gel using MeCN/H2O/sat. KNO3 (aq.) 
(7:1:0.5) as the eluent. A deep-red fraction was eluted and the product was 
crystallised by addition of excess NaPF6 in methanol (Scheme 6.7).  
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Scheme 6.7 Synthesis of [Ru(bpy)2(10)](PF6)2 (i) Ethanol at reflux under N2 for 
4 hours.(ii) NaPF6, MeOH 
Complex 26 was characterised by 1H NMR spectroscopy. The complex exhibits a 
diagnostic signal for a triazole proton which appears as a singlet at  8.63. The 
remaining protons of the pytz ligand can be assigned through nOe interactions 
with the triazole proton and resultant COSY connections. Due to the asymmetry 
of the pytz ligand, this renders the remaining 16 protons of the bpy ligands as 
unique this making the full NMR assignment difficult due to the significant 
overlap. The resonance at  5.54, with integration equivalent to two protons, 
arises from the methyl protons adjacent to the benzyl ring and appears as a 
geminal AB doublet of doublets with roofing. This is due to the chirallity of the 
ruthenium centre therefore producing two diasetereoisomers, could also be due to 
the hindered rotation of the benzyl substituent and the C2 symmetry of the 
26 
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[Ru(bpy)2] fragment which thus renders these protons diastereotopic. 
Confirmation of the identity of the ruthenium complex was carried out using MS 
and HRMS which showed a peak at 325.1 m/z and 795.1 m/z for the ion 
[Ru(bpy)2(10)]2+ and the ion pair {[Ru(bpy)2(10)]PF6}+ respectively. In addition 
the correct ruthenium isotope pattern was observed for each of these signals.  
[Ir(ppy)2(10)](PF6) (27) was prepared from the corresponding [Ir(ppy)2Cl]2 dimer, 
by stirring it with AgPF6 in MeCN for 2 hours at room temperature with the 
exclusion of light after which the solution was passed through celite to remove 
AgCl. This was then stirred with an equivalent of ligand 10 per iridium in MeCN 
for a further 24 hours. Purification of the complex was carried out by column 
chromatography and recrystallisation (Scheme 6.8).  
(i)
(ii)
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Scheme 6.8 Synthesis of [Ir(ppy)2(10)](PF6) (i) AgPF6 in MeCN for 24 hours 
(ii) ligand 10 in MeCN 
As with complex 26, the iridium complex 27 exhibits a signal in the 1H NMR 
spectrum at  8.63 for the triazole proton. The methylene signal is observed at  
5.61 and exhibits the same geminal AB doublet of doublets with roofing. Mass 
27 
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spectrometry was used to confirm the preparation of the product and a peak was 
observed at m/z 737.2 for the cation [Ir(ppy)2(10)]+.  
6.3.1 Cyclic Voltammetry Studies 
Cyclic voltammetry experiments were carried out on the ruthenium family of 
complexes in order to characterise their electrochemical properties. Figure 6.8 
shows an overlay of the cyclic voltammograms for the three ruthenium complexes 
in this series (16, 24 and 26) and Table 6.1 contains the observed oxidation 
potentials for comparison. 
 
Figure 6.8 Overlay of cyclic voltammograms for [{Ru(bpy)2}2(5c)][PF6]4, 
[Ru(bpy)2(5a)][PF6]2 and [Ru(bpy)2(10)][PF6]2  
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The data show that the oxidation and reduction potentials of the two mononuclear 
ruthenium complexes are approximately coincident. This is not unexpected as the 
HOMO in these complexes is expected to be Ru dz2 in character with little 
involvement of ligand centred orbitals. The oxidation peak potential for the 
mononuclear species 16 and 26 occurs at 0.94 V and the reduction peak potential 
of the oxidised complex is 0.84 V. The cyclic voltammogram for the dinuclear 
ruthenium complex 24 where the ruthenium is coordinated in both domains again 
shows a similar shape, with only 1 oxidation peak potential and 1 reduction peak 
potential of the oxidised complex, with the oxidation peak potential at 1.03 V and 
the reduction peak potential of this oxidised complex at 0.93 V. This indicates that 
both the ruthenium centres present are oxidised and reduced simultaneously and 
do not form an intermediate mixed valence Ru(II)/Ru(III) species. We had hoped 
to observe two redox waves indicative of the formation of a mixed valence 
Ru(II)/Ru(III) complex as an intermediate for which we might have expected to 
see near infrared (NIR) intervalence charge transfer transition.  
Table 6.1 Redox data for [{Ru(bpy)2}2(5c)](PF6)4, [Ru(bpy)2(5a)] (PF6)2 and 
[Ru(bpy)2(10)] (PF6)2 
Complex Redox Potential / eV 
[{Ru(bpy)2}2(5c)](PF6)4(24) 0.95 
[Ru(bpy)2(5a)](PF6)2 (16) 0.89 
[Ru(bpy)2(10)] (PF6)2 (26) 0.89 
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6.3.2 Photophysical Studies 
UV-visible absorption spectra of all three ruthenium complexes 16, 24 and 26 
were recorded in acetonitrile (Figure 6.9). For these complexes the dominant 
absorption bands in the lower region at 250-270nm we assigned as intraligand  
 * transitions. These assignments were made on comparison to closely related 
metal complexes in the literature. 10, 99, 218 The low energy broad bands in the near 
UV region approximately 400-500 nm are attributed to the metal to ligand charge-
transfer (MLCT) d(Ru)  * (N-N) transitions. The MLCT band of complex 26 
is blue-shifted with respect to that of the substituted tris bpy complex 16. This is 
expected as replacing the bpy ligand with a ligand with a smaller  system will 
destabilise the LUMO of the complex relative to the HOMO and thus increase the 
energy of the 1MLCT state relative to the ground state. The MLCT band of 
dinuclear complex 24 also appears slightly broadened relative to 26 as there is 
contribution from both metal centres in bpy and pytz domains. . 
 
Figure 6.9 UV-vis absorption spectra for [{Ru(bpy)2}2(5c)](PF6)4 (24), 
[Ru(bpy)2(5a)] (PF6)2 (16) and [Ru(bpy)2(10)] (PF6)2 (26)  
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UV-visible absorption spectra of the iridium complexes were also recorded in 
acetonitrile. The absorption spectra of complexes, 17, 25 and 27 are presented in 
Figure 6.10. The compounds show absorption features similar to those reported 
for other Ir(ppy)2 complexes with typical strong   * transitions in the UV 
region localized on the ppy and the bpy ligands at approximately 250-300 nm and 
weaker metal-to-ligand charge transfer bands at lower energies between 350 and 
430 nm.  
 
Figure 6.10 UV-vis absorption spectra for [{Ir(ppy)2}2(5c)](PF6)2 (25), 
[Ir(ppy)2(5a)] (PF6) (17) and [Ir(ppy)2(10)] (PF6) (27) 
Luminescence measurements were recorded at room temperature in aerated 
acetonitrile and recorded with an excitation wavelength of 400 nm. Figure 6.11 
shows the emission spectra for the three ruthenium complexes 16, 24 and 26. The 
emission for complex 16, displays an intense broad and unstructured emission 
band at 639 nm that is assigned as arising from a 3MLCT state. This is red-shifted 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
200 300 400 500 600 700 800
A
b
so
ra
n
ce
Wavelength (nm)
Ir(ppy)2(5a)
Ir(ppy)2(10)
{(Ir(ppy)2}2(5c)
Ir(ppy)2(5a)(PF6) (17) 
Ir(ppy)2}2(5c)(PF6)2 (25) 
Ir( py)2(10)(PF6) (27) 
 240 
when compared to that of [Ru(bpy)3]2+ (611 nm) due to the extended -system of 
the phenyl triazole substituted bpy ligand. That lowers the LUMO and hence 
stabalises the 3MLCT state. The emission band for complex 26 is blue shifted 
compared to [Ru(bpy)3]2+ in a similar manner to the shift observed for the MLCT 
absorption and appears at 612 nm. The emission for complex 26 is highly 
quenched which is an agreement with observations of Schubert, and is likely due 
to the raised 3MLCT state becoming closer to 3MC therefore enabling more 
efficient thermal population of the latter and non radiative deactivation to the 
ground state. 10, 99 The dinuclear complex 24 displays an intense emission band at 
653 nm which is red-shifted relative to the phenyl-triazole substituted bpy 
complex 16. This could be due to the fact that coordination of the ruthenium to the 
pytz domain makes the pyridine and triazole rings coplanar which may not be the 
case for the phenyl-triazole substituted complex 16. Coordination to the pytz 
domain make it more electron withdrawing hence lowering the LUMO of the bpy 
fragment. Also, the steric demands of the [Ru(bpy)2] moieties are likely to force 
planarity of the bridging ligand also extending the -system thus lowering the 
LUMO. The dinuclear complex 24, showed greater than 100% enhancement in 
luminescent intensity when compared to emission for 26, We assign this as being 
due to photoinduced energy transfer (PEnT) from the pytz coordinated ruthenium 
centre with emission from the bpy domain coordinated ruthenium centre.. Hence, 
whilst the [Ru(bpy)2(pytz)] fragment is not particularly emissive it acts as a 
sensitising chromophore for the emission from the [Ru(bpy)3] domain. However, 
quenching due to singlet O2 can not be entirely ruled out as the samples were 
recored in aerated solvents. 
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Figure 6.11 Luminescence spectra for [{Ru(bpy)2}2(5c)](PF6)4, [Ru(bpy)2(5a)] 
(PF6)2 and [Ru(bpy)2(10)] (PF6)2   
Figure 6.12 shows the emission spectra for the three iridium complexes 17, 25 and 
27. The emission band for complex 17 is red-shifted relative to that of the 
complex [Ir(ppy)2(bpy)]+ (590 nm) and appears at 624 nm which is similar to the 
observation observed for the related ruthenium complex 16 and assigned as 
emission from a 3MLCT/3LLCT state centred on the bpy ligand. For the pytz 
iridium complex 27 an intense structured emission band with vibronic 
progressions at 472 and 510 nm is observed, as observed by De Cola et al 98, 100, 
124
. This is indicative of a significant amount of 3LC character in the emission 
state which is ppy ligand centred. The emission is intense in comparison to the 
ruthenium complex 26 as 5d metals have larger ligand field splitting and therefore 
higher lying 3MC states that minimise thermal deactivation of emission. Also, the 
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cyclometalled ligand is a strong anionic C-donor ligand which similarly 
destabilises the 3MC state making it less thermally accessible. Overall, this results 
in minimal quenching of emission when compared to that of the ruthenium 
complex 26. In a similar fashion to the emission of the dinuclear ruthenium 
complex 24, the dinuclear iridium complex 25 shows enhanced and red-shifted 
emission due to the same reasons as stated for 24. Emission from the iridium in 
the pytz domain is actively quenched and emission occurs from an excited state 
localised on the bridging ligand possibly indicating PEnT-based sensitisation. 
Photophysical data for all complexes is summarised in Table 6.2. 
 
Figure 6.12 Luminescence spectra for [{Ir(ppy)2}2(5c)](PF6), 
[Ir(ppy)2(5a)](PF6) and [Ir(ppy)2(10)](PF6)   
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Table 6.2 UV-vis absorption and luminescence data for 
[{Ru(bpy)2}2(5c)](PF6)4, [Ru(bpy)2(5a)](PF6)2, [Ru(bpy)2(10)](PF6)2, 
[{Ir(ppy)2}2(5c)](PF6)2, [Ir(ppy)2(5a)](PF6) and [Ir(ppy)2(10)](PF6)   
Complex abs / nm maxem / nm  (ns) 
[Ru(bpy)2(5a)](PF6)2 (16) 288, 461 639 229.3 
[Ru(bpy)2(10)](PF6)2 (26) 287, 460 612  7.36 
[{Ru(bpy)2}2(5c)](PF6)4 (24) 288, 459 653 260.6 
[Ir(ppy)2(5a)](PF6) (17) 250, 315, 373, 466 624  
[Ir(ppy)2(10)](PF6) (27) 253, 310, 389, 468 472, 510  
[{Ir(ppy)2}2(5c)](PF6)2 (25) 248, 268, 391, 470 590  
 
The luminescent lifetimes where measured in aerated acetonitrile for all three of 
the ruthenium complexes 16, 24 and 26, and are shown in Error! Reference 
source not found.. Complex 26 has a short lifetime of 7.36 ns consistent with the 
quenched emission intensity. Complex 16 displays a much longer lifetime of 
229.3 ns whereas the dinuclear ruthenium complex 24 has an extended lifetime of 
260.6 ns possibly due to the observed sensitisation of the [Ru(bpy)3] domain by 
the [Ru(bpy)2(pytz)] domain.  
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6.4 Conclusion 
In conclusion we have successfully synthesised and characterised a small library 
of click derived bridging ligands. We have subsequently prepared two dinuclear 
ruthenium and iridium complexes of the 4-pyridyl-1-(2,2’-bipyrid-4-yl)-1,2,3-
triazole bridging ligand, and carried photophysical studies. From our studies we 
have shown that the dinuclear species exhibit greater luminescent intensities than 
mono-nuclear model complexes possibly because the metal centre coordinated to 
the pyridine-triazole domain acts as a sensitizer for the metal centre coordinated to 
the bipyridyl domain through a photoinduced energy transfer mechanism. This 
shows that there is efficient transfer across the bridging ligand. 
This therefore presents the potential use of this bridging ligand in functional 
supramolecular complexes. For example a mixed Ru/Re system could be 
envisaged for photocatalytic CO2 reduction 169 and dinuclear complexes of this 
sort could also be investigated as novel chromophores for dye-sensitised solar cell 
applications. 
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7 GENERAL CONCLUSIONS & 
OUTLOOK 
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7.1 General Conclusions 
In conclusion we have demonstrated that the CuAAC reaction is a versatile 
coupling reaction which has a great deal of application within supramolecular and 
coordination chemistry. 
Through our work with rhenium tricarbonyl complexes we have shown that 1,4-
disubstituted-1,2,3-triazole ligands can act as either axial monodentate ligands, 
through the N3 atom of the triazole ring, or as bidentate N^N donor ligands if a 
pyridyl substituent is incorporated into a chelate ligand framework. The 
bipyridyltricarbonylrhenium(I) complexes with axial monodentate 1,2,3-triazoles 
have been shown to slightly better donor ligands than pyridine in these types of 
complexes. The complexes show long luminescent lifetimes in excess of 500 ns in 
dichloromethane and therefore may have potential applications as luminescent 
probes in biological time-gated imaging (Figure 7.1).  
BIOMOLECULE
 
Figure 7.1 Rhenium polypyridine biological imaging agents 
 
 247 
The CuAAC reaction can also be used to chemical modify the periphery of a 
metal complex when an azido substituted ligand is allowed to react with a range 
of alkynes. We have implemented the CuAAC reaction to introduce a redox active 
component into ligands by reacting azido bpy with ethynyl ferrocene and 
investigated the redox behaviour of this ligand. Further, we have successfully 
prepared and characterised rhenium, ruthenium and iridium complexes 
incorporating this ligand and investigated the redox behaviour of these complexes. 
From these investigations we have shown that the luminescent properties of the 
ruthenium and iridium complexes can be modulated through oxidation of the 
ferrocene moiety.  
Furthermore, complexes of the type [Ru(p-cymene)(bpy-N3)Cl]+ have been 
implemented in CuAAC reactions with bis alkynes and successfully been used as 
building blocks for metallo-supramolecular structures with greater control of 
selective metal binding.  
We have also demonstrated that the CuAAC reaction can be used as an excellent 
tool for the preparation of new bidentate ligands incorporating either one or 
multiple binding sites starting from 4-azido-2,2’-bipyridyl and reacting them with 
a range of acetylenes.  
In a marriage of the two uses of the triazole, as a coordinating donor and linker 
moiety the CuAAC reaction was used to prepare a small library of ligands with 
multiple binding sites. The photophysical properties of a dinuclear ruthenium and 
iridium complex with 4-pyridyl-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole bridging 
ligand were studied and it was demonstrated that the metal coordinated in the 
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pyridine-triazole domain has the potential to acts as a sensitizer for the metal in 
the bpy domain and could have an effect on luminescent intensity when compared 
to the model mononuclear phenyltriazolyl-bpy analogue. 
7.2 Future Work 
‘Click’ chemistry and the CuAAC reaction in particular is a relatively new area of 
interest within coordination chemistry therefore all the work presented in this 
thesis has the potential to be extended further.  
Our work with rhenium tricarbonyl complexes can be extended by implementing 
a similar synthetic scheme to that described here to introduce into the 1,2,3-
triazole ligand a photophysically active complex, for example [Ru(bpy)2(5a)] or 
[Ir(ppy)2(5a)] (Figure 7.2). Ishitani 219 and co-workers have shown that 
ruthenium-rhenium polynuclear complexes act as light harvesting supramolecular 
photocatalysts for the reduction of CO2. 
3+
 
Figure 7.2 Potential ruthenium-rhenium complex as a supramolecular 
photocatalysts for the reduction of CO2. 
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Further work with our ruthenium cymene complexes can be explored, in particular 
the complex with 4-(pyrid-2-yl)-1-(2,2’-bipyrid-4-yl)-1,2,3-triazole ligand 
constructed at the coordinated azido-bpy ligand. This provides the basis for 
incorporating a second metal into the pyridyl-triazole domain and access to 
selective heteronuclear complexes. This approach would be beneficial as it would 
allow for absolute control over regiospecificity of metal coordination. Some of the 
potential applications of mixed metal complexes include 
• Mixed Ru/Re complexes again for the photocatalysis of CO2 reduction. 
• Mixed Ru/Ir complexes could be envisaged and have potential 
applications in water oxidation photocatalysis. 220 
• Dinuclear ruthenium complexes with carboxylic acid derivative of bpy in 
one site could be used as novel DSSC dyes. 
Similarly the multi oligotopic ligands discussed in chapter 6 that have not been 
utilised as yet in our work will provide the basis of various hetero 
dinuclear/trinuclear metal complexes for these and other applications. 
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Figure 7.3 Proposed synthesis of mixed metal complexes 
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The mild and modular Cu(I)-catalyzed 1,3-cycloaddition of terminal alkynes with 
organic azides allows the ready formation of functionalised 1,4-disubstituted-
1,2,3-triazole scaffolds and this has led to an explosion of interest in the 
coordination chemistry of these heterocycles. A diverse array of mono-, bi-, tri- 
and polydentate ligands incorporating 1,4-disubstituted-1,2,3-triazole units have 
been synthesised, characterised and reported during the course of this projec. Easy 
access to readily functionalised ligand architectures is of crucial importance in a 
range of different areas and we are exploiting these ligands for the development of 
new catalysts, metallo-pharmaceuticals, bio-imaging agents, 
metallosupramolecular architectures, and molecular machines.  
Therefore, the work presented in this thesis and the recent explosion of interest in 
the use of ‘click’ chemistry, in particular CuAAC reactions for ligand design and 
as supramolecular linkers has shown that the CuAAC reaction has great potential 
in inorganic chemistry.  
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9 APPENDIX 
  
 269 
9.1 X-ray crystallography 
Single crystal X-ray diffraction data were collected on a Bruker Apex Duo 
diffractometer equipped with a graphite monochromated Mo(Ka) radiation source 
(0.071073 nm) and a cold stream of N2 gas. Preliminary scans were employed to 
assess crystal quality, lattice symmetry, ideal exposure time etc. prior to collecting 
a full sphere of diffraction intensity data using SMART operating software. 
Intensities were then integrated from several series of exposures, merged and 
corrected for Lorentz and polarisation effects using SAINT software. Solutions 
were generated by conventional heavy atom Patterson or direct methods and 
refined by full-matrix non-linear least squares on all F2 data, using SHELXS-97 
and SHELXL software respectively (as implemented in the SHELXTL suite of 
programs). Empirical absorption corrections were applied based on multiple and 
symmetry-equivalent measurements using SADABS. All structures were refined 
until convergence (max shift/esd < 0.01) and in each case, the final Fourier 
difference map showed no chemically sensible features. 
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Complex [Re(bpy)(CO)3(1a)](PF)6 
  
Formula C22H17F6N5O3PRe 
Mr / g mol-1 730.58 
T/K 103 
Space group C2/c 
a / Å 36.1896(14) 
b / Å 8.5518(3) 
c / Å 17.3133(7) 
 (°)  90 
 (°) 116.081(1) 
 (°) 90 
V / Å3 4812.6(3) 
Dc / g cm-1 2.017 
Z 8 
µMo / mm-1 5.199 
‘T’min, max 0.430,0.620 
2max 69.94 
Nref 10543 
R1 0.0210 
wR2 0.0484 
S 1.031 
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Complex [Re(bpy)(CO)3(1b)](PF)6 
  
Formula C24H21F6N5O3PRe 
Mr / g mol-1 758.63 
T/K 110 
Space group Pbca 
a / Å 13.5102(5) 
b / Å 19.4031(6) 
c / Å 20.6142(7) 
 (°)  90 
 (°) 90 
 (°) 90 
V / Å3 5403.8(3) 
Dc / g cm-1 1.865 
Z 8 
µMo / mm-1 4.634 
‘T’min, max 0.330,0.710 
2max 60.06 
Nref 7884 
R1 0.0376 
wR2 0.1145 
S 0.947 
 
  
 272 
Complex [Re(bpy)(CO)3(1c)](PF)6 
  
Formula C28H21F6N5O3PRe 
Mr / g mol-1 806.67 
T/K 100 
Space group P-1 
a / Å 10.2372(7) 
b / Å 12.2663(8) 
c / Å 12.4058(8) 
 (°)  76.3200(10) 
 (°) 81.8120(10) 
 (°) 69.9900(10) 
V / Å3 1419.03(16) 
Dc / g cm-1 1.888 
Z 2 
µMo / mm-1 4.418 
‘T’min, max 0.351,0.472 
2max 60.06 
Nref 8262 
R1 0.0214 
wR2 0.0452 
S 1.088 
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Complex [Ru(p-cymene)(4b)Cl](PF6) 
  
Formula C20H20ClF6N8PRu 
Mr / g mol-1 653.93 
T/K 150 
Space group P-1 
a / Å 8.8409(10) 
b / Å 14.1712(16) 
c / Å 19.682(2) 
 (°)  81.279(3) 
 (°) 86.805(2) 
 (°) 87.935(3) 
V / Å3 2432.7(5) 
Dc / g cm-1 1.785 
Z 4 
µMo / mm-1 0.894 
‘T’min, max 0.856, 0.991 
2max 52.94 
Nref 9885 
R1 0.1104 
wR2 0.2580 
S 1.249 
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9.2 Atomic Coordinates of the optimised geometries of the S0 
ground states and T1 excited states of complexes  
To view molecular structures copy and paste portion between # marks into 
notepad, save as a .xyz file and open molecular viewing program such as 
Mercury. 
9.2.1 Atomic coordinates for calculated S0  state of [Re(bpy)(CO)3Cl] 
# 
28 
Re    12.6254245418    -9.91988245522    -0.587361492846 
C    9.19983528015    -6.43833256705    0.396865128406 
C    8.98751846087    -7.78101209912    0.67440296002 
C    9.94168798728    -8.72795269728    0.297707730475 
N    11.0800458237    -8.3511571887    -0.333811042971 
C    11.2655020418    -7.05348654177    -0.625650941364 
C    10.3545777594    -6.06586032872    -0.282756046011 
C    8.64968101594    -10.7437605078    1.12131616739 
C    8.55237700754    -12.1211736836    1.25567071512 
C    9.57355140194    -12.9202688426    0.753028978281 
C    10.6671966923    -12.3016131979    0.166631593011 
N    10.7813417588    -10.9678579713    0.0603763439796 
C    9.77587947617    -10.182252169    0.517024132689 
C    13.8263326343    -11.4479030036    -0.546766314303 
C    14.1346040077    -8.74956386262    -0.95187623204 
Cl    12.8820767627    -9.57358870892    1.90106302781 
O    14.500991028    -12.3787215894    -0.498934904874 
O    14.9989977564    -8.01772355476    -1.15404909866 
C    12.3057077578    -10.1664521609    -2.4753312529 
O    12.111958807    -10.3130531873    -3.60548181863 
H    8.47004669736    -5.69939070385    0.702739912111 
H    8.0882970337    -8.08991425153    1.18753743009 
H    12.1807819271    -6.80962040142    -1.14671872718 
H    10.5573021872    -5.03300419328    -0.537425334817 
H    7.85775186597    -10.1085342145    1.49085560095 
H    7.68808851209    -12.5590831559    1.73873787723 
H    9.53559946251    -14.0005263253    0.81795878451 
H    11.4883779531    -12.8821427511    -0.230051763095 
# 
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9.2.2 Atomic coordinates for calculated T1  state of [Re(bpy)(CO)3Cl] 
# 
28 
Re -0.0003172 -0.85829331 0.04383135 
C 2.88364937 3.15939279 -0.19496315 
C 1.51878074 3.24650364 -0.22718674 
C 0.71090023 2.07927123 -0.15008624 
N 1.33470056 0.83200288 -0.04991423 
C 2.68812101 0.77795738 -0.00884221 
C 3.4969303 1.88397486 -0.07787974 
C -1.51262239 3.24986953 -0.22811579 
C -2.87770718 3.16519772 -0.1962238 
C -3.49321725 1.89135473 -0.07854224 
C -2.68623754 0.78379638 -0.0085773 
N -1.33326862 0.83578347 -0.04957717 
C -0.70712313 2.08105125 -0.15012066 
C -1.3488216 -2.31442935 0.17061182 
C 1.34655251 -2.31376434 0.17497826 
Cl -0.00871899 -0.6298173 2.45747972 
O -2.12215445 -3.15449379 0.24175705 
O 2.11956247 -3.15409646 0.24863774 
C -0.00133365 -0.91961989 -1.95211822 
O -0.00283221 -0.9537998 -3.09306255 
H 3.49065465 4.05650595 -0.25200434 
H 1.04469789 4.21663987 -0.30681753 
H 3.11511383 -0.21231264 0.0906567 
H 4.57280187 1.77142466 -0.03522275 
H -1.03646008 4.21883768 -0.30800992 
H -3.48274882 4.06346089 -0.25417957 
H -4.56913669 1.78081995 -0.03618527 
H -3.11510406 -0.20563926 0.09158748 
# 
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9.2.3 Atomic coordinates for calculated S0  state of [Re(3a’)(CO)3Cl] 
# 
28 
 
Re    12.2276270565    -10.0580080241    -0.665848337555 
C    13.2213020801    -11.5435580964    -1.41964271745 
C    12.8898641843    -10.47535643    1.09964494046 
N    9.68336705966    -6.86322555526    0.631143163611 
C    8.77135082056    -7.86336706895    0.565558395009 
C    9.50168540818    -8.9770501227    0.209033646421 
N    10.7996442449    -8.56865047031    0.0783776225771 
N    10.9136341037    -7.29975588655    0.334047743843 
C    7.91793749456    -10.9228823714    0.0771559116372 
C    7.72335815914    -12.2675610813    -0.205437994541 
C    8.82003240576    -13.0395527998    -0.5769796222 
C    10.0684796961    -12.4372195138    -0.654740012725 
N    10.2667161737    -11.135682541    -0.391908168694 
C    9.1962399987    -10.3799165005    -0.0382809816862 
C    13.721890769    -8.85155690843    -0.97491866241 
O    13.7722642918    -12.4604900724    -1.8465347247 
O    13.2819461877    -10.721650064    2.15941776983 
O    14.5798850215    -8.1077486277    -1.14581933795 
C    9.48281379217    -5.45476942792    0.952174423279 
Cl    11.1928515431    -9.47426890657    -2.8976569389 
H    7.72385833724    -7.70643137444    0.758658363207 
H    7.08973400208    -10.2953967734    0.380399786051 
H    6.73488192907    -12.7054511329    -0.136974132635 
H    8.71996588174    -14.0919467851    -0.809758287294 
H    10.9460407444    -13.0022439692    -0.93986137409 
H    10.4512023575    -4.9700294844    0.862833258698 
H    9.11020746039    -5.34579103405    1.97116162331 
H    8.78260371655    -5.00713521689    0.246823393098 
# 
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9.2.4 Atomic coordinates for calculated T1  state of [Re(3a’)(CO)3Cl] 
# 
28 
 
Re -0.14231111 -0.86426357 0.06778034 
C 0.82440758 -2.54895528 0.31436723 
C -0.12343055 -1.08837918 -1.90409506 
N -2.10492203 2.91826216 -0.04290307 
C -0.81280051 3.33420079 -0.09719666 
C -0.05780196 2.16228353 -0.08796617 
N -0.98059723 1.13536717 -0.02641633 
N -2.21093436 1.59558207 -0.00078419 
C 2.38230024 2.72601994 -0.13721878 
C 3.68475454 2.29083892 -0.18325624 
C 3.93119992 0.87692755 -0.21969403 
C 2.87715268 0.01420287 -0.18412886 
N 1.56445762 0.41031446 -0.11152124 
C 1.31584652 1.81363424 -0.12160552 
C -1.91309962 -1.82632582 0.12079541 
O 1.4001172 -3.52799637 0.47284459 
O -0.11679359 -1.22937532 -3.03944108 
O -2.92795975 -2.34720563 0.13723733 
C -3.30925339 3.73680465 -0.02841311 
Cl -0.31387518 -0.60569068 2.48734101 
H -0.54477794 4.37557047 -0.14219348 
H 2.15817953 3.78819236 -0.11296293 
H 4.50648773 2.99677545 -0.19408512 
H 4.93968425 0.48444645 -0.26548767 
H 3.03826032 -1.05665267 -0.19775937 
H -4.16265982 3.06382945 -0.02379922 
H -3.34170559 4.36707919 -0.91821437 
H -3.32931423 4.36003625 0.86659519 
# 
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9.2.5 Atomic coordinates for calculated S0  state of [Re(3b)(CO)3Cl] 
# 
28 
 
Re    12.3057444298    -10.731141806    -0.569495789395 
C    13.7451410601    -9.49533290289    -0.121307953385 
C    12.7506000382    -10.6131968254    -2.44604231139 
C    7.99228225922    -11.7069323933    -0.965419723589 
C    7.89774568777    -13.090472645    -1.00856595861 
C    9.06336248981    -13.8518565343    -0.981544910969 
C    10.2838234607    -13.2001559026    -0.917638533057 
N    10.3941262259    -11.8598078186    -0.871472814071 
C    9.25945648855    -11.1399927935    -0.883337385753 
C    13.4970341482    -12.2489278595    -0.360675983401 
O    14.5620515449    -8.73713264821    0.148399593242 
O    13.0076070194    -10.541367874    -3.56986519023 
O    14.1572513016    -13.186768042    -0.261842388876 
Cl    11.5383487193    -10.8606622689    1.83114969719 
N    9.44342820642    -9.74374557327    -0.812970920861 
N    10.7072643872    -9.2519378359    -0.73624464803 
N    10.6588079669    -7.96210699915    -0.704679822075 
C    9.35175416503    -7.56853568006    -0.755831129249 
C    8.56690651459    -8.69723137947    -0.822571937925 
C    8.98139752343    -6.12133347737    -0.726734278986 
H    7.11004947753    -11.0821908956    -0.992568038302 
H    6.92557726406    -13.5629828318    -1.06513804914 
H    9.03419012599    -14.9329580014    -1.00753670935 
H    11.2146583981    -13.747966389    -0.894777081221 
H    7.50080393453    -8.83038247286    -0.866969517801 
H    8.30185392636    -5.89926942942    0.0978590092436 
H    9.88538424241    -5.52958457801    -0.593394798576 
H    8.50198073011    -5.80572548818    -1.65572392328 
 
 
  
 279 
9.2.6 Atomic coordinates for calculated T1  state of [Re(3b)(CO)3Cl] 
# 
28 
 
Re -0.16867924 0.8679123 0.02497743 
C -1.86368941 1.81177884 0.32313779 
C -0.36678898 1.08393577 -1.93229687 
C 2.19518424 -2.87228249 -0.17352268 
C 3.52063026 -2.5133017 -0.17722709 
C 3.87345715 -1.14700685 -0.1178327 
C 2.86484254 -0.21027433 -0.07202588 
N 1.55178094 -0.52388794 -0.08380588 
C 1.21704768 -1.8566051 -0.11624787 
C 0.87015669 2.5885905 0.04165665 
O -2.86347578 2.33060299 0.51761988 
O -0.48527612 1.23531698 -3.06098627 
O 1.48596156 3.55042744 0.03572333 
Cl 0.23174064 0.81322065 2.44707011 
N -0.12221021 -2.1103466 -0.08580563 
N -1.00772542 -1.02600602 -0.05665366 
N -2.27774973 -1.49702173 -0.07631125 
C -2.21702457 -2.82249226 -0.08092385 
C -0.87907518 -3.25695135 -0.08496985 
C -3.45089955 -3.66424426 -0.08169125 
H 1.89604453 -3.91217575 -0.21508617 
H 4.28911918 -3.27686179 -0.22296441 
H 4.90780913 -0.82923195 -0.10473159 
H 3.09131417 0.84713951 -0.01952368 
H -0.44631365 -4.24124974 -0.05498523 
H -3.49476732 -4.30960865 0.80008945 
H -4.33096737 -3.02166659 -0.08075153 
H -3.4930571 -4.30905057 -0.96425939 
# 
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9.2.7 Atomic coordinates for calculated S0  state of [Re(3c)(CO)3Cl] 
# 
28 
 
Re    10.4610690743    -6.1087415519    -0.857243562047 
C    10.1270482127    -5.65927570052    -2.7079661406 
C    11.4535435541    -7.6975222563    -1.37182718333 
C    7.98017336651    -2.89059157926    0.859060015018 
N    7.19314111466    -3.96620124747    0.861711668047 
N    7.92850960433    -4.92111172751    0.295855346387 
N    9.15462573109    -4.5242953363    -0.0769324931078 
C    9.2133249544    -3.24386273598    0.267907921486 
C    6.26263056275    -6.68717768087    0.475760656513 
C    5.92772438798    -8.0045411736    0.20160908144 
C    6.84721281799    -8.82370314785    -0.45234235172 
C    8.0797106077    -8.29653045866    -0.801680559142 
N    8.42421234901    -7.02138978709    -0.542373351437 
C    7.51892136748    -6.24818831698    0.0779281396333 
C    12.0983585347    -5.07150361924    -0.872150372302 
O    9.9186027994    -5.38480841844    -3.81038089932 
O    12.0205398289    -8.65609564662    -1.65703813436 
O    13.0312238714    -4.3994878825    -0.854397118964 
C    7.5531232941    -1.57325433372    1.42214329044 
Cl    10.6917073772    -6.67198342167    1.58797794289 
H    10.1024285173    -2.65922994434    0.0993620835944 
H    5.59086406838    -6.00544810654    0.97541884051 
H    4.95734183081    -8.38888057658    0.490442672378 
H    6.62095107349    -9.85513971306    -0.691280584175 
H    8.82999776119    -8.89559914595    -1.2991382135 
H    7.19415014937    -1.6902792343    2.44656238654 
H    8.39052150154    -0.874529922518    1.43348228353 
H    6.74500286254    -1.12883540214    0.834739463439 
# 
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9.2.8 Atomic coordinates for calculated T1  state of [Re(3c)(CO)3Cl] 
# 
28 
 
Re 0.183963 0.89558152 0.01413156 
C 0.36001533 1.03862184 1.98459562 
C -0.882627 2.60230409 0.0750112 
C 2.0803109 -2.99150765 0.00181689 
N 0.74556406 -3.28028837 0.01926214 
N 0.14724137 -2.07334881 0.04079799 
N 1.03884223 -1.01221178 0.01989601 
C 2.27187827 -1.63101418 0.00979363 
C -2.14888457 -2.86132176 0.09061761 
C -3.47747193 -2.51681586 0.09660208 
C -3.84514819 -1.1506927 0.0800418 
C -2.85172797 -0.19963986 0.06439769 
N -1.53218066 -0.4998416 0.07031236 
C -1.19107965 -1.8275262 0.07034974 
C 1.86669585 1.86568464 -0.23923989 
O 0.45978078 1.14983334 3.11888964 
O -1.51161826 3.553748 0.12397405 
O 2.87267137 2.38721699 -0.40708493 
C 3.09576032 -4.08430713 -0.02954155 
Cl -0.20581893 0.95986254 -2.40082551 
H 3.17806754 -1.04923809 -0.0108402 
H -1.80593799 -3.88728874 0.09477148 
H -4.23879915 -3.2890105 0.10901849 
H -4.88272035 -0.842999 0.07173569 
H -3.09255492 0.85590019 0.04257671 
H 2.98942542 -4.69231953 -0.93218218 
H 4.10688453 -3.67526947 -0.01157784 
H 2.98032214 -4.75148455 0.82902045 
# 
 
